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Abstract 
 
Type 1 diabetes (T1D) is an autoimmune disease characterized by circulating 
autoantibodies, lymphocytic infiltration of pancreatic islets of Langerhans, and cell-
specific destruction of beta cells, leading to insulin deficiency and symptomatic 
hyperglycemia. Some of the major target autoantigens in T1D are intracellular 
proteins, such as GAD65, IA-2 and proinsulin, whose initial encounter with the 
immune system is poorly understood. 
Here we describe a method for culturing monolayers of primary pancreatic islet 
cells in vitro, which enables detailed observation of proteins and sub-cellular 
processes in primary human and rat beta cells by super-resolution and live-cell light 
microscopy. This technical advance is broadly applicable to obtaining novel biological 
insights as demonstrated by our identification of a mechanism to control proliferation 
in primary beta cells through growth and disassembly of primary cilia. 
This protocol also allowed us to identify two novel interrelated mechanisms for 
how beta cell proteins, such as the antigen GAD65, can become target of 
autoimmunity and initiate T1D. A triggering factor that these two pathways have in 
common is represented by endoplasmic reticulum (ER) stress, to which pancreatic 
islet beta cells are particularly susceptible, and can be induced by inflammatory 
factors such as Th1 cytokines.  
In the first mechanism, we show that ER stress in beta cells perturbs the 
palmitoylation cycle controlling GAD65 endomembrane distribution, resulting in 
aberrant accumulation of the palmitoylated form in Golgi membranes. The 
palmitoylated form has heightened immunogenicity, exhibiting increased uptake by 
antigen presenting cells (APCs) and T cell stimulation compared to the non-
palmitoylated form. Similar accumulation of GAD65 in Golgi membranes is observed 
in human beta cells in pancreatic sections from GAD65 autoantibody positive 
individuals, who have not yet progressed to clinical onset of T1D, and T1D patients 
? 6
with residual beta cell mass and ongoing T cell infiltration of islets. Thus, aberrant 
accumulation of immunogenic GAD65 in Golgi membranes facilitates inappropriate 
presentation to the immune system following release from stressed and/or damaged 
beta cells, triggering autoimmunity. 
In the second mechanism, we present that, following a pathway originating 
from the Golgi, both rat and human pancreatic islets release the intracellular beta cell 
autoantigens GAD65, IA-2 and proinsulin in a subtype of extracellular vesicles called 
exosomes. Islet-exosomes are then taken up by and can activate APCs including 
dendritic cells. Accordingly, anchoring of GAD65 to exosome-mimetic liposomes 
strongly boosts antigen presentation and T cell activation in the context of the human 
T1D susceptibility haplotype HLA-DR4. Furthermore, cytokine-induced ER stress 
enhances exosome secretion by beta cells, induces exosomal release of the 
immunostimulatory chaperones calreticulin, Gp96 and ORP150 and increases 
exosomal stimulation of APCs. Therefore, stress-induced exosomal release of 
intracellular autoantigens and immunostimulatory chaperones may play a role in 
initiation of autoimmune responses in T1D. 
 
Key words: 
Type 1 diabetes, pancreatic beta cells, autoantigens, GAD65, Golgi, ER stress, 
Th1 cytokines, exosomes, immunogenicity, ER chaperones   
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Riassunto 
 
Il diabete di tipo 1 è una malattia autoimmune caratterizzata dalla presenza di 
anticorpi circolanti, infiltrazione linfocitaria nelle isole di Langerhans e distruzione 
delle cellule beta pancreatiche, con conseguente insulino-deficienza e iperglicemia 
sintomatica. Alcuni dei più importanti autoantigeni nel diabete di tipo I sono proteine 
intracellulari come GAD65, IA-2 e la proinsulina. Le modalità tramite cui avviene 
l’incontro iniziale di questi antigeni con il sistema immunitario sono ancora poco 
conosciute.  
Nella presente tesi di dottorato viene descritto un metodo che permette la 
coltivazione in vitro di monostrati di cellule pancreatiche primarie. Con l’aiuto di 
tecniche di microscopia a super-risoluzione ed in tempo reale, tale metodo consente 
di effettuare osservazioni dettagliate su proteine e processi sub-cellulari in cellule 
beta pancreatiche di uomo o ratto. Questa tecnica può essere utilizzata per ottenere 
nuove conoscenze a livello biologico. Ad esempio, grazie a questo sistema, siamo 
riusciti a individuare un meccanismo di controllo della proliferazione mediato dalla 
crescita e successivo disassemblaggio delle ciglia primarie nelle cellule beta 
pancreatiche. 
Questo protocollo ci ha inoltre permesso di identificare due nuovi meccanismi 
interconnessi che spiegano come le proteine delle cellule beta pancreatiche, tra cui 
GAD65, possono diventare bersaglio dell’autoimmunità e portare all’insorgenza del 
diabete di tipo I. Un fattore scatenante, che questi due meccanismi hanno in 
comune, è rappresentato dallo stress del Reticolo Endoplasmatico (RE), al quale le 
cellule beta pancreatiche sono particolarmente suscettibili e che può essere indotto 
da fattori infiammatori come le citochine di tipo Th1.  
Riguardo al primo meccanismo, mostriamo che lo stress del RE nelle cellule 
beta pancreatiche perturba il ciclo di palmitoilazione che controlla la distribuzione di 
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GAD65 tra le membrane, causando un accumulo anormale della forma palmitoilata 
di questo antigene nel Golgi. Rispetto alla forma non palmitoilata, la proteina GAD65 
palmitoilata presenta una maggiore immunogenicità, viene più facilmente catturata 
dalle cellule presentanti l’antigene (cellule APC) ed è in grado di indurre una più forte 
stimolazione dei linfociti T. Un simile accumulo di GAD65 nelle membrane del Golgi 
è inoltre osservabile all’interno di cellule beta umane presenti in sezioni istologiche di 
pancreas derivate sia da individui pre-diabetici positivi per autoanticorpi contro 
GAD65 che da pazienti diabetici con massa beta cellulare residua ed infiltrazione 
linfocitaria nelle isole pancreatiche. Pertanto, l’accumulo anomalo di GAD65 nel 
Golgi, insieme al suo rilascio da parte di cellule in condizioni di stress e/o 
danneggiate, potrebbe facilitare la sua anormale presentazione al sistema 
immunitario, scatenando così il processo di autoimmunità. 
Il secondo meccanismo qui presentato mostra che, seguendo un percorso 
intracellulare che vede la sua origine nel Golgi, le isole pancreatiche umane e di ratto 
rilasciano gli autoantigeni intracellulari GAD65, IA-2 e la proinsulina in un sottotipo di 
vescicole extracellulari chiamate esosomi. Questi esosomi sono poi catturati da 
cellule APC, in particolare cellule dendritiche, inducendo la loro attivazione. 
Analogamente, la coniugazione di GAD65 a liposomi simil-esosomi (ovvero generati 
in maniera tale da mimare gli esosomi) porta alla presentazione di questo antigene e 
ad una forte attivazione delle cellule T in presenza dell’aplotipo HLA-DR4 correlato a 
suscettibilità al diabete. Inoltre, lo stress del RE indotto da citochine aumenta la 
secrezione di esosomi da parte delle cellule beta e delle proteine chaperone con 
proprietà immunostimolatorie (tra cui calreticulina, Gp96 e ORP150) ad essi 
associate e, di conseguenza, aumenta la stimolazione delle cellule APC. Pertanto il 
rilascio, indotto da stress e mediato da esosomi, di autoantigeni intracellulari e 
proteine chaperone immunostimolatorie potrebbe avere un ruolo importante nella 
generazione della risposta autoimmune. 
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CHAPTER 1 
Introduction 
1.1 BACKGROUND  
 
1.1.1   T1D and target islet autoantigens  
?
Type 1 Diabetes (T1D) results from the immune-mediated destruction of 
insulin-producing beta cells in the islets of Langerhans in the pancreas. Loss of 
pancreatic beta cells leads to a decrease in insulin production, elevated blood sugar 
levels (hyperglycemia) and the onset of T1D (1). The prevalence of T1D in humans 
between the ages of 0 and 19 years was reported to be 1.7 per 1000 and has been 
rising globally and by as much as 5.3% annually in the United States (2). 
Although the etiology of T1D is not fully understood, a well-accepted view is 
that T1D is an autoimmune disease caused by genetic and environmental factors (1). 
There are several lines of evidence showing the autoimmune nature of T1D. First, 
certain haplotypes of the human leukocyte antigen (HLA) have strong linkage with 
disease, especially HLA-DR3, DQ2 and HLA-DR4, DQ8 (2). These HLA genes are 
also associated with other autoimmune diseases, such as coeliac disease and 
rheumatoid arthritis (3,4). Second, the presence of circulating antibodies to islet 
autoantigens occurs many years before clinical onset of T1D (5), and these 
autoantibodies are predictive and diagnostic markers for the development of the 
disease (Figure 1). Third, lymphocytic infiltrates (insulitis) appear in the islets during 
the beta cell destruction and development of T1D. Finally, autoreactive CD4 and 
CD8 T cells recognizing islet antigens are often present in recently diagnosed 
diabetic patients and in high-risk subjects (5-7). 
The presence of autoantibodies and autoreactive T cells indicates that certain 
islet antigens are erroneously recognized as foreign resulting in induction of 
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autoimmunity against beta cells. The major antigens implicated in human T1D 
include (pro)insulin (8), GAD65 (9), ZnT8 (10) and IA-2 (11). 
In the next paragraphs, I will give a brief introduction to the major target 
antigens in human T1D.   
 
1.1.1.1   GAD65 and IA-2 
Early identification of the smaller isoform of the enzyme L-glutamic acid 
decarboxylase, GAD65, and a tyrosine phosphatase like protein, IA-2 as T1D 
autoantigens came from immunoprecipitation studies involving incubation of non-
ionic detergent solubilized human islets of Langerhans with sera from newly 
diagnosed T1D patients or controls, showing that the diabetic sera specifically 
recognize and precipitate conformational but not linear epitopes in a 64 kDa islet cell 
protein (12). Immunoreactivity to the 64-kDa antigen was observed in about 80% of 
new-onset T1D patients (12) and in pre-T1D subjects, and was found to be present 
several years before the clinical onset (13). Thereafter, an amphiphilic component of 
the 64-kDa autoantigen in T1D was identified as GAD65 (9) while a second 
component of the 64-kDa autoantigen was identified as IA-2alpha (14). Subsequent 
research on humoral autoimmunity in diabetes led to the development of new assays 
to detect autoantibodies against conformational and not linear epitopes of GAD65 
and IA-2. These assays are now widely used (15).  
 
1.1.1.2   GAD65 
GAD65 and a highly homologous second isoform of glutamic acid 
decarboxylase, GAD67, are the major synthesizing enzymes for production of the 
neurotransmitter gamma-amino butyric acid (GABA). GAD67 is not an independent 
autoantigen in T1D but is recognized by cross-reactive conformational GAD65 
antibodies in a fraction of patients (16). The GAD enzymes require a cofactor, 
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pyridoxal 5’-phosphate (PLP, activated vitamin B6) for activity and are principally 
found in GABAergic neurons. However, they are also expressed in other tissues 
such as ovary and testis, and especially in pancreatic islet beta cells (17).  
GAD67 is a constitutively active holoenzyme, stably bound to PLP, and 
produces the majority of brain GABA, while GAD65 fluctuates between a PLP-bound 
active holoenzyme and PLP-free inactive apoenzyme and is critical for fine tuning of 
GABAergic neurotransmission in response to changes in GABA demand (18). 
GAD65 and GAD67 have some differences in their structure, with GAD65 
having more flexibility in the carboxy-terminal region, a feature that has been 
suggested to play a role in its antigenicity (19). Early humoral autoimmune response 
to GAD65 in T1D has been detected against epitopes primarily in the middle and 
carboxyl terminal regions of GAD65 (20). While autoantibodies in T1D are an 
important marker for prediction and as a diagnostic tool, they are not believed to play 
a role in beta cells destruction, which is mediated by Th1 T-helper cells and cytotoxic 
T-cells (21). However, autoantigen-specific B lymphocytes seem to play an important 
role in uptake of autoantigen through their membrane bound immunoglobulin 
receptor and presentation to T cells (22). Interestingly, the epitope specificity of the B 
cell can enhance or suppress T cell epitopes (23). Additionally, structural 
crystallography studies aided by monoclonal antibody testing of antigenic 
determinants have indicated that the more flexible carboxy-terminal region of GAD65 
shows a close grouping of autoantibody and T cell antigenic determinants, raising the 
possibility that antigen–antibody complexes could contribute to GAD65-induced T 
cell reactivity (24). Although the importance of the middle region and the carboxyl 
terminus bearing major immunoreactive epitopes is recognized, epitope spreading to 
the amino-terminal region of GAD65 as well as to GAD67 can occur later (15). 
GAD65 is localized differently from the other autoantigens in beta cells (25), 
which are associated with dense-core insulin secretory granules. Analogous to 
neuronal cells, both GAD65 and GAD67 are initially synthesized as cytosolic proteins 
? 18 
in beta cells rather than the ER, and are subject to different translational regulation 
than proinsulin or other autoantigens contained in secretory granules (26). GAD65 
undergoes a two-step post-translational modification by hydrophobic residues. The 
first step results in a form that is weakly membrane associated and cycles on and off 
the cytosolic face of ER and cis-Golgi membranes. The second step involves 
palmitoylation of two cysteine residues in the amino-terminal region (27) and is 
required for trafficking of GAD65 through the trans-Golgi network (TGN) and 
targeting to synaptic vesicles in neurons (28) or small peripheral vesicles in beta cells 
(29). The hydrophobic modifications and consequent membrane anchoring of GAD65 
to GABA-secreting vesicles may be significant for its role as an islet autoantigen (15). 
In the last years, the Diamyd vaccine, based on the whole recombinant human 
GAD65 molecule suspended in alum, has provided an interesting development in the 
area of tolerance induction in T1D. Phase I clinical trials in late onset autoimmune 
diabetes in adults and adolescents with newly diagnosed type 1 diabetes have 
suggested benefit. Treatment with this vaccine seemed to induce a deviation of the 
GAD65–specific T cell response toward a protective immune profile and reduce C-
peptide decline in recently diagnosed patients (30). However, these observations 
were not confirmed in subsequent phase II and III clinical trials leading to the 
conclusion that, at for such a late intervention, induction of immune deviation of the 
GAD65 response to a more tolerogenic phenotype was not sufficient to block beta 
cell decline (30). 
 
1.1.1.3   IA-2  
IA-2 (also known as ICA512) is a transmembrane proteins located to the insulin 
secretory granule membrane in beta cells (15). Autoantibodies against this protein 
can be detected decades before diabetes onset in first-degree relatives of T1D 
probands (31). Due to epitope spreading, IA-2β (also known as phogrin) can become 
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target antigen in small groups of T1D patients who develop autoantibodies to cross-
reactive epitopes in IA-2 and phogrin. 
IA-2 and IA-2 β have domains with close homology (88%) to protein 
phosphotyrosine phosphatases (PTPs), although they do not seem to possess such 
enzyme activity. IA-2 and IA-2 β are both initially synthesized as proprotein 
precursors that are proteolytically processed in coordination with proinsulin (see 
below). The mature IA-2 and IA-2 β proteins are type 1 integral membrane proteins, 
with the PTP domain oriented on the cytosolic side of the granule membrane and a 
short amino-terminal domain located on the inside of the granule (15).  
The actual function of IA-2 and IA-2β remains unknown, although in beta cells 
it has been postulated that they may play a role in regulating insulin secretory 
granule content and possibly beta cell growth (15). Indeed, the IA-2 and IA-2β 
knockout mice are glucose intolerant and exhibit reduced insulin secretion (32). 
Deletion of IA-2 and/or IA-2β results in a marked decrease in the number of dense-
core vesicles (DCVs) in beta cells and a decrease in beta cell intracellular calcium 
handling (33). 
Naturally processed HLA class II allele-specific epitopes recognized by CD4 T 
cells were found to correspond to the intracellular domain of IA-2. These epitopes 
were identified after delivering the native IA-2 antigen to Epstein-Barr virus (EBV)-
transformed B cells followed by mass spectrometry analyses of eluted peptides (34). 
Dendritic cell subsets can facilitate the processing and presentation of IA-2 antigen to 
CD4 T cells. Specifically, at times near the onset of T1D, the plasmacytoid subset of 
dendritic cells is overrepresented in the blood compared to the myeloid cell type. 
Both dendritic cell subsets process and present soluble IA-2 to CD4 T cells, but only 
plasmacytoid dendritic cells show a distinctive ability to capture islet autoantigenic 
immune complexes and enhance autoantigen presentation in the presence of serum 
from IA-2 autoantibody-positive patient. This may suggest a synergistic 
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proinflammatory role for plasmacytoid dendritic cells and IA-2 autoantibodies in T1D 
(35). 
 
1.1.1.4   Insulin and proinsulin 
Functional variation of the INS gene promoter conferred by the variable number 
of tandem repeats (VNTR) polymorphism, or mutations at other genetic loci, can lead 
to reduced insulin expression in the thymus and lymphoid organs resulting in a loss 
of tolerance to insulin (36). In susceptible mice, both CD4 and CD8 T cell clones that 
recognize insulin can transfer the disease (37). 
Insulin represents up to 50% of the total production of beta cell protein under 
stimulated conditions (38). In beta cells, delivery of newly synthesized preproinsulin 
into the lumen of the ER is initiated by signal peptide binding to the signal recognition 
particle, followed by docking and translocation at the ER membrane, and cleavage of 
the signal peptide associated with completion of proinsulin biosynthesis (15). The 
preproinsulin signal peptide is one of the sites containing epitopes to which cytotoxic 
T lymphocytes and insulin autoantibodies can be directed (39,40). Subsequently, in 
the secretory pathway, coordinated proteolytic cleavages excise the C peptide of 
proinsulin to produce the mature two-chain hormone linked by two interchain 
disulfide bonds. The enzymatic reactions converting proinsulin to insulin occur 
primarily within immature secretory granules beginning at the time of their 
emergence from the trans-Golgi network (15). 
Pathogenic T lymphocytes in NOD mice developing autoimmune diabetes 
recognize an immunodominant epitope contained within residues S(B9)–G(B23) of 
proinsulin, and this is also true in patients with recent-onset T1D (41). In T1D 
patients with the HLA-DRB1*0401 (DR4) DQ8 haplotype, another immunodominant 
epitope has been reported within proinsulin, which includes the carboxy-terminal 
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portion of the C-peptide running through the endoproteolytic cleavage site contiguous 
with the A chain (42).  
Insulin-related peptides continue to attract great interest in tolerogenic vaccine 
development. An altered peptide ligand of the immunodominant insulin peptide 
S(B9)–G(B23) (NBI-6024; Neurocrine Biosciences) completed phase I trials with a 
suggestion of immunologic efficacy (43) but was not effective in phase II trials (44). 
Phase I studies based on intradermal administration of the proinsulin peptide 19-A3 
have been completed, reporting that the treatment was safe and well tolerated but 
not particularly effective (45). 
The human clinical trials conducted to date using insulin as a therapeutic or 
prophylactic immunotherapy have shown disappointing results. Indeed, although 
clinical trials based on oral and intranasal administrations of insulin in recent-onset 
diabetic individuals showed reduced insulin-specific T cell responses, none of them 
was able to induce significant differences in C-peptide level between the treated and 
control groups (46). 
 
1.1.1.5   ZnT8 
Beta cells maintain an unusually high level of cellular zinc, and the most 
consistently expressed beta cell zinc transporter is ZnT8 (encoded by SLC30A8), a 
369 amino acid poly-topic, dimeric membrane protein whose pancreatic expression is 
concentrated in the islets (47). In beta cells, ZnT8 resides primarily in the membrane 
of insulin secretory granules where it serves to take up zinc that forms a complex 
with insulin molecules. ZnT8 has been shown to be a target of humoral autoimmunity 
in a large fraction of newly-onset T1D patients (48). SLC30A8 polymorphisms have 
been found associated with both type 2 (49) and type 1 diabetes (50). Autoantibodies 
against ZnT8 as well as T cell responses against ZnT8 are produced in patients who 
develop autoimmune diabetes (15). 
? 22 
In turn, ZnT8 expression in beta cells is down-regulated by cytokines, and this 
down-regulation has been proposed to play a role in beta cell dysfunction and 
apoptosis (15). Beta cells express several different zinc transporters. While the 
specific role of ZnT8 in beta cell physiology remains poorly understood, it appears to 
play a role in optimum secretion and storage of insulin. Thus, ZnT8-deficient mice 
display a decrease in glucose-stimulated insulin secretion (51) and develop glucose 
intolerance when fed a diabetogenic diet (52). Furthermore, knock-down of ZnT8 in 
beta cell lines results in a decrease in glucose stimulated insulin secretion (53), and 
double knockdown of ZnT8 and ZnT3 (another zinc transporter abundant in insulin 
secretory granules (54)) reportedly triggers cell death in pancreatic beta cell lines 
(55), perhaps owing to cytosolic or nuclear zinc intoxication. Altogether, these studies 
indicate that downregulation of ZnT8 expression can contribute to beta cell 
dysfunction and diminished survival, whereas its exposure as an autoantigen can 
trigger immune responses (15). 
 
Figure 1. Type 1 diabetes risk stratification by islet autoantibody properties.  
Increase in T1D risk is associated with progression of islet autoantibodies from single to multiple 
autoantibodies. Characteristics of the initial antibody response can help predict disease progression. 
(IAA, insulin autoantibodies; GAD65, glutamic acid decarboxylase 65; IA-2, islet-associated 
autoantibody 2; ZnT8, zinc transporter 8) (from 56). 
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1.1.2   Animal models in T1D 
Multiple animal models are available to study immune-mediated diabetes. The 
spontaneous models, the Biobreeding (BB) rat and the non-obese diabetic (NOD) 
mouse have been instructive for elucidating basic molecular mechanisms involved in 
autoimmune destruction of pancreatic beta cells. However, these models do not 
carry human MHC-class II molecules and the nature of the primary target antigens 
differ from the human disease, except that insulin seems to have a major role in T1D 
in the NOD mouse (57). 
In NOD mice, diabetes development starts at 5 weeks of age with an initial 
insulitis that manifests by means of leukocytic aggregates at the perimeter of the 
islets and a lymphocytic infiltration into the pancreatic islets. The dominant initial 
insulitis population consists of CD4 T cells and is followed by infiltration of CD8 T 
cells, macrophages and B cells in smaller numbers. The majority of female NOD 
mice develop diabetes by 12-40 weeks, but incidence in males is lower (57). The 
NOD mouse has several features, which distinguish it from the human disease. First, 
many islet autoantigens in NOD mice are different from those targeted in the human 
T1D (58). For example, distinct from humans and rats beta cells, mouse pancreatic 
beta cells do not express detectable levels of one of the major autoantigen in the 
human disease, GAD65, but they express the 67kDa isoform of GAD (59). In 
addition, the induction of organ-specific autoimmunity in humans may be caused by 
human pathogens and/or toxins, while autoimmunity seems to be the default 
mechanism in the NOD mouse (57) and infections block the development of 
autoimmunity and disease. 
In the case of the BB rat, spontaneous T cell mediated diabetes is significantly 
distinct from the human disease in that it is accompanied by autoantibodies to 
lymphocytes and a severe lymphocytopenia, which is essential for development of 
beta cell autoimmunity and diabetes in this model (57).  
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In an attempt to develop better models of diabetes, ‘humanized’ transgenic 
mice that express diabetes-susceptibility human MHC-class II molecules were 
developed. Since these animals did not develop spontaneous diabetes, many were 
backcrossed into the NOD background. However, such backcrossing failed to induce 
diabetes in most cases (57,60).  
Other animal models of T1D, some of them carrying human MHC-class II 
diabetes-susceptibility genes, were developed by inducing expression of ectopic 
antigens in pancreatic islets using the rat insulin promoter (RIP). While diabetes did 
not develop spontaneously in those models, autoimmunity and beta cell destruction 
was induced following immunization with the ectopic antigen or infection with a virus 
expressing the antigen (57).  
Pharmacological models are also available. These diabetes-inducible models 
take advantage of alloxan and streptozotocin (STZ), which are toxic glucose 
analogues that preferentially accumulate in pancreatic beta cells via the GLUT2 
glucose transporter. Alloxan and high doses of STZ selectively kill the insulin-
producing beta cells, whereas multiple low doses of STZ generate H2O2 and induce 
expression of GAD65 and GAD67 autoantigens, triggering beta cell-specific 
autoimmunity (57). 
 
1.1.3   ER stress in T1D 
There is a growing experimental evidence suggesting that dysregulation of the 
endoplasmic reticulum (ER) homeostasis contributes to T1D pathogenesis through 
multiple potential mechanisms that eventually lead to beta cell death (38,61-63). For 
example, acute and chronic stimulation of beta cells by nutrients such as glucose, 
arginine, or lipids, induces the production of large amounts of insulin, which places a 
continuous demand on the ER for increasing protein synthesis, folding, trafficking 
and secretion. When the folding capacity of the ER is exceeded, misfolded or 
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unfolded proteins accumulate in the ER lumen, triggering the unfolded protein 
response (UPR) (64). The UPR is an integrated response program that reduces 
translation, increases chaperone availability, and enhances the degradation of 
misfolded proteins in an attempt to restore ER homeostasis (64). Although 
physiological stimulation of the UPR may be beneficial for beta cell function and 
acute adaptation to stress, severe or prolonged ER stress response that fails to 
reestablish homeostasis results in induction of apoptosis (65,66). In experimental 
animal models and in humans, mutations in genes critical for ER function result in 
beta cell failure and severe early-onset diabetes (67,68). In fact, misfolded insulin 
alone can cause diabetes in both mice and humans (69,70). Pro-inflammatory 
cytokines produced by islet-infiltrating immune cells also lead to beta cell destruction 
by direct cytotoxicity and enhancement of immune recognition (38). Putative 
inflammatory mediators of beta cell loss in T1D, such as interleukin-1beta (IL1β), 
tumor necrosis factor-alpha (TNFα) and interferon-gamma (IFNγ), were all shown to 
induce ER stress through several intracellular pathways (71,72), leading to the 
depletion of ER calcium, dysfunction of ER chaperones, and a severe disruption in 
ER homeostasis (73). Thus, cytokine-induced alterations in ER function can affect 
cell adaptation and amplify pro-apoptotic pathways. Reciprocally, chronic ER stress 
can engage stress and inflammatory pathways through activation of c-Jun N-terminal 
kinase (JNK), inhibitor of nuclear factor kB kinase (IKK), and protein kinase R (PKR), 
and this low-grade chronic inflammation may also contribute to eventual islet 
destruction (62). 
Indicators of ER stress are present in inflamed islets of both diabetes-prone 
NOD mice (74) and patients with T1D (75). Viral infection, environmental toxins, 
chronic inflammation, abnormal protein folding, and a surplus of nutrients all can 
cause ER stress and trigger the UPR (76). In addition, when stress is prolonged and 
unresolved, the UPR can engage apoptotic pathways. The canonical UPR operates 
through inositol-requiring protein 1 (IRE1), protein kinase RNA-like ER kinase 
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(PERK), and activating transcription factor 6 (ATF6), all of which are localized in the 
ER membrane and respond to stress by relaying signals from the ER to the 
cytoplasm and nucleus.  
A recent study showed the importance of ER stress and the beneficial effects 
of restoring organelle function through using a UPR-modulating chemical chaperone 
in the context of T1D in the NOD mouse (64). 
 
1.1.4   Posttranslational modifications in T1D 
A total of 20 amino acids constitute the building blocks of human proteins, but 
this number increases to more than 140 building blocks after accounting for 
posttranslational modifications (PTM) through enzymatic modifications (e.g. 
deamidation, citrullination, glycosylation) and nonenzymatic (spontaneous) 
modifications (e.g. methylation, carbamylation, oxidation, nitration). Data on PTM of 
islet autoantigens is emerging. In T1D, both citrullinated and deamidated 
autoantigens have been identified, indicating a role for peptidylarginine deiminases 
(PADs) and tissue transglutaminase (tTG) respectively, in the generation of islet neo-
autoantigens (77). 
In human islets, tTG is active during insulin secretion, acting on cytosolic, 
mitochondrial and nuclear substrates (78). Therefore, islets have the potential to 
generate neo-autoantigens through tTG-mediated deamidation. Inflammatory stimuli 
can result in deamidation of the proinsulin C-peptide (79). T cells reactive to this 
deamidated C-peptide were found in patients with T1D (80), linking neo-antigen 
generation in human islets with the induction of autoreactive T cells. tTG is also 
present in cells of the myeloid lineage and direct vesicular transfer of islet material to 
resident antigen presenting cells (APCs) has been demonstrated in both mice and 
humans, suggesting that islet proteins can be deamidated by tTG during antigen 
processing within the APC (81). PAD expression and activity have not been 
? 27 
investigated in human islets, but APCs, such as human monocytes and 
macrophages, contain both PAD2 and PAD4 transcripts and active PAD2 and PAD4, 
indicating that cells of the monocytic lineage have the potential to citrullinate self-
proteins (82). 
HLA binding is a key factor in the selection of processed (neo)epitopes 
presented by APC and beta cells. The genetic association of T1D with HLA-DQ can 
potentially be explained by the deamidating function of tTG, which creates more 
negatively charged peptides that can be exceptionally potent HLA-DQ binders. 
Indeed, deamidation of a naturally processed and presented peptide of preproinsulin 
(PPI) enhanced binding to HLA-DQ2/8 molecules and specifically to DQ8trans, a 
heterodimeric HLA molecule composed of the DQ2 alpha and DQ8 beta chains, and 
patient T cell responses (IFNγ) were increased after stimulation with the deamidated 
PPI peptide (80). Citrullinated GAD65 peptides displayed enhanced binding to HLA-
DR4 and were recognized by autoreactive CD4 T cells isolated from patients with 
T1D (83). Citrullinated glucose-regulated protein 78 was identified as a modified 
autoantigen in murine beta cells and was a target for autoreactive T cells in mice 
(84). Citrullination could increase the binding affinity to predisposing HLA molecules 
by making the peptide more acidic, resulting in enhanced immunogenicity. The 
common factor linking these modifications is the increase in HLA binding affinity that 
results from PTM. As such, stringent selection of a high-affinity TCR repertoire 
against modified islet proteins is likely to play a role in T1D pathogenesis (77). 
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1.1.5   Extracellular vesicles and exosomes in T1D 
Exosomes (EXOs) are small (diameter 30-100nm) biologically active vesicles 
that are secreted in the extracellular space by many different cell types (85). Thanks 
to their biological composition, these vesicles, particularly enriched in lipid raft 
containing cholesterol and sphingomyelin, are highly stable in body fluids, including 
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blood, saliva and urine (86). Many studies of EXO proteomics have been performed 
and the possible application of these extracellular vesicles as novel disease 
biomarkers is drawing considerable interest in numerous fields of research (87). The 
molecular mechanism of EXO biogenesis is not fully understood, but is believed to 
share a common pathway involving formation of multivesicular bodies (MVBs). 
Indeed, in addition to the conventional pathway based on the fusion of MVBs with 
lysosomes for degradation, MVBs can fuse with the plasma membrane releasing 
EXOs in the extracellular space (85). 
EXOs can display immunostimulatory or immunoregulatory functions (85,88). 
For example, vaccination with tumor antigen-loaded EXOs resulted in tumor rejection 
in an antigen-specific manner (89). In the context of T1D, EXOs released by the 
mouse insulinoma cell line MIN6 were able to stimulate autoreactive T cells in NOD 
mice (90). These EXOs contain insulin and possibly GAD65, although we have been 
unable to detect any GAD65 in MIN6 cells (Chapter 4). Moreover, EXOs from MIN6 
cells were found to stimulate autoreactive marginal zone-like B cells accumulating in 
prediabetic NOD mice (91). The same group also showed that islet mesenchymal 
stem cell-like cells produce immunostimulatory EXOs that can activate autoreactive T 
and B cells in NOD mice (92). 
In addition to exosomes, other types of extracellular vesicles (EVs) have been 
described. Among these, the best known are microparticles (MPs), also called shed 
vesicles or microvesicles (MVs), and apoptotic bodies. MPs present irregular shape 
and have a size between 100 and 1000 nm (93). They are released by budding of 
the plasma membrane upon activation of cell surface receptors or apoptosis and 
subsequent increase of intracellular calcium (94). MPs are mainly produced by 
platelets, red blood cells and endothelial cells, and they have been shown to have a 
pro-coagulant activity (95), a role in IL1β secretion (96) and in promoting tumor 
invasiveness (97). Compared to other extracellular vesicles, apoptotic bodies are the 
least characterized. They are 1-5 μm in diameter and are released as blebs of cells 
? 29 
undergoing apoptosis (93). They are generally characterized by phosphatidylserine 
externalization (due to its exposure in the outer leaflet of the plasma membrane 
during apoptosis) and may contain fragmented DNA (98). Examples of key functions 
of apoptotic bodies are horizontal transfer of oncogenes (99) and DNA (100). In vitro 
experiments have shown that apoptotic bodies can also deliver T cell epitopes that 
are presented on MHC I molecules upon uptake by phagocytic cells (101). 
Furthermore, apoptotic bodies seem to be involved in the presentation of 
autoantigens to B cells (102). Uptake of apoptotic bodies has been shown to lead to 
immunosuppression (93). Protocols capable of isolating the different types of EVs, 
especially exosomes, are available, although potential contaminations among 
different extracellular vesicles need to be carefully addressed (93).  
In the study by Palmisano et al. (103), EXOs and MPs were shown to be 
released by a rat insulinoma cell line, especially during cytokine-induced apoptosis. A 
quantitative study of proteins from cell-derived EVs, using stable isotope labeled 
amino acids (SILAC) in cell culture combined with mass spectrometry, mapped the 
most distinctive changes in protein content between EVs generated with and without 
cytokine stimulation to several cell death and cell signaling molecules. These 
included TNF receptor superfamily member 1A, TNF, alpha-induced protein 3, TNF-
interacting kinase receptor-interacting serine-threonine kinase 1 and intercellular 
adhesion molecule (103). Despite this increasing interest in studying EXOs and MPs 
in the context of T1D, no studies aimed at extensively characterizing the proteomics 
of EVs released by primary pancreatic islets have been reported thus far. 
 
1.1.6   Bioengineering approach to designing synthetic exosome mimetics 
Purification of EVs, especially exosomes, from cell culture supernatants is 
hampered by several disadvantages, such as very low yield and limited 
reproducibility among different preparations. The realization that synthetic exosome 
? 30 
mimetics may overcome these issues opens potential applications in numerous fields 
of research, such as drug delivery, gene therapy, vaccine design and treatment of 
autoimmune and inflammatory diseases.      
It is possible that not every component in natural exosomes is required for 
specific and efficient delivery of cargo to the target cell. By extensive characterization 
of the lipid, protein, and nucleic acid content of exosomes, functional components 
could be used for selective conjugation or incorporation in synthetic exosome 
mimetics. Given that natural exosomes exist as spherical lipid bilayer structures, 
liposomes would provide a logical basis for the generation of exosome mimetics 
(104).  
Similar to exosomes, liposomes are bilayered phospholipid structures with 
adjustable diameters around 100 nm (from 25 nm to 2.5 μm), which can be loaded 
with a variety of proteins, nucleic acids or drug molecules. The liposome bilayer can 
be composed of either synthetic or natural phospholipids. The predominant physical 
and chemical properties of a liposome are based on the net properties of the 
constituent phospholipids, including permeability, charge density and steric 
hindrance. The lipid bilayer closes in on itself due to interactions between water 
molecules and the hydrophobic phosphate groups of the phospholipids. This process 
of liposome formation is spontaneous because the amphiphilic phospholipids self-
associate into bilayers. Loading of proteins into liposomes can be achieved through 
(i) liposome formation in an aqueous solution saturated with a soluble drug; (ii) the 
use of organic solvents and solvent exchange mechanisms; (iii) the use of lipophilic 
drugs; and (iv) pH gradient methods. In addition, liposomes can easily be 
manipulated by adding additional molecules to the outer surface of the lipid bilayer 
(105).  
Liposomes have been shown to be valuable tools in drug delivery; several 
liposome-based drug delivery systems are currently in preclinical development and 
clinical trials, while others have been approved for clinical development. Production 
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of exosome mimetics is more easily scalable for use in preclinical or clinical settings. 
In addition, the assembly process of exosome mimetics is controllable and results in 
the formation of “clean”, well characterized drug delivery systems with high 
pharmaceutical acceptability. Moreover, the use of exosome mimetics allows us to 
study the effect of each component separately. However, the components which are 
likely to be required for proper functioning of exosome mimetics as drug delivery 
systems are not yet well defined in the literature (104). Thus, elucidating the 
mechanisms by which exosomes mediate intracellular delivery of biomolecules may 
also identify design strategies to guide the development of synthetic exosomes (106).  
Exosomes are enriched in sphingomyelins, cholesterol, glycolipid GM3, and 
glycerophospholipids with long and saturated fatty acyl chains. Rigid lipid 
compositions such as those of exosomes may increase circulation stability of lipid 
particles, which may be beneficial for increasing liposome half-life in the blood. Some 
exosomal components, including phosphatidylserine, integrins and tetraspanins, 
increase uptake by recipient cells. Exosomes also display complement inhibitors 
CD55 and CD59, which minimize exosome lysis upon incubation with serum. Since 
liposome-mediated activation of complement can induce lethal immune stimulation, 
incorporation of complement inhibitors found in exosomes may increase the safety of 
liposomes (106). 
In conclusion, in the effort to elucidate physiological roles and biophysical 
properties of exosomal components, liposomes could be valuable tools for displaying 
defined exosomal components, either individually or in combination. This would allow 
for a better understanding of the isolated effects of each component of exosomes, as 
well as providing a method for discovering potential synergistic effects between 
combinations of components (106). 
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1.2   OVERVIEW OF THE THESIS 
The reasons for the loss of tolerance to beta cell antigens and the activation of 
autoreactive T cells in T1D are not fully understood. Before lymphocytic infiltration 
(insulitis), physiological islet abnormalities have been described in both humans and 
in animal models, such as upregulation of inflammatory cytokines (107) and 
increased endoplasmic reticulum (ER) stress in beta cells (74). It is well known that 
cytokines and other cytolytic components can induce beta cell stress and death 
(108). In addition, these factors may also lead to alterations in the normal trafficking 
pathways of the islet antigens resulting in their release in the extracellular space. The 
main target autoantigens in the human disease, insulin, proinsulin, GAD65, ZnT8 and 
IA-2, are proteins expressed in pancreatic beta cells. Except for insulin that is 
released by exocytosis of secretory granules, the other target autoantigens are 
intracellular membrane proteins, thus potentially not visible by the immune system 
(15). The mechanisms underlying how these antigens can be recognized by the 
immune system, taken up by APCs and presented to self-reactive T cells are not 
clarified yet.  
The present PhD thesis results from the combination of three scientific 
manuscripts, whose overall purpose is the identification of the possible mechanisms 
underlying the development of autoimmunity in T1D. 
The first manuscript presented here is the description of a novel methodology 
for culturing monolayers of pancreatic endocrine cells dissociated from human and 
rat islets of Langerhans. Inspired by culture techniques normally applied to neurons 
(with which endocrine islet cells share many similarities), we were able to overcome 
the difficulties in obtaining high-quality monolayers of dissociated islet cells, thus 
allowing the application of high resolution imaging techniques and the visualization of 
intracellular biological phenomena with un unprecedented level of clarity and 
resolution. This procedure made possible most of the observations reported in the 
subsequent two manuscripts reported here.  
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In the second publication, we show that ER stress induced by pro-inflammatory 
factors or saturated fatty acids leads to a block in the palmitoylation cycle of the 
antigen GAD65 and a consequent accumulation of the palmitoylated form of this 
protein in Golgi membranes. The palmitoylated form of GAD65 is highly 
immunogenic and can stimulate a stronger activation of GAD65-specific T cells 
compared to the form not carrying this post-translation modification. In addition, 
accumulation of GAD65 in Golgi membranes seems to occur in humans during T1D, 
as demonstrated by direct observation on human beta cells in pancreatic sections 
from both GAD65-autoantibody positive individuals right before the onset of the 
disease and in T1D patients with ongoing T cell infiltration in the islets.  
The third manuscript, which constitutes the core of my thesis project, illustrates 
a possible mechanism by which intracellular beta cells antigens, such as GAD65, IA-
2 and proinsulin, might be released in extracellular vesicles, especially exosomes, 
and consequently become potential target of the immune system. The route of 
antigen release seems to involve an exosomal pathway originating from the trans-
Golgi network (TGN). Once released, such exosomes can be taken up by APCs 
resulting in their activation. In addition, cell stress induced by pro-inflammatory 
cytokines increases the release of islet-exosomes and fosters the association of pro-
inflammatory ER proteins with the autoantigens, conditions that overall could 
potentially contribute to the initiation of autoimmunity.  
We also adopted bioengineering approaches to design exosome-mimetic 
liposomes carrying relevant features of pancreatic islet-derived exosomes. Using this 
platform, we were able to show that the activation of autoantigen-specific T cells is 
about 50 times stronger when antigens, such as GAD65, are associated to exosome-
like structures compared to when they are present in the extracellular space in the 
form of free proteins. 
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CHAPTER 2 
 
Advances in pancreatic islet monolayer culture permit 
super-resolution microscopy and reveal a cilia-centric 
mechanism of beta cell proliferation 
Adapted from the original manuscript 
Edward A. Phelps*, Chiara Cianciaruso*, Jaime Santo-Domingo, Miriella Pasquier, 
Gabriele Galliverti, Lorenzo Piemonti, Ekaterine Berishvili, Andreas Wiederkehr, 
Jeffrey A. Hubbell, Steinunn Baekkeskov 
* These authors contributed equally to this work 
 
2.1   ABSTRACT 
The field of islet cell biology has been hampered by insufficient techniques to 
culture monolayers of primary islet cells on glass coverslips for study by light 
microscopy. Guided by an observation that dispersed islet cells spread and adhere 
well on surfaces in neuronal co-culture, we demonstrate that in the absence of 
neurons, well-defined surface coatings combined with components of neuronal 
culture media collectively support robust monolayers of primary human or rat islet 
cells on glass surfaces. The resultant islet cell monolayers stably maintain endocrine 
cell phenotype and exhibit glucose-sensitive calcium signaling similar to whole islets. 
This technical advance enabled detailed observation of sub-cellular processes in 
primary human and rat islet cells by super-resolution and live-cell light microscopy. 
The protocol is broadly applicable to obtaining novel biological insights as 
demonstrated by our identification of a mechanism to control proliferation in primary 
beta cells through growth and disassembly of primary cilia. 
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2.2   INTRODUCTION 
Light microscopy is a cornerstone of cell biology facilitating the understanding 
of how cells function. Powerful staining methods permit the labeling of specific 
molecules within live and fixed cells and the emergence of super-resolution 
techniques continue to push the boundaries of scientific discovery through light 
microscopy. Yet, applications of the latest advanced imaging techniques in the field 
of pancreatic islet biology have been hampered by the limitations of resolving sub-
organelle level structures in intact islets and an inability to culture dissociated primary 
islet cells on the surface of glass coverslips (1-3). Imaging targets in close proximity 
to the surface of glass coverslips are a general requirement for visualization with high 
power objectives. Super-resolution microscopy techniques (4) such as stimulated 
emission depletion (STED) microscopy, which permit the sub-diffraction limit 
discernment of biological structures, require cells to be grown on 0.17 mm glass 
coverslips for optimal performance and are incompatible with plastic substrates. 
While cell lines derived from pancreatic endocrine tumors such as INS-1 (5) and 
MIN6 (6) are amenable for culturing on glass, they have lost many of the 
characteristics of primary beta cells. A robust method enabling generation of primary 
islet cell monolayers on glass, particularly from human islets, would represent a 
major advancement for high-resolution light microscopy studies of islet cells and 
allow detailed imaging of subcellular activities such as insulin granule secretion, 
calcium signaling, mitochondrial function or cytoskeletal dynamics.  
Previous efforts to generate two-dimensional cultures of dispersed primary islet 
cells include surface coatings of extracellular matrix (ECM) secreted from 804G rat 
bladder carcinoma cells (2,3,7), HTB-9 human bladder carcinoma cells (3,8,9), A-431 
human epidermoid carcinoma cells (10), and bovine corneal epithelial cell matrix 
(BCEM) (3,10,11). While somewhat effective for promoting primary islet cell adhesion 
on tissue-culture treated plastic surfaces, these cell-line ECMs do not permit 
sufficient islet cell adhesion on glass surfaces, particularly when islet cells are 
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cultured in traditional islet media. In addition, cell-line derived ECMs have a high 
batch to batch variability and are sub-optimal for sensitive biological studies of single 
islet cells as they are poorly characterized and have been shown to promote de-
differentiation of beta cells (9,12).  
Pancreatic islet endocrine cells display a protruding primary cilium proposed to 
play a role in glucose homeostasis, insulin signaling and risk of developing type 2 
diabetes (13). Primary cilia act as major hubs for cell signaling, cell differentiation, 
and cell polarity. Disassembly of primary cilia precedes entry into the cell cycle for 
many cell types (14,15). Islet beta cells are mainly quiescent and identification of a 
protocol to promote proliferation and expand beta cell mass in vitro for treatment of 
diabetes is a major goal (16). Intriguingly, factors reported to induce proliferation of 
insulin-producing beta cells such as increased Wnt/beta-catenin signaling (17,18), 
Rho Kinase (ROCK) inhibition (18) and overexpression of Aurora Kinase A (19) are 
also implicated in pathways controlling primary cilia function, formation and/or 
disassembly. In mouse embryonic fibroblasts ciliary disassembly leads to nuclear 
translocation of beta-catenin and activation of transcription factors responsible for 
cell cycle progression, while the presence of primary cilia restrains Wnt/beta-catenin 
signaling (20). ROCK inhibition leads to cilia resorption through promoting 
cytoskeletal rearrangements, basal body repositioning and centrosome splitting 
(21,22). Furthermore, the beta cell mitogenic protein Aurora Kinase A stimulates cell 
cycle progression by specifically mediating cilia disassembly in multiple cell types 
(14,23). 
In this study, we show that defined surface coatings of collagen IV or laminin 
combined with a cell culture medium with features formulated for primary neurons 
promotes superior adhesion, spreading and viability of human and rat islet cell 
monolayers respectively while retaining key features of differentiated islet endocrine 
cells. Analyses of such monolayer cultures of primary islet cells on glass by high 
resolution microscopy enabled visibility of cilia expression and length on primary beta 
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cells and the identification of a mechanistic correlation between disassembly of 
primary cilia and stimulation of beta cell proliferation. 
 
2.3   METHODS 
2.3.1   Islet isolation and culture 
Rat islets were isolated from pancreases of P5 Sprague Dawley rats (Charles 
River) as previously described (11) except using Liberase TL (Roche) for pancreas 
digestion. Hand-picked islets were cultured at 37°C in 10 cm non-adherent cell 
culture dishes (500 islets/dish) in islet basal medium: RPMI 1640 medium with 
GlutaMAX (Gibco), 11 mM glucose, 10% fetal bovine serum (FBS). One-percent 
Penicillin/Streptomycin was added to the islet basal medium for whole islet culture 
but not for islet cell monolayer culture. 
Human pancreatic islets were obtained through the European Consortium on 
Islet Transplantation, (ECIT), Islets for Basic Research Program. Human islets were 
cultured at 24°C in 10 cm non-adherent cell culture dishes (500 islets/dish) in CMRL 
medium with 2% glutamine, 10% FBS, 10 mM HEPES and 1% 
Penicillin/Streptomycin. Human islets used in this study were obtained from three 
normal non-diabetic donors, two male and one female, ranging in age 18-59 years 
with a body mass index of 20-29 kg/m2. 
 
2.3.2   Co-culture of islet cells and neurons 
Primary rat hippocampal neurons were prepared from P2-P3 Sprague Dawley 
rats, as described by Codazzi et al. (24). Neurons were seeded on round poly-L-
ornithine-coated glass or Thermanox coverslips (Nunc), at 100,000 cells per 
coverslip in a 24-well plate and in 1 ml of neuronal medium: Minimum essential 
medium (MEM) with GlutaMAX (Gibco), 11 mM glucose, 5% FBS, 1 mM sodium 
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pyruvate, 10 mM HEPES and 1X B-27 Supplement (25) (Gibco). One day after 
isolation, 3 μM of the chemotherapeutic agent ARA-C (Sigma-Aldrich) was added to 
the culture medium to eliminate astrocytes and obtain a neuronal culture of high 
purity (> 90% neurons). Three-four days after preparation of a neuronal culture, 
without changing the medium, a suspension of either human or rat islet cells was 
prepared as described below, and 50,000 islet cells in 50 µL of neuronal medium 
were added per well to the established neurons. 
 
2.3.3   Preparation of matrix-coated coverslips 
Lab-Tek 4-well Chambered Coverglass (Nunc, Thermo Fisher Scientific) were 
used for live/dead cell staining. Round 12 mm diameter and 0.17 mm thickness 
borosilicate glass coverslips (Electron Microscopy Sciences) were used for 
immunofluorescence staining. Coverglass-bottom Fluorodishes (World Precision 
Instruments) and MatTek dishes (MatTek Corporation) were used for live cell 
imaging experiments. Glass surfaces were coated with purified laminin (Gibco) or 
purified collagen IV (Sigma Aldrich) at 50 µg/ml in HBSS with Ca2+/Mg2+ for 1 hour at 
37°C, then washed 3x in HBSS with Ca2+/Mg2+. HTB-9 matrix was generated from 
HTB-9 human bladder carcinoma cells (ATCC) grown to 95% confluence, lysed with 
20 mM NH4OH + 0.5% Triton X-100 in pyrogen-free water, followed by three washes 
in pyrogen-free water. Coverslips were also prepared with Poly-L-ornithine coating 
(400 µg/ml). 
 
2.3.4   Preparation of human and rat islet cell monolayer cultures  
Within one week of isolation, rat or human islets were hand-picked from 
suspension cultures, collected in a 15 ml tube and washed twice in PBS without Ca2+ 
and Mg2+ (Gibco). Islets were dissociated into a suspension of single islet cells by 
continuous gentle pipetting in 0.3 ml 0.05% trypsin-EDTA (Gibco) per 500 islets for 3 
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minutes at 37°C. Trypsin digestion was halted by adding neuronal or islet basal 
medium to a total volume of 15 ml, followed by pelleting of islet cells by centrifugation 
for 5 min at 800 rpm (47 x g) and resuspension in neuronal or islet basal medium. 
Islet cells were seeded on matrix-coated surfaces at approximately 35,000 cells/cm2 
in neuronal medium for all experiments except for groups indicated as seeded in islet 
basal medium. Islet cells required 3-4 days of culture to adhere and spread on 
surfaces before further experimentation. While typically not necessary, elimination of 
fibroblast like cells in human islet cell monolayer cultures maintained for 7 days or 
longer, could be achieved by adding 3 μM of ARA-C to the culture medium one day 
after islet cell seeding. ARA-C was used for establishing the neuronal cultures 
seeded with islet cells in Figure 1 and for islet cell monolayer cultures shown in 
Supplementary Figure 1. 
 
2.3.5   Live / dead cell staining 
Calcein AM (2 µM), ethidium homodimer-1 (4 µM) and Hoechst 33342 (8 µM) 
(Molecular Probes) were added directly to cell monolayers without removing culture 
media to avoid removal of non-adherent cells. Cells were incubated for 30 minutes at 
room temperature and imaged live with a Zeiss LSM700 confocal microscope with 
20x/0.8 NA Plan-Apochromat air objective. Analyses of cell adhesion, spreading and 
viability were performed in ImageJ (26). 
 
2.3.6   Immunofluorescence staining 
Human pancreas sections obtained from the Network for Pancreatic Organ 
Donors with Diabetes (nPOD case ID #6174 and 6230) were deparaffinized followed 
by acidic-pH heat-mediated antigen retrieval according to the nPOD standard 
operating procedure for immunopathology (27). Whole islets, monolayers of 
pancreatic islet cells and co-cultures of islet cells and neurons were fixed with 4% 
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EM-grade PFA (Electron Microscopy Sciences) at room temperature for 20 minutes 
or 1 hour, respectively. Samples were blocked and permeabilized in PBS + 0.3% 
Triton X-100 with 10% goat or donkey serum. Primary antibodies were incubated 
overnight at 4°C. Alexa Fluor 405, 488, 568, and 647 conjugated secondary 
antibodies (Molecular Probes) were incubated at 1:200 dilution in 0.3% Triton X-100 
in PBS for 30 minutes at room temperature. Coverslips were mounted with ProLong 
Gold Antifade Reagent (Molecular Probes). Immunostained whole islets were 
handled in 1.5 ml Eppendorf tubes by centrifugation between immunostaining steps 
and mounted beneath glass coverslips.  
For alpha-tubulin staining, cells were washed in 37°C PHEM buffer (60 mM 
PIPES, 25 mM HEPES, 10 mM EGTA, 4 mM MgSO4), fixed for 10 min at 37°C in 
3.2% EM-grade PFA (Electron Microscopy Sciences) with 0.05% EM-grade 
glutaraldehyde (Electron Microscopy Sciences), washed three times with PBS and 
permeabilized for 15 min with 0.3% TX-100 in PBS. Unreacted aldehydes were 
quenched by 3 x 10 min washes with 1 mg/mL sodium borohydride in PBS. 
Immunostaining was performed as above. 
 
2.3.7   Microscopy 
Standard confocal microscopy was performed on multi-color immunostained 
samples on a Zeiss LSM700 confocal microscope with 20x/0.8 NA Plan-Apochromat 
air, 40x/1.30 and 63x/1.40 NA Plan-Apochromat oil-immersion objectives. 
Super-resolution microscopy was performed on rat and human islet cell 
monolayers cultured on laminin (for rat) or collagen IV (for human) coated 0.17 mm 
thickness glass coverslips. Cells were immunostained for insulin detected with Alexa 
Fluor 488 secondary antibody and alpha tubulin detected with Alexa Fluor 532 
secondary antibody; or stained for actin with Alexa Fluor 488 phalloidin (Molecular 
Probes). STED super-resolution microscopy was performed on Leica TCS SP5 
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STED CW white light laser (WLL) and Leica SP8 STED 3X microscopes with HC PL 
APO 100x/1.40 NA oil immersion objectives, 488 nm WLL excitation line with 592 nm 
depletion laser or 532 nm WLL excitation line with 660 nm depletion laser, Hybrid 
detector (HyD) with timing gate 1.0-6.5 ns, and with 21 nm/pixel xy resolution. 
Images were processed and measured in ImageJ (26). 
3D-SIM microscopy was performed on a Nikon N-SIM configured Nikon Eclipse 
Ti inverted microscope with Apochromat total internal reflection fluorescence (TIRF) 
100x/1.49 NA objective and electron-multiplying charge-coupled device camera 
(EMCCD, IXON3; Andor Technology) at 512 x 512 pixels with 63 nm/pixel resolution 
in the x,y coordinates and 60 nm/voxel resolution in the z coordinate. Super-
resolution images were reconstructed using built-in algorithms of NIS-Elements 
software (28). Reconstruction parameters were: contrast 0.70; apodization 1.00; and 
Widh3DFilter 0.20. 
Live-cell imaging of insulin granule motility was measured in rat islet cell 
monolayers transfected with pVenus-N1-NPY plasmid (NPY-Venus) (29,30) plasmid 
using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, 1-5 
minute time-lapse videos with 730 ms temporal resolution were captured during 
static incubation in KREBS buffer with 2 mM or 11 mM glucose, on a Leica TCS SP5 
WLL microscope with HCX PL APO CS 100x/1.46 NA oil immersion objective. 
Automated particle-tracking analysis and diffusivity constant calculations were 
performed on 60 s clips from each time-lapse video using the Mosaic Particle 
Tracker 2D plugin (31) for ImageJ. 
Cytosolic Ca2+ was measured in monolayer cultures of rat islet cells transduced 
with adenovirus encoding the Cameleon ratiometric Ca2+ sensor YC3.6cyto (32) under 
the control of the rat insulin promoter (Ad-RIP-YC3.6cyto) (33). Rat islet cells, cultured 
for four days in neuronal medium on laminin-coated MatTek dishes, were infected 
with 3x106 infectious units (IFU) Ad-RIP-YC3.6cyto adenovirus for 24h at 37°C. Two 
days after infection, rat islet cell monolayers were washed 4 times in Krebs-Ringer 
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bicarbonate HEPES buffer (KRBH): 140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 
0.5 mM MgSO4, 1.5 mM CaCl2, 10 mM HEPES, 5 mM NaHCO3, 2.5 mM glucose, pH 
7.4. Calcium imaging was performed in a thermostatic chamber at 37°C on a 
DMI6000 B inverted fluorescence microscope with HCX PL APO 40x/1.30 NA oil 
immersion objective (Leica), Evolve 512 EMCCD (Photometrics), BP436/20 nm 
excitation filter, and BP480/40 nm and BP535/30 nm emission filters. Small volumes 
of concentrated solutions were added by hand to cells in KRBH at the given time 
points to produce a final concentration of 16.7 mM glucose, 100 µM diazoxide, or 35 
mM KCl. Fluorescence ratios were calculated in MetaFluor 7.0 (Meta Imaging 
Series). 
Counting of primary cilia in beta cells and analyses of cilia length were 
performed on images acquired with a Leica DM5500B fluorescence microscope with 
a 40x air objective. Analyses of beta cell density were performed on images captured 
with Olympus Slide Scanner VS120-L100 with a 10x/0.40 UPLSAPO air objective.  
For transmission electron microscopy (TEM), Co-cultures of islet cells with 
neurons or whole rat islets were fixed in 2.5% glutaraldehyde / 2.0% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 2 hours, washed with 
cacodylate (0.1 M, pH 7.4), post-fixed for 40 min in 1.0 % osmium tetroxide, followed 
by 40 min wash in 1% uranyl acetate in water, dehydrated through increasing 
concentrations of alcohol and embedded in Durcupan ACM (Sigma Aldrich). Sections 
(50 nm thickness) contrasted with lead citrate and uranyl acetate were imaged on a 
Tecnai Spirit microscope with Eagle CCD camera (FEI Company). 
 
2.3.8   Antibodies 
The following unconjugated primary antibodies were used for 
immunofluorescence staining: guinea pig anti-insulin (Linco 4011-01) 1:10,000 (for 
STED and SIM microscopy); chicken anti-insulin (Abcam ab14042) 1:2000 (for multi-
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color confocal microscopy); GAD6, a mouse monoclonal antibody specific for GAD65 
(34) 1:1000; chicken anti-MAP2 (Abcam ab5392) 1:10,000; sheep anti-somatostatin 
(Abcam ab35425) 1:200; rabbit anti-pancreatic polypeptide (Abcam ab113694) 
1:1000; rabbit anti-Ki67 (Abcam ab16667) 1:100; mouse anti-beta actin (Sigma 
A1978) 1:500; rabbit anti-calnexin (Abcam ab22595) 1:200; rabbit anti-alpha-tubulin 
(Abcam ab18251) 1:200; guinea-pig anti-PDX1 (Abcam ab47308) 1:2000; mouse 
anti-NKX6-1 (Developmental Studies Hybridoma Bank F55A12s) 1:6; mouse anti-
acetylated alpha tubulin (Sigma T7451.) 1:1000; rabbit anti-pericentrin (Abcam 
ab4448) 1:5000. 
 
2.3.9   Cilia-disassembly and beta cell proliferation 
Neonatal rat islet monolayers were established during an initial 3-day culture 
period in complete neuronal medium with 11 mM glucose. To encourage cilia 
formation and growth, culture medium was replaced with serum and B-27-free 
neuronal medium containing 5.5 mM or 11 mM glucose for 36 hours. To induce cilia 
reabsorption and cell cycle progression following serum starvation, medium was 
replaced with complete neuronal medium containing 11 mM or 17 mM glucose 
and/or 15 μm ROCK inhibitor Y-27632 for 36 hours followed by fixation of cells in 4% 
EM-grade paraformaldehyde (PFA) for analysis. 
 
2.3.10   Statistical analyses 
Means among three or more groups were compared by analysis of variance 
(ANOVA) in GraphPad Prism 6 software. If deemed significant, Tukey’s post-hoc 
pairwise comparisons were performed. Means between two groups were compared 
by Student t test. A confidence level of 95% was considered significant. Statistical 
significance of the data is indicated as follows: * P < 0.05, ** P < 0.01, *** P < 0.001, 
ns no significant difference. 
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2.3.11   Ethical approval 
Animals were used under EPFL animal regulation guidelines and an IACUC 
approved protocol. Human islets were received from the University Hospital of 
Geneva and San Raffaele Scientific Institute, Milan through the ECIT islets for basic 
research program and were approved by the Institutional Review Board of the 
University Hospital of Geneva (CER Nr. 05–028) and by the Ethics Committee of the 
San Raffaele Scientific Institute of Milan (IPF002-2014). Human pancreatic sections 
obtained via the nPOD tissue bank, University of Florida, Gainesville, FL, USA were 
harvested from cadaveric organ donors by certified organ procurement organizations 
partnering with nPOD in accordance with organ donation laws and regulations and 
classified as “Non-Human Subjects” by the University of Florida Institutional Review 
Board (35,36). EPFL grants permit for the use of human material as long as the 
provider can certify that the samples were obtained according to local laws and 
regulations, as well as good practices in the country were they were collected. 
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2.4   RESULTS 
 
2.4.1   Co-culture of primary islet cells with primary hippocampal neurons  
Pancreatic islets are innervated by the autonomic nervous system posing 
intriguing questions about the role of neuronal signaling in islet function and the 
possibility of sensory feedback of islet activities (37). We questioned whether co-
culture with primary neurons would support the growth of monolayers of primary 
pancreatic islet cells. When islet cells derived from dispersed human or rat islets 
were seeded in minimum essential medium (MEM) containing 5% FBS and 2% B-27 
medium supplement onto established cultures of rat neurons on glass coverslips, the 
seeded islet cells exhibited excellent cell adhesion and spreading (Figure 1A), far 
surpassing the quality of islet cell monolayer cultures we had previously produced on 
HTB-9 or bovine corneal epithelial cell ECM (11). Islet cells seeded in neuronal 
culture medium on poly-ornithine coated glass but without neurons failed to adhere 
(Figure 1B). The islet cells cultured with neurons formed an interconnected network 
with readily apparent neuronal-islet cell contacts observed by immunostaining for 
insulin, the beta cell and GABA-ergic neuronal cell marker GAD65, and the neuronal 
cell marker MAP2 (Figure 1C, D). By transmission electron microscopy (TEM), we 
identified neuronal axons forming synapse-like structural interactions with islet 
endocrine cells, including insulin producing beta cells (Figure 1E). The islet-neuronal 
experiment, while raising intriguing questions for future studies of this system, 
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importantly established that conditions in the co-culture provided primary islet cells 
with adhesion and survival factors enabling high quality islet cell monolayers on glass 
substrates. 
 
Figure 1. Neuron and rat islet cell co-culture.  
(A) A representative transmitted light image of rat islet cells (magenta) co-cultured with rat neurons 
(blue) on polyornithine-coated coverslips in neuronal medium, pseudocoloring added to highlight cell 
types identified by morphology. (B) A Representative transmitted light image of rat islet cells seeded 
alone on polyornithine-coated coverslips in neuronal medium. (C) Co-culture of neurons and rat islet 
cells immunostained for insulin expressed in beta cells, GAD65 expressed in both beta cells and in the 
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soma and axons of GABA-ergic neurons, and MAP2 expressed in dendrites of all neurons. (D) Co-
culture of neurons and human islet cells immunostained for insulin, expressed in beta cells, GAD65 
expressed in beta cells and in the soma and axons of GABA-ergic neurons and MAP2 expressed in 
dendrites of all neuronal cells. (E) TEM image of rat islet cells co-cultured with rat neurons showing 
synapse-like cell junctions (arrow) between neuron (blue) containing synaptic vesicles and a beta cell 
(magenta) containing insulin granules, pseudo-coloring added to highlight cell types. 
 
2.4.2   Monolayer primary islet cell culture in neuronal medium with defined 
surface-coating 
We hypothesized that ECM deposited by the neuronal cultures could be a key 
factor enabling the impressive primary islet cell adhesion. Integrin subunit β1 is 
highly expressed in islet cells (1,10,38-41) and mediates islet cell-adhesion to laminin 
(42) and collagen IV (39) which are abundant in the ECM of native islets (43). We 
investigated the potential of purified laminin or collagen IV as a surface coating to 
replace neurons and the importance of culturing islet cells in medium formulated for 
primary neurons.  
 Glass coverslips were coated with laminin or collagen IV, followed by seeding 
single neonatal rat or adult human islet cells in either neuronal medium or islet basal 
medium. We also prepared uncoated coverslips and coverslips coated with 
polyornithine or HTB-9 matrix. Both human and rat islet cells required culture in 
neuronal medium for strong attachment and spreading, and failed to adhere to any 
glass surface coating when cultured in islet basal medium (Figure 2). When grown in 
neuronal medium, rat islet cells attached and spread well on both laminin and HTB-9 
matrix but not on other surface coatings (Figure 2A-D). Rat islet cell density was 
40% higher on laminin than on HTB-9 matrix. Laminin and HTB-9 matrix supported 
comparable levels of rat islet cell spreading. Viability of rat islet cells was high across 
all conditions. In contrast to rat islet cells, human islet cells grown in neuronal 
medium attached and spread best on collagen IV and did not adhere well to laminin 
(Figure 2E-H). Human islet cell spreading on HTB-9 matrix was higher than for the 
other conditions except for collagen IV, however human islet cell density on HTB-9 
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matrix was low. Neuronal medium promoted increased viability of human islet cells 
compared to islet basal medium on all surface coatings. The HTB-9 matrix promoted 
the attachment and proliferation of fibroblast-like cells, particularly from human islets. 
These fibroblast-like cells were also observed in low numbers in human islet cells 
cultured on collagen IV, but did not appear to interfere with endocrine cell attachment 
or survival. For long-term culture of human islet cell monolayers, it was possible to 
largely eliminate the fibroblast-like cells by adding the chemotherapeutic drug ARA-C 
to the culture medium (Supplementary Figure 1). 
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Figure 2. Optimization of primary islet monolayer conditions.  
Monolayer cultures of rat (A-D) and human (E-H) islet cells 4 days after seeding onto glass coverslips 
with different coatings. (A, E) Representative confocal images of rat (A) and human (E) islet cells grown 
in neuronal media stained with calcein AM (live cells), ethidium homodimer 1 (dead cell nuclei) and 
counterstained by Hoechst 33342 (total nuclei). White arrows indicate fibroblast-like non endocrine cells. 
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(B-D, F-H) Quantification of islet cell density (B, F), islet cell spreading (C, G) and islet cell viability (D, 
H) for rat (B-D) and human (F-H) islet cells cultured in neuronal or islet basal media. Mean ± SEM (n = 6 
image random fields per condition). Statistical analysis by one-way ANOVA (** p < 0.01, *** p < 0.001, 
Tukey’s post-hoc pairwise comparisons of coated versus uncoated cover slips in the same medium 
condition). 
 
2.4.3   Monolayer primary islet cell cultures retain key characteristics of 
differentiated endocrine cells 
Human and rat islet cell monolayers organized into clusters of differentiated 
endocrine cells expressing endocrine hormones glucagon, insulin, somatostatin and 
pancreatic polypeptide in alpha, beta, delta, and PP cells, respectively, which 
occurred in similar proportions as in native islets (Figure 3A-D). Insulin-positive beta 
cells in human and rat islet cell monolayers maintained high nuclear expression of 
the beta cell markers PDX1 and NKX6.1 after 2 weeks of monolayer culture (Figure 
3E-H). No bihormonal expressing cells were observed. After a week of culture, 
considerable proliferation of neonatal rat islet beta cells grown on laminin was 
observed in neuronal but not islet basal medium by Ki67 staining (Supplementary 
Figure 2A, B). Proliferation in adult human islet beta cells grown on collagen IV in 
neuronal medium was extremely rare (Supplementary Figure 2C). Standard 
confocal microscopy on islet cell monolayers stained for insulin, the neuroendocrine 
GABA-synthesizing enzyme GAD65, and the endoplasmic reticulum marker calnexin 
enabled detailed imaging of subcellular structures unresolvable on whole islets 
(Supplementary Figure 2D) and revealed islet monolayer cells adopting typical 
polarized polyhedron morphology (44) and rosette-like micro-societies (44) 
(Supplementary Figure 2E).  
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Figure 3. Maintenance of endocrine cell phenotype in primary islet monolayer cultures.   
(A) Rat islet cells cultured for four days on laminin-coated coverslips in neuronal medium and (B) 
human islet cells cultured for four days on collagen IV-coated coverslips in neuronal medium and 
immunostained for glucagon, insulin, somatostatin and pancreatic polypeptide (PP) to identify islet 
alpha, beta, delta and PP cells, respectively. Left image panels show monolayer islet cell cultures. 
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Middle panels show increased magnification of the encircled regions in the left panel. Right panels show 
native islets from sections of rat and human pancreas. (C, D) Quantification of cell type distribution in rat 
(C) and human (D) islet cell monolayers and pancreatic tissue sections. Mean ± SEM (n = 6 random 
image fields from each of 2 different donors). Statistical analysis by Student’s t-test (ns, no significant 
difference). (E, F) Expression of beta cell markers PDX1 and NKX6-1 persist 2 weeks after seeding in 
monolayers in rat (E) and human (F) cultures. Arrows indicate lack of PDX1 and NKX6.1 expression in 
insulin-negative cells. Mean ± SEM (n = 6 random image fields). Images are representative of 3 
independent experiments. (G) Quantification of PDX1 and (H) NKX6.1 expression in insulin-positive and 
insulin-negative islet cells in rat and human islet cell monolayer cultures. 
 
To test the functionality of primary islet cell monolayers, we acquired time-lapse 
videos of cytosolic calcium signaling in primary rat beta cells expressing the cytosolic 
Cameleon Ca2+ sensor YC3.6cyto (32) under the control of the rat insulin promoter 
(Ad-RIP-YC3.6cyto) (Figure 4A-C). The beta cells in the islet cell monolayers 
displayed characteristic islet-like calcium signaling behavior. Calcium transients were 
absent under resting glucose (2.5 mM) conditions whereas rhythmic coordinated 
calcium spikes were observed in response to glucose stimulation (16.7 mM) and 
depolarization with KCl caused a large calcium rise. High-glucose stimulated calcium 
signaling was abolished by maintaining the ATP-dependent K+ channels in its open 
state using diazoxide. Together, these data indicate that differentiated primary 
endocrine cell phenotypes are maintained in our monolayer culture system.  
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Figure 4. Functional calcium-responsive glucose sensing in islet cell monolayer cultures.  
(A) Rat islet cell monolayers transduced with adenovirus to express Cameleon cytosolic Ca2+ sensor 
YC3.6cyto under the control of the rat insulin promoter. Top panel shows localization of YC3.6cyto in the 
cytosol. Bottom panel shows wavelike propagation of Ca2+ signaling between adjacent beta cells during 
high glucose stimulation. (B) A representative Ca2+ imaging experiment in primary rat beta cells showing 
simultaneously-recorded Ca2+ traces from 41 beta cells in a single field-of-view. Lower panel shows 
strongly coordinated Ca2+ activity in subsets of beta cells during 16.7 mM glucose stimulation. Each 
color represents an individual cell recording (6 cell traces shown). Colors do not correspond to those in 
(A). (C) Quantification of the number of beta cells transiting Ca2+ per min during recording experiments 
shown in (B). Mean ± SD (n = 3 independent experiments). Statistical analysis by one-way ANOVA (*** 
p < 0.001, Tukey’s post-hoc pairwise comparisons). 
 
2.4.4   Live-cell microscopy of plasmid-transfected primary islet cell cultures 
We acquired time-lapse videos of insulin vesicular trafficking dynamics in 
primary rat beta cells transfected with the insulin-granule targeting neuronal peptide 
NPY-Venus (30), (Figure 5A-D). We observed characteristic glucose concentration-
dependent behavior of insulin granule motility. In low glucose (2 mM), insulin 
granules appeared to be completely static within the beta cell. Under high glucose 
stimulation (11 mM), insulin granules exhibited high intracellular motility. Glucose-
dependent motility of insulin granules was previously reported with lower image 
resolution in insulinoma cells (45) and whole islets (46) and attributed to interactions 
between insulin granules and microtubule and actin cytoskeleton networks (47) that 
reorganize in response to glucose stimulation. We measured microtubule network 
spacing in rat islet monolayers by confocal microscopy and confirmed the previous 
reports that inter-microtubule spacing and insulin granule motility are both inversely 
correlated with glucose concentration (Figure 5E-G). 
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Figure 5. Live-cell imaging of insulin granule dynamics in rat islet cells monolayers.  
(A) Representative still frames from time-lapse live-cell confocal microscopy videos of NPY-Venus 
labeled insulin granules during exposure to KREBS buffer containing 2 mM or 11 mM glucose. Dashed 
line indicates cell outline. (B) Particle tracking analysis of 1-min clips of time-lapse of NPY-Venus 
labeled insulin granule movement showing particle tracks. Dashed line indicates cell outline. (C) 
Increased magnification of NPY-Venus particle tracks of bounded region shown in (B). (D) Diffusion 
coefficients of insulin granules calculated from particle tacking analysis of NPY-Venus. Mean ± SD (n = 
3 independent experiments) Statistical analysis by Student's t-test (*** p < 0.001).  (E) Representative 
confocal images of primary rat beta cells fixed after exposure to 2.5 mM or 16.7 mM glucose for 1 h and 
immunostained for α-tubulin. (F) Quantification of microtubule density in confocal images of rat beta 
cells following exposure to 2.5 mM or 16.7 mM glucose for 1 h displayed as a 15-bin histogram. 
Statistical analysis by one-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, Tukey’s post-hoc pairwise 
comparisons respective to 2.5 mM glucose condition of same bin-width). (G) Same data as in F, but 
displayed as a 2-bin histogram. Statistical analysis by Student’s t-test (** p < 0.01). 
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2.4.5   Super-resolution microscopy of primary islet cell cultures  
We performed STED super-resolution imaging of insulin granules, 
microtubules, and actin filaments in primary rat and human islet cells (Figure 6 and 
Supplementary Figure 3). The size of insulin granules and cytoskeletal features 
imaged by STED demonstrate successful sub-diffraction limit imaging of cellular 
structures on length-scales below the resolving power of traditional light microscopy, 
in agreement with measurements made by transmission electron microscopy (TEM) 
(Supplementary Figure 4). STED imaging of insulin on human beta cells fixed 
following a brief incubation in high glucose revealed individual insulin granules 
docked at the plasma membrane (Figure 6E). We observed that the cell-cell 
interface between adjacent beta cells is characterized by a dense cortical actin 
network (Figure 6F) which is implicated in the recruitment and docking of secretory 
granules (44). We also captured three-dimensional (3D) super-resolution images of 
human islet beta cells immunostained for insulin by the alternative super-resolution 
method of structured illumination microscopy (SIM) (48) (Figure 6G). To our 
knowledge, this is the first example of high-quality super-resolution microscopy of 
primary human beta cell monolayers. 
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Figure 6. Super-resolution microscopy techniques applied to islet cell monolayers on glass.  
(A) Representative confocal and STED super-resolution microscopy images of rat islet cell monolayers 
immunostained for insulin. Right panels show increased magnification of the boxed regions in the left 
panels. (B) Representative intensity profile measurement across a group of three insulin granules 
according to confocal or STED microscopy. Feature sizes measured as full width at half maximum. (C) 
Size distribution of insulin granules as measured by confocal, STED or TEM microscopy. (D) 
Comparison of confocal and STED super-resolution microscopy portrait of a human islet beta cell 
monolayers immunostained for insulin and α-tubulin. Inset frames show higher magnification of boxed 
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region. (E) STED image of insulin granule recruitment and docking to plasma membranes at a cell-cell 
interface in rat islet cell monolayers following a brief exposure to high glucose. (F) STED image of the 
cortical F-actin network at a cell-cell interface in human islet cell monolayers. (G) 3D-SIM super 
resolution microscopy of a human islet beta cell, immunostained for insulin. (H) Representative STED 
image of insulin granules in a human beta cell. (I) Representative STED image of α-tubulin in a human 
beta cell. (J) Representative STED image of F-actin in a rat beta cell. 
 
2.4.6   Induction of beta cell proliferation by repression of primary cilia 
formation 
To take advantage of the technical development described above, islet cell 
monolayer cultures on glass were used to observe primary cilia by immunostaining 
for the cilia marker acetylated alpha tubulin and the centrosomal protein pericentrin 
(Supplementary Figure 5 and Figure 7). The new method enabled identification of 
individual cilia-expressing beta cells, the length of their cilium and the subcellular 
localization of ciliary proteins. 
We noted that the percentage of ciliated beta cells was 3 fold higher in human 
islet cell monolayers compared to neonatal rat islet cell monolayers (48% vs 16% of 
insulin-positive cells) (Figure 7A, B). Because analyses of expression of the 
proliferative marker Ki67 indicated a lower rate of proliferation of adult human beta 
cells than neonatal rat beta cells (Supplementary Figure 2), we speculated that the 
lower incidence of primary cilia in rat islet cells might reflect differences in cell cycle 
status between the two cultures. In support of this hypothesis, we observed that 
primary cilia were uniformly absent from proliferating Ki67-positive rat islet beta cells 
(Figure 7C, D), indicating an inverse correlation between presence of cilia and beta 
cell proliferation state. Furthermore, images of primary beta cells undergoing cell 
division showed acetylated alpha tubulin localized to the mitotic spindle during 
mitosis rather than in ciliary structures (Figure 7E). Together these observations 
implicate an inverse correlation between the presence of primary cilia and cell cycle 
progression in primary beta cells. 
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Figure 7. Presence of primary cilia inversely correlates with beta cell proliferation.  
(A) Percentage of insulin-positive beta cells with primary cilia in rat and human islet monolayer cultures. 
Mean ± SEM (n = 10 random image fields from each of two different donors). Statistical analysis by 
Student’s t-test (*** p < 0.001). (B) Representative confocal images of rat and human islet cells 
immunostained for insulin and the cilia marker acetylated alpha tubulin. (C) Percentage of proliferating 
beta cells positive for both Ki67 and insulin with and without primary cilia in rat islet cells. Mean ± SEM 
(n = 10 random image fields per group). Statistical analysis by Student’s t-test (*** p < 0.001). (D) A 
representative confocal image showing unciliated proliferating Ki67-positive rat insulin-positive cells 
(arrowheads) and a group of Ki67-negative beta cells with cilia (arrows). (E) Confocal images showing 
the localization of acetylated tubulin during metaphase and telophase in mitotic beta cells. 
 
We next asked if adaptation of a two-step protocol to drive cilia disassembly 
based on nutrient withdrawal and reintroduction (49) could be exploited as a 
mechanism to induce proliferation of primary beta cells (Figure 8A). Low glucose 
concentration causes islet cells to become more rounded, while high glucose culture 
medium causes the opposite effect, enhancing the adhesion and spreading of 
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primary islet cells (50). We tested the effect of high and low glucose on cell shape in 
our rat islet cell monolayer cultures and confirmed the dramatic effect on islet cell 
shape obtained by switching the glucose concentration from 11 mM to 5.5 mM 
(rounded cells) or from 5.5 mM to 11 mM (extended well adhered cells) 
(Supplementary Figure 6 and results not shown). Cytoskeletal rearrangements, 
occurring when cells transition shape from rounded to extended highly-spread shape, 
have been shown to drive cilia reabsorption in human retinal cells and promote re-
entry into the cell cycle (22). Furthermore, the ROCK inhibitor Y-27632, which 
induces a repositioning of the basal bodies below the nucleus, thus reducing 
ciliogenesis (22), has been reported to have mitogenic effects on beta cells (18). We 
employed a two-step protocol to induce beta cell rounding and elongate cilia, 
followed by a second step re-initiating cell spreading simultaneously with cilia 
disassembly. We focused these experiments on neonatal rat islet cell monolayer 
cultures due to the rarity of Ki67-positive beta cells in human islet monolayer 
cultures. 
 Neonatal rat islet cell monolayers were established in neuronal medium 
containing 11 mM glucose. After three days in culture, cells were subjected to serum 
and B27 starvation for 36 hours to induce ciliogenesis in either 5.5 mM or 11 mM 
glucose. To induce cilia disassembly, serum and B-27 were reintroduced and 
glucose concentration increased from 5.5 mM to 11 mM or from 11 mM to 17 mM in 
the presence or absence of the ROCK inhibitor Y-27632 (Figure 8A, B).  
Fluorescence analyses of cells at the different stages of the protocol revealed a 
rounding effect of serum and B-27 starvation in 11 mM glucose, which was reversed 
during the cilia disassembly phase (Figure 8B). Analyses of Ki67 expression at 
different stages of the protocol (Figure 8C), revealed ~6% of beta cells proliferating 
in the initial seeding phase. The percentage of proliferating cells decreased during 
the starvation phase but rebound during the cilia disassembly phase. Thus, 
increasing glucose from 11 mM to 17 mM following the starvation phase significantly 
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increased beta cell proliferation over the initial seeding with ~15% of beta cells being 
Ki67 positive. Addition of the ROCK inhibitor Y-27632 enhanced the proliferative 
effect slightly but not significantly to ~16% in this condition. Omitting the starvation 
step, failed to induce a significant increase in beta cell proliferation during the cilia 
disassembly phase. In cells subjected to starvation in 5.5 mM glucose, the rounding 
effect was much more pronounced than in 11 mM glucose (results not shown). 
Increasing the glucose concentration to 11 mM in the cilia disassembly step resulted 
in a non-significant increase in proliferation over the seeding phase. In this condition 
however, combining an increase in glucose concentration with addition of Y-27632 
resulted in a significant increase in proliferation over the seeding phase with ~12% of 
beta cells being Ki67 positive (Figure 8C) suggesting that inhibition of ROCK may 
exert an influence on proliferation in a condition where the maximum effect of 
glucose is not exploited. 
 As serum starvation appeared to be a critical step in order to observe gains in 
beta cell proliferation from these stimuli, we asked whether the proliferative effects 
were connected with changes in cilia expression and/or length. Cilia parameters 
were analyzed at each step of the protocol for monolayer cultures subjected to 17 
mM glucose and ROCK inhibitor following serum and B-27 starvation in 11 mM 
glucose (Figure 8D). Following initial seeding, primary cilia were expressed in ~15% 
of beta cells and average cilia length was ~3 µm. During starvation in 11 mM 
glucose, cilia expression increased to ~24% of beta cells and average cilia length 
increased to ~5 µm. Following re-introduction of serum and B-27, increasing glucose 
to 17 mM and adding ROCK inhibitor, cilia expression decreased to ~5% of beta cells 
and the remaining cilia length decreased to ~3 µm. The effects of the protocol on 
proliferation rate and cilia were mirrored in the overall beta cell density of the 
monolayers (Figure 8E, F). Initial seeding density was ~30,000 cells/cm2 which 
decreased ~20,000 cell/cm2 during starvation in 11 mM glucose. In the cilia 
disassembly phase, beta cell mass was significantly increased to ~70,000 cells/cm2. 
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In summary, serum starvation caused cilia to grow, while induction of cilia 
disassembly caused cilia to resorb and beta cell proliferation to increase. 
 
 
Figure 8. Protocol for cilia disassembly stimulates beta cell proliferation.  
(A) Schematic representation of the protocol used for cilia disassembly in beta cells. Rat islet cell 
monolayers were established for 3 days in complete neuronal medium with 11mM glucose, and then 
exposed for 36 hours to serum starvation in either 5.5 mM or 11 mM glucose to stimulate rounding of 
cells and ciliogenesis. Extension of cells and cilia disassembly was induced through re-addition of 
FBS/B-27 combined with raising the glucose concentration from 5.5 mM to 11 mM or from 11 mM to 17 
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mM with or without addition of the ROCK inhibitor Y-27632. (B) Representative fluorescence images of 
rat islet monolayer cells at the different stages of the protocol described in (A) and immunostained for 
DAPI, Ki67, acetylated tubulin and insulin (5.5G, 11G, 17G are abbreviations for 5.5, 11 and 17 mM 
glucose respectively). (C) Beta cell proliferation during different stages and permutations of the cilia 
disassembly protocol. Mean ± SEM (n = 10 random image fields per group). Statistical analysis by one-
way ANOVA (* p < 0.05, *** p < 0.001,  **** p < .0001, Dunnett’s pairwise comparisons relative to the 
Seeding condition). (D) Quantification of the percentage of ciliated beta cells and cilia length during 
different stages of the cilia disassembly protocol and using 11mM glucose during the starvation phase. 
Mean ± SEM (n = 10-20 random image fields per group). Statistical analysis by one-way ANOVA (* p < 
0.05, ** p < 0.01, *** p < 0.001, ns no statistical difference, Tukey’s post-hoc pairwise comparisons). (E) 
Representative fluorescence images of rat islet monolayer cells at three different stages of the cilia 
disassembly protocol, immunostained for DAPI and insulin. (F) Quantitation of density of islet cell 
monolayers in three groups representing the different stages of the cilia disassembly protocol. All three 
groups in (E) and (F) were cultured for a total of 144 hours before counting of cells with media change in 
each at 72 and 108 hours. In the first group, cells were cultured in neuronal medium with 11 mM 
glucose for 144 hours. In the second group, cells were cultured in neuronal medium with 11 mM glucose 
for 108 hours and in the same medium without serum and B-27 for 36 hours. In the third group, cells 
were cultured in neuronal medium with 11 mM glucose for 72 hours, in the same medium without serum 
and B-27 for 36 hours and in neuronal medium with 17 mM glucose and ROCK inhibitor for 36 hours. All 
analyses were performed in triplicate. Data are representative of two independent experiments. 
 
 
2.5   DISCUSSION 
We have developed a simple method for two-dimensional culture of primary 
human and rat islet cells. Critically, it is the combination of neuronal culture medium 
containing B-27 supplement together with collagen IV (human) or laminin (rat) 
surface-coating which enable formation of well spread and robustly attached islet cell 
monolayers. B-27 supplement contains a cocktail of growth factors and antioxidants 
formulated to support the viability of central nervous system neurons. Several of the 
constituent components of B-27 including retinoic acid (51), insulin (52), and 
triiodothyronine (53), are known to support islet cell function and survival, while the 
B-27 components superoxide dismutase, glutathione and corticosterone may reduce 
cellular inflammation resulting from the stress of whole islet dispersal. While we have 
not systematically analyzed the relative importance of each individual component of 
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B-27, we observed that in concert this cocktail leads to greatly improved health of 
islet single cell cultures. 
 Pancreatic islet cells share many features with neurons including the 
secretion of neurotransmitters and expression of neurotransmitter receptors for auto 
and paracrine coordination of islet function (54,55). The commonly used islet culture 
medium RPMI 1640 contains high concentrations of neuroactive amino-acids, L-
Glutamate, L-Aspartate, and L-Cysteine. These amino acid components give RPMI 
medium an excitatory neurotoxic effect resulting in poor viability of primary neurons 
(56). As islet cells also express high levels of neurotransmitter receptors (55), the 
amino acid content of RPMI may induce similar toxic effects on fragile dispersed islet 
cells. The use of a neuron-compatible culture medium such as Neurobasal Medium 
or MEM which are intentionally formulated without neuroactive amino acids (25) may 
improve islet cell viability. 
 Cell-ECM (40) and cell-cell (57,58) interactions are critical to islet viability and 
function. When whole islets are dispersed to individual cells these connections are 
lost and dispersed islet cells often have reduced or dysregulated calcium signaling 
and insulin-secretory capability (59). In the culture system we describe, cell-ECM and 
cell-cell interactions are partially restored through defined matrix coatings, which 
ligate beta cell integrin receptors, and through the tendency for seeded dissociated 
islet cells to coalesce into micro societies of clustered neighboring endocrine cells. 
We found that collagen IV surface coating preferentially supports human islet cell 
adhesion while laminin, and to a lesser extent HTB-9, surface coating preferentially 
support rat islet cell adhesion. The lack of adhesion of human islet cells on laminin 
and HTB-9 is consistent with laminin being a major constituent protein in HTB-9 
extracellular matrix. This species-specific preferential adhesion for collagen IV or 
laminin is likely a reflection of differential expression of alpha-beta integrin pairings 
between human and rat islets (40) and may imply the existence of underlying species 
differences in islet cell-matrix architecture. 
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The analysis of calcium signals in our monolayer culture indicates that the beta 
cells maintain full responsiveness to glucose. Furthermore, the wavelike propagation 
of calcium signals across neighboring beta cells within the islet cell monolayers are 
consistent with the efficient establishment and maintenance of cell-cell contacts. 
Such cell-cell interactions are essential to obtain good nutrient activation of beta cells 
(58). Strikingly, the cells analyzed showed no calcium signals under resting 
conditions. The beta cell activation that immediately followed initiation of the glucose 
stimulus was dependent on the metabolic triggering pathway of insulin secretion as it 
was suppressed when using the ATP-dependent K+ channel opener diazoxide. The 
calcium data provide strong evidence for the functional robustness of beta cells in the 
present monolayer culture system. Finally, it should be noted that the effectiveness 
of adenovirus infection in these monolayer cultures was impressive. Such expression 
of transgene after adenovirus infection in the large majority of beta cells would be 
hard or impossible to achieve in intact three dimensional pancreatic islets. 
The method for culturing islet monolayer cells allowed us to study primary cilia 
in beta cells and establish the existence of an inverse correlation between beta cell 
proliferation and ciliogenesis, a relationship that has been described previously for 
other cell types but not for primary beta cells. This result is highly significant because 
primary beta cells are particularly refractory in culture and do not easily proliferate. 
Here, we identified a cilia disassembly mechanism, which is tightly interconnected 
with cell cycle progression, to be an active driver of proliferation in primary beta cells. 
Our results suggest that protocols to rapidly induce spreading of beta cells on 
surfaces can be exploited in a straightforward manner to drive beta cell mass 
expansion while preserving differentiated phenotype. It is possible that this 
proliferation pathway has not been previously identified in islets because beta cells 
must be grown on two-dimensional surfaces to encourage a high degree of 
spreading. Rounded beta cells may be less susceptible to stimuli that increase 
spreading and cilia resorption in the confined three-dimensional environment of intact 
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islets than in two-dimensional monolayer culture. With further development, a 
method to induce ex vivo beta cell expansion without dedifferentiation may serve to 
generate large numbers of beta cells from cadaveric human islets for treatment of 
diabetes or for research purposes. 
The advancement in monolayer islet cell culture enables the study of 
subcellular-resolution processes in highly functional primary islet endocrine cells by 
live-cell and super-resolution microscopy techniques that require cells to be adherent 
on thin glass surfaces for optimal performance. With such imaging capacities, islet 
biology studies performed in primary islet cells can now benefit from the full array of 
possibilities offered by the latest advancements in light microscopy, particularly the 
visualization of molecular interactions and biochemical events at the sub-organelle 
level. 
 
2.6   CONTRIBUTION OF THE DOCTORAL CANDIDATE  
The doctoral candidate initially developed the concept and design of neurons 
and pancreatic islet cell co-culture (2.3.1). Then, together with the co-first author
E.A.P., she established the islet cell monolayer culture concept and design and 
performed the analysis of islet monolayer characterization (2.3.2 and 2.3.3). She 
developed the cilia disassembly-driven beta cell proliferation strategies and 
performed experiments and analysis for islet monolayer characterization and cilia 
disassembly-driven beta cell proliferation (2.3.6). She helped the lab technician M.P. 
with the isolation of rodent islets and immunostaining. She also contributed to the 
writing of the paper, together with the co-first author E.A.P. and the corresponding 
author and thesis advisor S.B. 
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2.7   SUPPLEMENTARY INFORMATION 
 
 
Supplementary Figure 1. ARA-C-mediates elimination of fibroblast-like cells from human islet 
monolayers during culture for seven days on collagen IV-coated coverslips in neuronal medium. 
(A) Transmitted light images showing human islet cells on collagen IV-coated coverslips treated or not 
with ARA-C (3 μM). Arrows indicate regions of fibroblast-like cells. (B) Confocal images of human islet 
cells treated or not with ARA-C (3 μM) and immunostained for β-actin and insulin. Nuclei were stained 
with DAPI. Arrows indicate regions of fibroblast-like cells. (C) Quantification of islet cell purity. Beta cells, 
constituting the majority of endocrine cells in the culture were identified based on insulin expression, 
while non-beta endocrine cells were identified by characteristic morphology similar to beta cells, easily 
distinguished from the much larger fibroblast-like cells. Mean ± SEM (N = 6 random image fields per 
condition). Statistical analysis by Student’s t-test (** p < 0.01). 
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Supplementary Figure 2. Islet cell monolayer proliferation. (A) A representative confocal image of rat 
islet cells cultured for seven days on laminin-coated coverslips in neuronal medium and immunostained 
for insulin, glucagon, somatostatin and Ki67. (B) Quantification of the percentage of Ki67+ rat islet cells 
when cultured in neuronal medium compared to islet basal medium. Mean ± SEM. (N = 10 random 
image fields). Statistical analysis by Student’s t-test (*** p < 0.001). (C) A representative confocal image 
of adult human islet cells from an 18-year-old donor, cultured for seven days on collagen IV-coated 
coverslips in neuronal medium and immunostained for insulin, glucagon, somatostatin and Ki67. (D, E) 
Representative confocal microscopy images of (D) a whole rat islet and (E) a rat islet cell monolayer 
immunostained for insulin, the neuroendocrine protein GAD65, or calnexin. Nuclei are stained by DAPI. 
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Supplementary Figure 3. Confocal and STED super-resolution microscopy of the actin 
cytoskeleton in rat islet cell monolayers.  
(A) Representative images of rat islet cells stained with Alexa Fluor 488 phalloidin show high resolution 
structure of the beta cell cortical actin network. (B) Increased magnification of the bounded regions 
shown in the lower panels of (A). (C) Transverse fluorescence intensity profile measured across a group 
of actin filaments shown in (B) captured by STED and compared to confocal images. 
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Supplementary Figure 4. TEM of rat islets.  
Representative TEM images of whole rat islets used to measure the diameter of insulin granules in 
Figure 6C. 
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Supplementary Figure 5. Confocal microscopy of primary cilia in human beta cells.  
(A) Left panel shows confocal analyses of primary human islet cells immunostained for insulin, the cilia 
marker acetylated alpha tubulin and the centrosomal protein pericentrin. Right panel, an increased 
magnification of the boxed region in the left panel, shows the localization of pericentrin at the base of a 
primary cilium originating from an insulin-expressing beta cell. (B) Three dimensional projections 
reconstructed from z-stacks obtained with confocal acquisitions of human islets cells immunostained for 
insulin, acetylated alpha tubulin and pericentrin. Arrows indicate individual cilia protruding from the 
apical side of human beta cells.  
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Supplementary Figure 6. Glucose-dependent adhesion of rat islet cells.  
Representative transmitted light images of rat islet monolayer cells seeded on laminin coated glass for 
three days in neuronal medium containing 11 mM glucose and then switched to fresh neuronal medium 
containing either 5 mM or 11 mM glucose for 16 hours. The ability of cells to switch back and forth 
between rounded (5 mM glucose) vs a well spread (11 mM glucose) phenotype in response to a change 
in the glucose concentration was maintained for at least 3 days after the initial 3 day seeding period.  
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Aberrant accumulation of the diabetes autoantigen 
GAD65 in Golgi membranes in conditions of             
ER stress and autoimmunity 
Adapted from the original manuscript 
Edward A. Phelps, Chiara Cianciaruso, Iacovos P. Michael, Miriella Pasquier, 
Jamil Kanaani, Rita Nano, Vanessa Lavallard, Nils Billestrup, Jeffrey A. Hubbell, 
Steinunn Baekkeskov 
 
 
3.1   ABSTRACT 
Pancreatic islet beta cells are particularly susceptible to endoplasmic reticulum 
(ER) stress, which is implicated in beta cell dysfunction and loss during the 
pathogenesis of type 1 diabetes (T1D). The peripheral membrane protein GAD65 is 
an autoantigen in human T1D. GAD65 synthesizes GABA, an important autocrine 
and paracrine signaling molecule and a survival factor in islets. We show that ER 
stress in primary beta cells perturbs the palmitoylation cycle controlling GAD65 
endomembrane distribution, resulting in aberrant accumulation of the palmitoylated 
form in trans-Golgi membranes. The palmitoylated form has heightened 
immunogenicity, exhibiting increased uptake by antigen presenting cells and T cell 
stimulation compared to the non-palmitoylated form. Similar accumulation of GAD65 
in Golgi membranes is observed in human beta cells in pancreatic sections from 
GAD65 autoantibody positive individuals, who have not yet progressed to clinical 
onset of T1D, and T1D patients with residual beta cell mass and ongoing T cell 
infiltration of islets. We propose that aberrant accumulation of immunogenic GAD65 
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in Golgi membranes facilitates inappropriate presentation to the immune system 
following release from stressed and/or damaged beta cells, triggering autoimmunity.  
 
3.2   INTRODUCTION  
The GABA-synthesizing enzyme glutamic acid decarboxylase (GAD) exists in 
two isoforms, GAD65 and GAD67, encoded by different genes (1). The smaller 
isoform, GAD65, is an early target of autoimmunity in 70-80% of patients who 
develop T1D (2-4). Rat and human beta cells primarily express GAD65, while no 
GAD65 is detected at the protein level in mouse beta cells (5,6). Our understanding 
of how GAD65 becomes an autoantigen in T1D is limited due to the lack of this 
protein in beta cells of mice, and therefore an apparent lack of a significant role in the 
pathogenesis of diabetes in the highly studied NOD mouse model of T1D (7). 
The GAD65 enzyme is synthesized in the cytosol as a hydrophilic cytosolic 
molecule, which undergoes hydrophobic post-translational modifications in the N-
terminal domain to become membrane anchored (8-11). The first step of hydrophobic 
modifications is irreversible and results in a hydrophobic form that targets specifically 
to the cytosolic face of endoplasmic reticulum (ER) and cis-Golgi membranes, 
establishing an equilibrium between membrane and cytosolic pools (12). The second 
step of modifications, which include stabilization of membrane anchoring followed by 
a reversible double palmitoylation of cysteines 30 and 45 (10) by a Golgi localized 
protein acyl transferase (PAT) DHHC17 (also known as HIP14) (13), result in 
trapping of GAD65 in Golgi membranes, sorting to the trans-Golgi network (TGN) 
and targeting to an axonal vesicular pathway in route to synaptic vesicles in 
presynaptic clusters in neurons and to peripheral vesicles in beta cells (12,14,15). 
Palmitoylation is not required for anchoring of GAD65 to Golgi membranes but is 
critical for anterograde targeting of GAD65 from cis-Golgi to TGN membranes and 
post-Golgi peripheral vesicles (12). A depalmitoylation step by an acyl protein 
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thioesterase (APT) can release GAD65 from peripheral vesicle membranes and/or 
TGN membranes mediating retrograde trafficking back to Golgi membranes by a 
non-vesicular pathway. The protein can then enter a cycle of re-palmitoylation and 
de-palmitoylation (12). Palmitoylation is suggested to serve a critical function in 
regulating the rate of GABA synthesis in the presynaptic compartment of neurons 
(16,17). 
Pancreatic beta cells have a well-developed, extensive, and highly active ER, 
reflecting their role in synthesizing and secreting large amounts of insulin. When the 
protein synthesis and secretion machinery becomes overloaded, either due to a high 
physiological demand on a limited number of cells or from exogenous stressors such 
as inflammation or a diet high in fatty acids, the accumulation of unfolded and 
improperly folded proteins transiting through the ER results in the cell experiencing a 
state of ER stress (18). Beta cells are highly sensitive to ER stress, which is 
implicated in the pathogenesis of T1D (19-22). It has been proposed that the 
initiation of autoimmunity against the beta cell follows an initial period of prolonged 
beta cell ER stress and apoptosis, induced by inflammatory cytokines secreted by 
early invading immune cells as well as the beta cells themselves (19,23). 
Here we report a dramatic effect of ER stress on the subcellular distribution of 
the T1D autoantigen GAD65 in primary rat and human beta cells and accumulation 
of a more highly immunogenic palmitoylated form in Golgi membranes. A similar 
accumulation is detected in pancreatic sections of human GAD65 autoantibody 
positive individuals and T1D patients. 
? 86 
3.3   METHODS 
3.3.1   Cell cultures 
INS-1E rat insulinoma cells (24) were cultured in RPMI 1640 with GlutaMAX, 
10% FBS, 1% Penicillin/Streptomycin (P/S), 1 mM sodium pyruvate, 10 mM HEPES, 
and 50 μM β-mercaptoethanol. The DR4 (DRA1*0101, DRB1*0401) positive human 
EBV-transformed B cell line Priess (25) was cultured in IMDM GlutaMAX medium 
with 10% FBS, and 1% P/S. A DR4 (DRA1*0101, DRB1*0401) restricted mouse T 
cell hybridoma cell line T33.1, recognizing the GAD65 aa 274-286 epitope 
(GAD65274-286) (26), was cultured in RPMI 1640 with GlutaMAX, 10% FBS, 1% P/S, 
and 0.1% β-mercaptoethanol. Primary rat hippocampal neurons were prepared from 
2- to 3-day-old Sprague Dawley rats as described by Codazzi et al (27). 
 
3.3.2   Islet culture 
Rat islets isolated from P5 Sprague Dawley rats as previously described (15) 
were cultured in RPMI 1640, 10% FBS, and 1% P/S at 37°C, 5% CO2. Human islets 
were cultured in CMRL 1066 with 2 mM L-Glutamine, 25 mM HEPES, 10% FBS, and 
1% P/S at 25°C, 5% CO2. 
3.3.3   Islet single cell cultures  
Rat or human islets dissociated into single cells by digestion with trypsin-EDTA 
were cultured at 50,000 cells/well on laminin-coated Thermanox coverslips (Nunc) or 
100,000 cells/well on Fluorodishes (World Precision Instruments) in MEM, 11 mM 
glucose, 5% FBS, 1 mM Sodium Pyruvate, 10 mM HEPES, 1X B-27 (Gibco), and 1% 
P/S at 37°C, 5% CO2. 
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3.3.4   Human pancreatic sections 
Human pancreatic sections were obtained from the Juvenile Diabetes 
Research Foundation (JDRF) Network for Pancreatic Organ Donors with Diabetes 
(nPOD) tissue bank (28; 29). Sections were obtained from 8 autoantibody negative 
healthy donors with normal islets (Supplementary Table 1), 8 potentially prediabetic 
individuals positive for GAD65 autoantibodies (GADA+) (Supplementary Table 2), 
and 8 autoantibody positive T1D patients, including 6 who were GADA+ 
(Supplementary Table 3). Donors were selected to have remaining insulin positive 
beta cells to enable analyses of the subcellular localization of GAD65. Furthermore, 
we sought to include individuals, who were reported by nPOD as positive for CD3+ T 
cell infiltration and/or insulitis (Supplementary Tables 2 and 3). Insulitis is defined by 
nPOD as the presence of 6 or more CD3+ T cells immediately adjacent to or within 3 
or more islets of a defined minimum size in pancreatic sections (30). 
 
3.3.5   Immunofluorescence staining  
Human pancreas sections were deparaffinized followed by acidic-pH heat-
mediated antigen retrieval. Cultures of single pancreatic islet cells were fixed with 4% 
PFA. Samples were blocked and permeabilized in PBS + 0.3% Triton X-100, 10% 
goat or donkey serum. Primary antibodies (CHOP, Santa Cruz, sc-575, 1:100; 
GAD6, mouse monoclonal antibody against C-terminus of GAD65 (31), 1:1000; N-
GAD65 mAb, mouse monoclonal antibody against N-terminus of GAD65 (32), 1:300; 
Giantin, Abcam, ab24586, 1:1000; Insulin, Linco 4011-01, 1:10,000; Insulin, Abcam, 
ab14042, 1:2,000; CD3, Dako M7254, 1:30) were incubated overnight at 4°C in PBS 
+ 0.3% Triton X-100, 1% goat or donkey serum. Alexa Fluor conjugated secondary 
antibodies (Molecular Probes) were incubated at 1:200 dilution in PBS + 0.3% Triton 
X-100 for 30 min at room temperature. 
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3.3.6   Image capture, analysis, and quantification 
Samples were imaged on a Zeiss LSM700 confocal microscope with 63x/1.40 
NA Plan-Apochromat oil-immersion objective for single islet cells and 40x/1.30 NA 
Plan-Apochromat oil-immersion objective for pancreatic tissue sections. All images 
for quantification within a single experiment were captured with the same laser power 
and detector gain. The ratio of GAD65 mean fluorescence intensity in the Golgi 
compartment and post-Golgi vesicles compared to the rest of the cytosol was 
calculated with a custom ImageJ macro. Individual beta cells in a given field of view 
were identified and outlined by hand. For each cell, the macro automatically defined 
a region of interest (ROI) outlining the Golgi compartment, identified by giantin co-
stain or by characteristic morphology and brightness thresholding of GAD65 stain, 
and GAD65+ vesicles, identified by brightness thresholding of GAD65+ bright 
puncta. A second ROI defined the remainder of the cell, excluding the Golgi, 
GAD65+ vesicles, and nucleus. GAD65 Golgi accumulation was reported as the ratio 
of mean fluorescence intensity (MFI) for the two ROIs. 
 
3.3.7   SDS-PAGE and Western Blotting 
Gel electrophoresis was performed with the NuPAGE system (Invitrogen) with 
transfer onto PVDF membranes with the iBlot 2.0 (Life Technologies) device. 
Membranes were blocked with Odyssey Blocking Buffer (LI-COR Biosciences), 
incubated in primary antibody (GAD1701, a custom antibody against C-terminus of 
GAD67 that reacts equally well with GAD65 and GAD67 (5), 1:5000) overnight at 
4°C, and detected with secondary antibody IRDye 800CW (LI-COR Biosciences). 
Blots were imaged on the LI-COR Odyssey scanner. 
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3.3.8   Treatment of cells to induce ER stress 
Sodium palmitate (1 mM) (Sigma-Aldrich) was conjugated to fatty-acid-free 
BSA (0.17 mM) (Calbiochem) in 150 mM NaCl pH 7.4 for 1 h. Stock palmitate-BSA 
(1 mM palmitate, 0.17 mM BSA) was added to culture media to achieve a final 
palmitate concentration of either 0.1 mM or 0.5 mM. A stock solution of BSA (0.17 
mM BSA) without palmitate was added to the control (untreated) wells. Thapsigargin 
(Invitrogen) was used at a final concentration of 2 µM. Rat IFNγ and rat IL-1β (R&D 
Systems) were used at a final concentration of 10 U/ml for each. 
 
3.3.9   Fluorescence recovery after photobleaching imaging and analysis 
Fluorescence recovery after photobleaching (FRAP) experiments were 
performed on a Zeiss LSM700 confocal microscope with environmental stage at 
512x512 pixel resolution, 1% laser power and 1.94 s frame interval. GAD65-GFP 
fluorescence in the Golgi compartment of transfected cells, treated or not to induce 
ER stress, was bleached with 50% laser power. Time-stacks of GAD65-GFP 
fluorescence recovery in the Golgi compartment were double normalized for 
percentage of initial intensity and whole cell photobleaching in ImageJ. Two-phase 
and single-phase association curves were plotted in Graphpad Prism to obtain half-
time of recovery. 
 
3.3.10   S-acylation resin-assisted capture (Acyl Rac) palmitoylation assay 
Acyl-RAC on recombinant human GAD65 (rhGAD65, FIRS Laboratories, RSR) 
was performed as described by Forrester, et al. (33). 
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3.3.11   Uptake of GAD65-488 by Priess Cells  
rhGAD65 was depalmitoylated overnight by treatment with 200 mM HA and 
labeled with DyLight 488 NHS Ester (Thermo Fisher Scientific). Palmitoylated or 
depalmitoylated GAD65-488 was incubated at 10 µg/ml with 50,000 Priess cells/well 
in 96-well plates. Cells were stained with LIVE/DEAD® Aqua (Molecular Probes) and 
analyzed by Cyan Flow Cytometer (Beckman Coulter) and FlowJo software. 
 
3.3.12   Activation of GAD65-specific T cells 
Unmodified rhGAD65 containing native palmitate modifications or HA-treated 
depalmitoylated GAD65 were incubated overnight with 50,000 Priess cells/well at 2 
µg/ml in 96-well plates. GAD65 loaded Priess cells were then incubated for 24 h with 
30,000 T33.1 T cells. IL2 secretion was analyzed by ELISA kit (eBioscience). 
 
3.3.13   Plasmids 
Generation of GAD65-GFP and GAD65(C30,45A)-GFP was described 
previously (11,12,14). INS-1E and primary rat islet cells were transfected by 
Lipofectamine 2000 (Invitrogen). 
 
3.3.14   Statistics 
Means among three or more groups were compared by analysis of variance 
(ANOVA) in GraphPad Prism 6 software. If deemed significant, Tukey’s post-hoc 
pairwise comparisons were performed. Means between two groups were compared 
using Student's t-test. A confidence level of 95% was considered significant. 
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3.3.15   Ethical approval 
Animals were used under EPFL animal regulation guidelines and an IACUC 
approved protocol. Human islets were received from the University Hospital of 
Geneva and San Raffaele Scientific Institute, Milan through the European 
Consortium for Islet Transplantation (ECIT) islets for basic research program ECIT 
and were approved by the Institutional Review Board of the University Hospital of 
Geneva (CER Nr. 05–028) and by the Ethics Committee of the San Raffaele 
Scientific Institute of Milan (IPF002-2014). Human pancreatic sections obtained via 
the nPOD tissue bank, University of Florida, Gainesville, FL, USA were harvested 
from cadaveric organ donors by certified organ procurement organizations partnering 
with nPOD in accordance with organ donation laws and regulations and classified as 
“Non-Human Subjects” by the University of Florida Institutional Review Board 
(28,29). EPFL grants permit for the use of human material as long as the provider 
can certify that the samples were obtained according to local laws and regulations, 
as well as good practices in the country were they were collected.  
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3.4   RESULTS 
 
3.4.1   ER stress results in accumulation of GAD65 in the Golgi compartment 
Primary rat and human beta cells derived from dissociated whole islets were 
cultured as monolayers on coverslips to allow for high-resolution confocal 
microscopy. The monolayer islet cells were fixed and immunostained for insulin, 
GAD65, and the Golgi marker giantin (Figure 1). As previously reported (15), GAD65 
is detected diffuse in the cytosol as well as in Golgi membranes and post-Golgi 
vesicles in beta cells. Insulin is detected in distinct large dense core vesicles 
(LDCVs). 
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Figure 1. Confocal analyses of GAD65 localization in primary beta cells.  
(A) Primary rat beta cells immunostained for GAD65 and giantin (Golgi) show a subcellular distribution 
of GAD65 in the cytosol and the Golgi compartment. Apart from the Golgi compartment, GAD65 is 
localized to vesicles, which are distinct from insulin granules. The confocal images are representative of 
similar analyses of 7 independent isolations of rat islets. Scale bar 10 µm. (B) Immunostaining of 
primary human beta cells for GAD65, giantin, and insulin reveals localization of GAD65 in the Golgi 
compartment as well as in peripheral vesicles distinct from insulin containing vesicles. The confocal 
images are representative of similar analyses of independent isolations of human islets from 4 donors. 
Scale bar 10 µm. 
 
To induce mild ER stress, primary islet cell monolayers were subjected to a 48 
h time course of low levels (10 U/ml) of the inflammatory cytokines IL-1β and IFNγ or 
overnight treatment with the saturated fatty acid palmitate (500 µM) (Figure 2), both 
of which have been previously shown to trigger ER stress in beta cells (34-36). Cells 
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were also treated for 8 h with thapsigargin, which is a potent ER stress inducing 
agent (37) (Figure 2). We monitored ER stress by nuclear translocation of CHOP, a 
multifunctional transcription factor in the ER stress response (Figure 2).  
The different treatment conditions resulted in varying degrees of ER stress as 
shown by the timeframe until nuclear translocation of CHOP, indicating that the 
different treatment conditions affected the cells with variable strength and specificity. 
While incubation with thapsigargin or palmitate induced CHOP activation at 8 and 18 
h respectively, CHOP activation was detected at 48 h (but not 24 h) of cytokine 
treatment (Figure 2). Notably, all three treatment conditions resulted in a marked 
increase in the Golgi-localization of GAD65 (Figure 2). Accumulation of GAD65 in 
Golgi membranes during palmitate induced ER stress was also observed in primary 
human beta cells and in another cell type expressing GAD65, primary rat 
hippocampal GABA-ergic neurons (Supplementary Figure 1).  
Figure 2. Activation of ER stress pathways in beta cells by thapsigargin, palmitate, or 
inflammatory cytokines.  
Primary rat beta cells were treated with palmitate (500 µM, 18 h), thapsigargin (2 µM, 8 h), or cytokines 
(10 U/ml, 8, 24, or 48 h) to induce ER stress and immunostained for GAD65 (top two panels) and CHOP 
(bottom panel). GAD65 positive Golgi compartments are indicated by arrowheads. For all three 
treatment modules, GAD65 expression in the Golgi compartment becomes noticeably brighter. Middle 
panels show increased magnification of framed regions in the top panels. The confocal images are 
representative of similar analyses of 6 independent isolations of rat islets. Scale bars 10 µm. 
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Accumulation of GAD65 in the Golgi compartment during induction of ER 
stress by either palmitate or thapsigargin was confirmed by co-staining for the Golgi 
marker giantin (Figure 3A, Supplementary Figure 1A-C) but Golgi structures are 
also clearly identifiable by GAD65 localization in both beta cells and neurons 
(12,15,38). Quantification following a two hour incubation with either palmitate or 
thapsigargin revealed a significant accumulation of GAD65 in the Golgi compartment 
(Figure 3B, Supplementary Figure 1D).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Treatment of beta cells with palmitate or thapsigargin promotes Golgi accumulation of 
GAD65.  
(A) Primary rat beta cells were treated with palmitate (500 µM, 2 h) or thapsigargin (2 µM, 2 h) to induce 
ER stress and immunostained for GAD65 and Giantin. Scale bars 10 µm. (B) Image quantification of 
GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi 
compartment and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the 
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nucleus. Results are presented as mean ± SEM (n = 39-43 beta cells from 8 image fields analyzed per 
condition. Cells positive for giantin and negative for GAD65 represent non-beta islet cells). Data were 
analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test (** P < 0.001). Analyses 
of accumulation of GAD65 in Golgi membranes in rat beta cells, human beta cells, and rat hippocampal 
neurons incubated with palmitate for 2 h is shown in Supplementary Figure 1.  
 
 
The time course of accumulation of GAD65 in Golgi membranes during 
palmitate induced ER stress was studied further. Rat islet cell monolayers were 
treated with 100 µM or 500 µM of palmitate for 10 min, 2 h, and 18 h and 
immunostained for CHOP, GAD65, and insulin (Figure 4, Supplementary Figure 2). 
Golgi accumulation of GAD65 occurred almost immediately upon addition of 
palmitate and was clearly visible at 10 min (Figure 4A, Supplementary Figure 2A). 
The strong Golgi accumulation of GAD65 persisted at 2 h and was still visible at 18 
h, although the intensity began to fade coinciding with activation of CHOP (Figure 
4C,D). Quantification of GAD65 membrane accumulation showed a statistically 
significant increase in the ratio of MFI for GAD65 in the Golgi compartment for cells 
incubated for 10 min and 2 h in 100 or 500 µM palmitate (Figure 4B). Across all 
conditions and time points there were no notable changes in the subcellular 
localization of insulin (Supplementary Figure 2B). Taken together the results 
indicate that induction of ER stress results in aberrant accumulation of GAD65 in the 
Golgi compartment.  
? 97 
 
Figure 4. Time course of Golgi accumulation of GAD65 upon palmitate treatment.  
(A) Confocal analyses of monolayer cultures of primary rat beta cells  treated or not with 100 µM 
palmitate, or 500 µM palmitate for 10 min, 2 h, and 18 h respectively. Fixed cells were immunostained 
for GAD65 and CHOP. Scale bar 10 µm. (B) Image quantification of GAD65 accumulation in the Golgi 
compartment reported as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI 
for GAD65 in the rest of the cell excluding the nucleus. Results are presented as mean ± SEM (n = 28-
45 cells from 4-5 image fields analyzed per condition). Data were analyzed using two-way ANOVA 
followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). (C) Image 
quantification of CHOP positive nuclei as a percentage of total nuclei. Results are presented as mean ± 
SEM (n = 4-10 image fields analyzed per condition). Data were analyzed using two-way ANOVA 
followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01 and *** P < 0.001). Corresponding 
lower magnification images of primary beta rat beta cells stained for GAD65 and insulin are shown in 
Supplementary Figure 2.  
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3.4.2   Palmitoylation is required for GAD65 accumulation in the Golgi 
compartment during ER stress 
The distribution of GAD65 between ER/cis-Golgi and TGN/vesicular 
membranes is controlled by its palmitoylation/depalmitoylation/repalmitoylation cycle. 
While palmitoylation of cysteines 30 and 45 is not required for firm anchoring of 
GAD65 to Golgi membranes, it is critical for its anterograde trafficking from cis-Golgi 
to TGN membranes and targeting to post-Golgi vesicles (12). We assessed whether 
a palmitoylation-deficient mutant of GAD65 was capable of accumulating in the Golgi 
compartment in beta cells undergoing ER stress. Primary rat beta cells were 
transfected with either wild-type (WT) GAD65-GFP or palmitoylation deficient 
GAD65(C30,45A)-GFP, and treated with palmitate or thapsigargin for 1 h to induce 
ER stress. Cells were imaged live by confocal microscopy and the images were 
measured for MFI of GAD65-GFP in the Golgi compartment (Figure 5). ER stress 
induced by palmitate or thapsigargin significantly increased the fraction of WT 
GAD65-GFP in Golgi and vesicle membranes, while palmitoylation-deficient 
GAD65(C30,45)-GFP was unaffected (Figure 5). Thus, Golgi accumulation of 
GAD65 in response to ER stress is restricted to palmitoylation competent GAD65.  
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Figure 5. Palmitoylation is required for Golgi accumulation of GAD65.  
(A) Primary rat beta cells were transfected with either WT GAD65-GFP or the palmitoylation deficient 
mutant GAD65(C30,45A)-GFP and imaged live following a 1 h treatment with palmitate (500 µM) or 
thapsigargin (2 µM) to induce ER stress. Images are also displayed with a heat-map to highlight the 
increase in Golgi and vesicle brightness. Golgi regions are indicated with a dashed outline. Scale bar 10 
µm. (B) Image quantification of GAD65 accumulation in the Golgi compartment expressed as the ratio of 
MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell 
excluding the nucleus. Results are presented as mean ± SEM (n = 6-10 cells analyzed per condition). 
Data were analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05). 
 
3.4.3   Recovery of wild-type but not palmitoylation-deficient GAD65 in the 
Golgi compartment after photobleaching is inhibited during ER stress 
We next assessed the effect of ER stress on the kinetics of replenishment of 
WT GAD65-GFP as well as the palmitoylation deficient mutant GAD65(C30,45A)-
GFP into Golgi membranes following irreversible photobleaching. We previously 
reported that the fluorescence recovery after photobleaching (FRAP) of WT GAD65-
GFP in Golgi membranes involves two pools of the protein, a rapid pool and a slow 
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pool (12). The rapid Golgi replenishment pool represents the non-palmitoylated form 
of GAD65, which has undergone the first step of hydrophobic modifications resulting 
in weak on/off membrane association. The second and slower replenishment pool 
represents palmitoylation competent GAD65, which, following anterograde vesicular 
trafficking to the TGN and periphery, can undergo depalmitoylation and non-vesicular 
retrograde trafficking back to Golgi membranes. INS-1E cells (Figure 6A-D) and 
primary rat islet cells (Supplementary Figures 3,4) were subjected to irreversible 
photobleaching of the Golgi compartment. Recovery of GAD65-GFP in Golgi 
membranes was recorded for untreated cells and for cells pre-treated with palmitate 
(Figure 6, Supplementary Figure 3) or thapsigargin (Supplementary Figure 4) for 
1 hour to induce early-stage ER stress. Analysis of the data was performed using 
non-linear regression, assuming one or multiple pools of replenishing protein. 
Induction of ER stress significantly impaired the Golgi replenishment kinetics of WT 
GAD65-GFP in INS-1E cells treated with palmitate (Figure 6C,D) and in primary islet 
cells treated with either palmitate (Supplementary Figure 3) or thapsigargin 
(Supplementary Figure 4). In contrast, the Golgi replenishment kinetics of 
palmitoylation deficient GAD65(C30,45A)-GFP was similar for both untreated and 
treated cells (Figure 6C,D, Supplementary Figures 3,4). Calculations of half time of 
recovery of the rapid and slow pools of WT GAD65-GFP, revealed that while the half 
time of recovery of the rapid pool replenishing the Golgi was minimally or not 
affected, the half time of recovery of the slow pool was increased 3-4 fold (Figure 
6C,D, Supplementary Figures 3,4). The results of these experiments indicate that 
ER stress, whether induced by palmitate or thapsigargin, inhibits and perturbs the 
palmitoylation cycle of WT GAD65-GFP. 
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Figure 6. Fluorescence recovery after photobleaching in the Golgi of WT but not palmitoylation-
deficient GAD65 is inhibited during ER stress.  
(A) Live cell images of INS-1E cells transfected with GAD65-GFP before and after treatment with 
palmitate (500 µM) for 1 h show accumulation of GAD65-GFP in the Golgi. Scale bar 10 µm. (B) 
Representative images from FRAP analyses of INS-1E cells expressing either WT GAD65-GFP or 
palmitoylation-deficient GAD65(C30,45A)-GFP. The entire Golgi compartment was photobleached and 
recovery of fluorescence was followed by live cell imaging. Scale bar 10 µm. (C) Kinetics of 
fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-GFP or 
GAD65(C30,45A) in INS-1E cells pretreated or not with palmitate for 1 h. Results from a representative 
experiment are presented as mean ± SEM (n = 10 cells per condition). (D) Calculated halftimes of Golgi 
fluorescence recovery in INS-1E cells following photobleaching. WT GAD65-GFP exhibits two-phase 
recovery kinetics corresponding to a rapid as well as a slow recovery pool, while palmitoylation-deficient 
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GAD65(C30,45A)-GFP exhibits single-phase recovery kinetics corresponding to a rapid recovery pool. 
Results are presented as the mean halftime of recovery ± SEM (n = 3 independent experiments, 10 
cells per experiment). Data were analyzed by Student’s t-test comparing the halftime parameter 
between the association curve fits of the combined data set from three independent experiments (*** P 
< .001). FRAP analyses of GAD65 Golgi recovery in primary rat beta cells treated with palmitate or 
thapsigargin are shown in Supplementary Figure 3 and Supplementary Figure 4, respectively. 
 
3.4.4   Uptake and processing of GAD65 by antigen presenting B lymphocytes 
is enhanced by palmitoylation 
Given that modification of peptides and proteins by palmitoylation may enhance 
their immunogenicity (39), we assessed whether the palmitoylation state of GAD65 
has an effect on its uptake by antigen presenting cells (APCs) and/or activation of T 
cells in an APC / T-cell co-culture assay. Recombinant human GAD65 produced in 
yeast was depalmitoylated by thiol-acyl cleavage with hydroxylamine (HA), and 
depalmitoylation was confirmed biochemically by the S-acylation resin-assisted 
capture (Acyl-RAC) assay (33) (Figure 7A). Analyses of uptake of DyLight-488 
labeled palmitoylated and non-palmitoylated GAD65 by the HLA-DR4 (DRB1*0401) 
positive human B-cell line Priess revealed a 2.5 fold increase in uptake of 
palmitoylated compared to the de-palmitoylated GAD65 (Figure 7B). Furthermore, 
Priess cells were loaded with palmitoylated or depalmitoylated GAD65 and used as 
APCs to stimulate the GAD65 specific HLA-DR4 (DRB1*0401)-restricted murine T-
cell hybridoma line T33.1 that recognizes the GAD65274-286 epitope. In this APC / T 
cell co-culture assay, presentation of palmitoylated GAD65 induced a 3-fold higher 
secretion of IL-2 by T33.1 cells compared to the depalmitoylated protein (Figure 7C). 
Taken together, the results indicate that palmitoylation facilitates uptake and 
processing of GAD65 by APCs resulting in increased antigen-specific stimulation of T 
cells. Thus the palmitoylated form of GAD65 that accumulates in Golgi during ER 
stress has higher immunogenicity, consistent with a possible role of ER stress in 
activating autoreactive T cells in T1D. 
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Figure 7. Palmitoylation confers increased immunogenicity upon GAD65.  
(A) Recombinant human GAD65 produced in yeast was shown to be palmitoylated by the S-acylation 
resin-assisted capture (Acyl-RAC) assay. Free thiols in recombinant GAD65 were capped with methyl 
methanethiosulfonate (MMTS) followed by cleavage of palmitate-thiol modifications with hydroxylamine 
(HA), pulldown with a thiol-reactive pyridyl-disulfide agarose resin, and detection by Western blot. 
Lanes: i =input, positive control of unmodified recombinant GAD65; -HA = negative control without HA 
resulting in no palmitate cleavage and no protein pulldown; +HA = HA added with palmitate groups 
cleaved and protein recovered by thiol-reactive pulldown. (B) Time course of uptake of equimolar 
amounts of DyLight-488 labeled palmitoylated or depalmitoylated (HA cleaved) recombinant GAD65 by 
MHC-class II DR4 positive human Priess B-cell APCs measured by flow cytometry. Results are 
presented as mean ± SEM (n = 3 experimental replicates). Data were analyzed by two-way ANOVA 
followed by Tukey’s multiple comparisons test (*** P < 0.001). (C) Priess cells were loaded with 
equimolar amounts of palmitoylated or depalmitoylated GAD65 (HA cleaved) and tested for stimulation 
of the DR4 restricted GAD65-specific T33.1 T-cell hybridoma cells by IL-2 secretion measured by 
ELISA. Results are presented as mean ± SEM (n = 3 experimental replicates). Data were analyzed by 
two-way ANOVA followed by Tukey’s multiple comparisons test (*** P < 0.001). 
 
3.4.5   GAD65 accumulates in the Golgi compartment in human beta cells 
during progression of T1D autoimmunity 
We addressed the question whether the experimental accumulation of GAD65 
in the Golgi compartment induced by treatment with ER stressors in vitro is of 
relevance for human diabetes. Human pancreatic sections provided by the nPOD 
tissue bank (28; 29) representing 8 healthy donors (Supplementary Table 1), 8 
potentially prediabetic individuals positive for GAD65 autoantibodies (GADA+) 
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(Supplementary Table 2), and 8 T1D patients with residual beta cell mass 
(Supplementary Table 3) were immunostained for GAD65, giantin, insulin, glucagon 
and the pan-T cell marker CD3 (Figure 8A-D). In five of eight GADA+ individuals and 
seven of eight T1D patients, the GAD65 signal in beta cell Golgi membranes 
compared to cytosol was higher than one standard deviation above the mean for 
healthy control individuals where GAD65 immunostaining was mostly uniform 
(Figure 8E, Supplementary Tables 1-3, last column). Staining of serial sections for 
the pan-T cell marker, CD3 (Figure 8A), confirmed peri- and intra-islet infiltrating T 
cells in islets from three of eight GADA+ individuals as well as in six of eight T1D 
patients (Figure 8A and results not shown). Examination of the nPOD-provided 
patient information (Supplementary Tables 1-3) for individual donors revealed that 
the highest Golgi accumulation observed in the pre-diabetic GADA+ group was from 
a single autoantibody positive (GADA+) 2.2-year-old child expressing the HLA-class 
II T1D susceptibility haplotype DR4, DQ8 (Supplementary Table 2) showing 
infiltrates of CD3-positive T cells in and around islets (Figure 8A, nPOD 6090) but 
not meeting the nPOD insulitis criteria (Supplementary Table 2). This child may 
represent a case of a young, genetically susceptible individual in the early stages of 
autoimmunity associated with development of T1D. The lowest Golgi accumulation in 
the GADA+ group was observed in a 31-year-old, single autoantibody positive 
(GADA+) individual with normal islet morphology and no insulitis (Supplementary 
Table 2, nPOD 6181). The highest Golgi accumulation observed in the T1D group 
was observed in a double autoantibody positive (GADA+ and mIAA+) 11-year-old 
individual expressing the T1D HLA-class II susceptibility haplotypes DR3, DQ2 and 
DR4, DQ8 and with ongoing insulitis (Supplementary Table 3) (30) as confirmed by 
our CD3 immunostaining (Figure 8A, nPOD 6265). Taken together, the results 
suggest that aberrant accumulation of GAD65 in Golgi membranes may correlate 
with active islet autoimmunity in human T1D.  
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Figure 8. Confocal analyses of islets in paraffin sections of human pancreas from healthy, non-
diabetic GAD65 autoantibody positive, or T1D with residual beta cell mass.  
(A) Immunostaining of human pancreatic sections for insulin, glucagon or CD3 from the indicated nPOD 
case numbers. Arrowheads indicate CD3+ T-cells. Scale bar 50 µm. (B) The same human islet from a 
serial section, immunostained for GAD65 and giantin. Scale bar 50 µm. (C) Increased magnification of 
GAD65 staining in the framed region shown in (B). Scale bar 10 µm. (D) Thresholded binary images of 
the same region in (C) show the colocalization between giantin (Golgi) and the bright GAD65 signal. 
Scale bar 10 µm. (E) Image quantification of GAD65 accumulation in the Golgi compartment in 3 
representative islets from 8 individuals per donor category, reported as the ratio of MFI for GAD65 in the 
Golgi of beta cells to MFI for GAD65 in the rest of the cell excluding the nucleus. Results are presented 
as scatter dot plots overlaying the mean ± SEM (n = 24 islets from 8 donors). Data were analyzed by 
one-way ANOVA followed by Tukey’s multiple comparisons test (* P < 0.05, ** P < 0.01). The average 
GAD65 Golgi accumulation calculated per individual as well as demographic information for healthy, 
GADA+, and T1D donors is listed in Supplementary Tables 1-3. 
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3.5   DISCUSSION 
In this study, we show that treatment of islet cell cultures by three separate 
regimens known to induce ER stress in beta cells results in accumulation of GAD65 
in Golgi membranes. Importantly, analysis of human pancreatic tissue sections 
revealed significant accumulation of GAD65 in beta cell Golgi membranes in GADA+ 
potentially pre-diabetic individuals and in T1D patients with residual beta cell mass. 
Thus, aberrant accumulation of GAD65 in Golgi membranes is observed both in beta 
cells in culture undergoing experimentally-induced ER stress as well as in beta cells 
of individuals experiencing active beta cell autoimmunity. 
We have shown earlier that palmitoylation of GAD65 results in anterograde 
trafficking from cis-Golgi to TGN membranes (12). The evidence presented in this 
study shows that only WT GAD65 but not palmitoylation deficient GAD65(C30,45A) 
accumulates in Golgi membranes during ER stress. This increase of GAD65 in Golgi 
membranes is consistent with the accumulated protein representing the 
palmitoylated form of GAD65 in TGN membranes, suggesting that the palmitoylation 
cycle of GAD65 significantly slows down during induction of ER stress. This 
retardation in transport likely affects the control of GAD65 distribution between 
peripheral vesicle membranes, where the majority of GAD65 enzymatic functional 
activity is believed to take place, and Golgi membranes, which may serve as a 
sorting station for this protein. We therefore propose that perturbation in the 
regulation GAD65 membrane distribution by ER stress may have negative 
consequences for GABA synthesis and secretion. GABA serves as an important 
signaling molecule and survival/growth factor in islets of Langerhans (40). 
The mechanisms by which cytokines, palmitate, and thapsigargin induce ER 
stress in beta cells may differ (34). One commonality between the three different 
treatments is that each is implicated in dysregulation of calcium homeostasis (41). 
Both inflammatory cytokines and thapsigargin have been shown to induce beta cell 
ER stress through downregulation or inhibition of the sarco/endoplasmic reticulum 
? 107 
Ca2+ ATPase, resulting in elevation of cytosolic calcium concentrations and depletion 
of ER Ca2+ stores (42). Palmitate is reported to induce ER stress through lipotoxic 
signaling pathways mediating a block in ER uptake of Ca2+ and a sustained depletion 
of ER Ca2+ stores (35,43). The idea that dysregulation of ER/cytosolic Ca2+ 
concentrations is involved in Golgi accumulation of GAD65 is supported by the fact 
that a similar effect could be achieved by strongly depolarizing cells by abruptly 
elevating extracellular glucose or KCl concentration (Phelps, Cianciaruso, and 
Baekkeskov unpublished results). While it is currently unknown how a change in 
calcium homeostasis could affect membrane trafficking of GAD65, it is of note that 
earlier studies have suggested modulation of the affinity of GAD65 to liposome 
membranes by calcium ion concentration (44). Interestingly, there is evidence to 
suggest that palmitate treatment of insulinoma cells alters the lipid composition of 
endomembranes and specifically disrupts lipid raft microdomains (45), a dynamic 
hub for palmitoylated proteins (46). It is of note that distribution of H-Ras into lipid 
rafts is regulated by its palmitoylation/depalmitoylation cycle (47), which shares 
similarities with the acylation cycle of GAD65 (16).  Thus, it is possible that 
alterations in lipid raft composition are part of the mechanism involved in perturbation 
of GAD65 trafficking and accumulation in Golgi membranes. 
Parallel to the important role of GAD65 as the highly regulated and the only 
GABA synthesizing enzyme in human beta cells, it can assume a detrimental role as 
a major target of autoimmunity associated with pancreatic human beta cell 
destruction and development of T1D in genetically susceptible individuals (2). The 
autoantigenicity of GAD65 is in stark contrast to the highly homologous GAD67 
isoform, which is not an independent autoantigen. GAD67 primarily differs from 
GAD65 in the N-terminal domain (48) that mediates hydrophobic post-translational 
modifications, membrane anchoring, palmitoylation and trafficking of GAD65 (12), 
suggesting that this region is integral to the susceptibility of GAD65 to become a 
pathogenic auto-antigen. GAD67 does not undergo hydrophobic modifications (49) 
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and can only be targeted to membranes by piggy-backing onto other proteins 
(15,38).  
Our data show that compared to depalmitoylated GAD65, palmitoylated GAD65 
induces a significantly stronger effector T-cell response by the T cell hybridoma 
T33.1, which recognizes GAD65274-286 in the context of DR4, a T1D MHC-class II 
susceptibility haplotype. Palmitoylation of peptide epitopes has been shown to 
enhance immunogenicity of autoimmune epitopes in experimental autoimmune 
encephalomyelitis (50) and in synthetic peptide vaccines (51). Palmitoylation of a 
protein increases its avidity for binding to membranes. The uptake of palmitoylated 
GAD65 by the DR4-positive human B-cell line Priess was significantly enhanced 
compared to non-palmitoylated GAD65. We posit that the increase in uptake, 
conferred by palmitoylation, may involve enhanced binding to the surface of Priess 
cells resulting in increased uptake by endocytosis and enhanced targeting to late 
endosomes for proteolytic processing and presentation to T cells in the context of 
MHC-class II antigens (reviewed in (52)). Palmitoylation of GAD65 may also affect 
antigen unfolding and proteolysis and alter the hierarchy of peptides displayed to 
CD4+ T cells. The T33.1 hybridoma reporter cell line is clonally restricted to a single 
MHC-class II binding epitope, GAD65274-286, which is distant from the palmitoylated 
cysteine residues in GAD65, aa 30 and 45. Therefore, the possibility of palmitoylation 
increasing the MHC-class II binding affinity of this epitope can be excluded in our 
experimental system. Rather, we suggest that increased stimulation of T33.1 cells 
reflects a quantitative increase in the levels of the GAD65274-286 epitope available for 
binding to DR4 in late endosomes and elevated expression on the surface of Priess 
cells. If palmitoylated GAD65, which has accumulated in TGN during ER stress, is 
released by distressed or dying beta cells and encountered by APCs, its heightened 
immunogenicity compared to non-palmitoylated GAD65 may stimulate autoimmunity 
in genetically predisposed individuals. An important agenda for future studies will be 
to elucidate the mechanisms by which palmitoylated, immunogenic GAD65 is 
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released from beta cells undergoing ER stress, as well as the determinants of that 
stress, which the results presented herein suggest could be key factors in the 
mechanism that results in autoimmunity to GAD65 associated with development of 
type I diabetes.  
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Supplementary Figure 1. Accumulation of GAD65 in Golgi membranes during palmitate induced 
ER stress in rat and human beta cells and in rat neurons.  
(A) Rat beta cells, (B) human beta cells, or (C) rat neurons were left untreated or treated with palmitate 
(500 μM) for 2 h. Fixed cells were immunostained for GAD65 and giantin (Golgi). Scale bar 10 μm. (D) 
Image quantification of GAD65 accumulation in the Golgi compartment expressed as the ratio of MFI for 
GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell excluding the 
nucleus. Results are presented as mean ± SEM (n = 30-63 cells analyzed per condition for rat beta 
cells, n = 24-38 cells analyzed per condition for human beta cells, n = 15-17 cells analyzed per condition 
for rat neurons). Data were analyzed using Student’s t-test (*** P < 0.001).  
 
 
Supplementary Figure 2. Time course of Golgi accumulation of GAD65 upon palmitate treatment. 
Confocal analyses of monolayer cultures of primary rat beta cells left untreated or treated with 100 μM 
palmitate or 500 μM palmitate for 10 min, 2 h, and 18 h respectively. Fixed cells were immunostained for 
GAD65, insulin, and CHOP. Staining for CHOP and higher magnification GAD65 images of the framed 
regions in the left panel are shown in Figure 4. Scale bars 10 μm.  
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Supplementary Figure 3. Fluorescence recovery after photobleaching in the Golgi of WT but not 
palmitoylation-deficient GAD65 is inhibited during palmitate-induced ER stress.  
(A) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-
GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with palmitate (500 μM) for 1 h. 
Results are presented as mean ± SEM (n = 9-15 cells per condition). (B) Halftimes of Golgi 
fluorescence recovery in primary rat beta cells. Results are presented as the mean ± SEM (n = 9-15 
cells per condition). Data were analyzed by Student’s t-test comparing the halftime parameter between 
association curve fits (* P < 0.05, *** P < 0.001).  
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Supplementary Figure 4. Fluorescence recovery after photobleaching in the Golgi of WT but not 
palmitoylation-deficient GAD65 is inhibited during thapsigargin-induced ER stress.  
(A) Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WT GAD65-
GFP or GAD65(C30,45A) in primary rat beta cells pretreated or not with thapsigargin (2 μM) for 1 h. 
Results are presented as mean ± SEM (n = 6-10 cells per condition). (B) Halftimes of Golgi 
fluorescence recovery in primary rat beta cells. Results are presented as the mean ± SEM (n = 6-10 
cells per condition). Data were analyzed by Student’s t-test comparing the halftime parameter between 
association curve fits (* P < 0.05, *** P < 0.001).  
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Supplementary Table 1. Demographic and patient information for JDRF nPOD human pancreatic 
sections from non-diabetic donors. Donor information obtained from the nPOD online pathology 
database. Data shown in the last column are from this study.  
 
 
Supplementary Table 2. Demographic and patient information for JDRF nPOD human pancreatic 
sections from GADA+ donors who have not yet progressed to clinical type 1 diabetes. Donor information 
obtained from the nPOD online pathology database. Data shown in the last column are from this study.  
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Supplementary Table 3. Demographic and patient information for JDRF nPOD human pancreatic 
sections from type 1 diabetic donors. Donor information obtained from the nPOD online pathology 
database. Data shown in the last column are from this study.  
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CHAPTER 4 
Primary human and rat beta cells release the 
intracellular autoantigens GAD65, IA-2 and proinsulin 
in exosomes together with cytokine-induced 
enhancers of immunity 
Adapted from the original manuscript 
Chiara Cianciaruso, Edward A. Phelps, Miriella Pasquier, Romain Hamelin, Davide 
Demurtas, Mohamed Alibashe Ahmed, Lorenzo Piemonti, Sachiko Hirosue, Melody 
Swartz, Michele De Palma, Jeffrey A. Hubbell, Steinunn Baekkeskov 
 
4.1   ABSTRACT  
The target autoantigens in several organ-specific autoimmune diseases, 
including type 1 diabetes (T1D), are intracellular membrane proteins, whose initial 
encounter with the immune system is poorly understood. Here we propose a new 
model for how these proteins can initiate autoimmunity. We found that rat and human 
pancreatic islets release the intracellular beta cell autoantigens in human T1D, 
GAD65, IA-2 and proinsulin, in exosomes, which are taken up by and activate 
dendritic cells. Accordingly, anchoring of GAD65 to exosome-mimetic liposomes 
strongly boosted antigen presentation and T cell activation in the context of the 
human type 1 diabetes susceptibility haplotype HLA-DR4. Cytokine-induced ER 
stress enhanced exosome secretion by beta cells, induced exosomal release of the 
immunostimulatory chaperones calreticulin, Gp96 and ORP150 and increased 
exosomal stimulation of antigen presenting cells. We propose that stress-induced 
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exosomal release of intracellular autoantigens and immunostimulatory chaperones 
may play a role in initiation of autoimmune responses in T1D. 
 
4.2   INTRODUCTION  
Type 1 diabetes (T1D) in humans is an autoimmune disease characterized by 
circulating autoantibodies, lymphocytic infiltration of pancreatic islets of Langerhans, 
and cell-specific destruction of beta cells, leading to insulin deficiency (1). Prior to 
lymphocytic infiltration, physiological islet abnormalities have been described in the 
non-obese diabetic (NOD) mouse model of T1D, including upregulation of 
inflammatory cytokines (1) and increased endoplasmic reticulum (ER) stress in beta 
cells (2). Furthermore, the importance of ER stress and the beneficial effects of 
restoring organelle function have been reported (3).  
Two main target autoantigens in human T1D, GAD65 (4) and IA-2 (5) are rare 
intracellular membrane proteins in beta cells. Circulating autoantibodies to these 
proteins are an early marker of beta cell autoimmunity in man and can be used 
together with HLA-Class II haplotyping to detect individuals at risk long before clinical 
onset of disease (6). The mechanisms by which these intracellular autoantigens are 
initially recognized by the immune system, taken up by antigen presenting cells 
(APCs), and presented to self-reactive T cells have, however, not been clarified. A 
third autoantigen, insulin, constitutes ~50% of beta cell proteins and is released by 
regulated exocytosis of secretory granules (7). There is evidence that epitopes in 
proinsulin, the uncleaved prohormone form of insulin, escape immune tolerance in 
T1D (7,8). 
MIN6 and INS-1 insulinoma cells, derived from a mouse and rat beta cell 
tumor, respectively, have been reported to release extracellular vesicles (EVs), 
including exosomes (9). Exosomes are small-diameter (30-150 nm) biologically 
active vesicles that are secreted in the extracellular space by most cell types, 
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following the formation of multivesicular bodies (MVBs) in the late endosomal 
pathway and their fusion with the plasma membrane (10). 
Exosomes can display immunostimulatory and immunoregulatory functions 
(11). In the context of T1D, exosomes from MIN6 cells were reported to stimulate 
autoreactive NOD T cells (9) and marginal zone-like B cells that accumulate in the 
pancreas of prediabetic NOD mice (12). In addition, islet-associated mesenchymal 
stem cell-like cells were shown to produce immunostimulatory exosomes that 
activated autoreactive T and B cells in NOD mice (13). We and others have been 
unable to detect expression of the GAD65 protein in mouse islet cells and in 
insulinoma cells (14-16) and neither GAD65 nor IA-2 appear to be required for 
development of T1D in the NOD mouse (17,18).  
Here we have isolated exosomes from primary human and rat islets, which, 
differently from insulinoma cells and mouse islets, express GAD65 in addition to IA-2 
and insulin. We present the characterization of flotillin1, CD9, and CD81-containing 
exosomes and report the release of GAD65, IA-2 and proinsulin/insulin therein. We 
further show that cytokine-induced ER stress results in increased release of 
exosomes decorated with inflammatory proteins that may promote beta cell 
autoimmunity. 
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4.3   METHODS  
 
4.3.1  Islets and cell cultures 
Rat islets were isolated from P5 Sprague Dawley rats (18) and from HLA-
DR4+/+ NOD mice (19) and cultured as previously described (18). DR4+/+NOD mice 
were obtained from Dr. Grete Sønderstrup, Stanford University. These mice are 
homozygous for the human T1D MHC-class II susceptibility haplotype DRA1*0101, 
DRB1*0401 (hereafter referred to as DR4) and express DR4 antigens as well as 
human CD4 in lymphoid cells, and human proinsulin in pancreatic β cells. The mice 
are negative for expression of murine MHC-class II IA and IE antigens (20). They do 
not develop T1D. Human islets, received through the European Consortium for Islet 
Transplantation (ECIT) Islets for Basic Research Program, were obtained from six 
non-diabetic donors, four males and two females, age 36-59 years with a body mass 
index of 20-29 kg/m2. The causes of death were stroke (3 donors), cerebral bleeding 
(1 donor) and cardiac arrest (1 donor). Humans islets (95-100% purity) were cultured 
in Connaught Medical Research Laboratories 1066 (CMRL) medium with 2 mM L-
Glutamine, 25 mM Hepes and 10% FBS. Monolayer cultures were derived from 
whole islets dispersed into single cells and seeded on Thermanox-coverslips 
(ThermoFisher Scientific) coated with HTB-9 cell-derived extracellular matrix (21). 
Bone marrow dendritic cells (BMDC) were isolated from HLA-DR4+/+ NOD mice (22) 
and cultured for 8 days with RPMI 1640 GlutaMAX medium with 11 mM glucose, 
10% FBS, 1% Antibiotic-Antimycotic and GM-CSF (200 μg /ml, PeproTech). INS-1E 
cells (23) were cultured in RPMI 1640 GlutaMAX with 10% FBS, 1% P/S, 1 mM 
sodium pyruvate, 10 mM Hepes and 50 μM β-mercaptoethanol. MIN6 cells (24) were 
cultured in DMEM GlutaMAX medium with 25 mM glucose, 15%FBS, 1% P/S and 70 
μM β-mercaptoethanol. HTB-9 cells were cultured in RPMI 1640 GlutaMAX medium 
with 10% FBS and 1% P/S. The DR4 (DRA1*0101, DRB1*0401) positive human 
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EBV-transformed B cell line Priess (25) was cultured in Iscove’s Modified Dulbecco’s 
Medium GlutaMAX medium (IMDM) with 10% FBS and 1% P/S and used for antigen 
presentation. 
 
4.3.2  Exosome isolation 
Rat islets, human islets, INS-1E or Priess cells were seeded in exosome-
depleted medium (26). Supernatant was collected every two or three days. For 
comparative analyses of exosomes released with and without cytokines, rat and 
human islets were divided into cell culture dishes (500 islets each) and rat IL1β 
(10U/ml) and IFNγ (10U/ml) (R&D Systems) or human IL1β (20U/ml) and IFNγ (10 
U/ml) (R&D Systems) added to half of the plates. This concentration of cytokines has 
been shown to result in a very mild form of ER stress in beta cells (18). Culture 
media were collected and replaced with fresh media with or without cytokines every 
two days for a total of six days. Islets were counted after each replacement of 
medium: the total loss of islets in medium with and without cytokines was ≤20% and 
≤5% respectively for rat islets at the end of the collection period. Trypan blue staining 
of islets cells following dispersion of islet samples in trypsin/EDTA revealed robust 
viability of cells with and without cytokines throughout the collection period 
(Supporting Figures 1A and 2A). 
Exosomes from culture media were isolated by differential centrifugation (26). 
In brief, media were centrifuged at 300xg for 10 min to remove live cells, followed by 
2,000xg for 10 min to remove dead cells followed by centrifugation at 10,000xg for 35 
min at 4°C to remove cell debris, large vesicles and heavy membranes, including 
Golgi membranes, lysosomes and apoptotic bodies. Supernatants were transferred 
to a new tube and centrifuged at 110,000xg for 70 min at 4°C to isolate exosomes. 
The resulting pellet was re-suspended, washed in 35 ml PBS to eliminate serum and 
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secreted proteins and re-centrifuged. The final pellet was re-suspended in 50-100 μl 
of PBS and stored at -80°C.  
 
4.3.3  Transmission Electron Microscopy  
Exosomes or liposomes (15 μl, at different dilutions in PBS) were applied to 
carbon-coated 400 mesh grids (Canemco-Marivac), negatively stained with 2% 
uranyl acetate, and images obtained with a transmission electron microscope 
(Tecnai Spirit, FEI Company).  
 
4.3.4  Nanoparticle Tracking Analysis 
Exosomes and liposomes (1:1,000 in PBS) were analyzed using a Nanoparticle 
Tracking Analyses (NTA) instrument NS300 (NanoSight, Malvern Instruments Ltd.). 
Five measurements of 60 seconds were recorded consecutively for each sample and 
a 532 nm laser diode source was used to analyze fluorescence of Bodipy-labeled 
exosomes. 
 
4.3.5  Proteomics  
EV preparations (5 μg protein) from untreated or cytokine-treated rat islets, 
untreated human islets, or INS-1E cells were analyzed by liquid chromatography 
tandem mass spectrometry (LC-MS/MS). Briefly, each sample was digested in 
solution as previously described (27). Peptides were desalted using StageTips and 
dried in a vacuum concentrator. For LC-MS/MS analysis, resuspended peptides were 
separated by reverse phase chromatography on a Dionex Ultimate 3000 RSLC nano 
UPLC system connected in-line with an Orbitrap Elite (ThermoFisher Scientific). 
Database search was performed using Mascot 2.5 (Matrix Science) and SEQUEST 
in Proteome Discoverer v.1.4. against a human or rat Uniprot protein database. Data 
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were further processed and inspected in ScaffoldTM 4.2.1 (Proteome Software). 
Normalized quantitative values were utilized to compare the protein profile in 
exosomes from three different preparations of untreated and cytokine-treated rat 
islets. The normalization scheme in Scaffold adjusts the sum of the selected 
quantitative value for all proteins in the list within each MS sample to a common 
value: the average of the sums of all MS samples present in the experiment. This is 
achieved by applying a scaling factor for each sample to each protein or protein 
group adjusting in this way the selected value to a normalized “Quantitative Value”. 
Normalized quantitative values were utilized to compare the protein profile in 
exosomes from untreated and cytokine-treated rat islets. For proteomic detection of 
GAD65 and IA-2, exosomal proteins were separated by SDS-PAGE (Invitrogen). 
Proteins were eluted from gel slices corresponding to the relative mobility of GAD65 
and IA-2 and subjected to LC-MS/MS analyses (27).  
 
4.3.6  SDS-PAGE and Western Blot analysis 
Cell lysates were prepared by resuspending pellets of 200 islets or 2 x 106 INS-
1E or MIN6 cells in 200 μl of RIPA buffer (Sigma) and incubating on ice for 20 
minutes followed by centrifugation at 13,000xg for 20 minutes at 4°C and collection 
of the supernatant. Brain extracts from P5 rats were obtained by collagenase D 
(Roche) digestion on a 40 μm cell strainer. After centrifugation at 600xg for 5 minutes 
at 4°C, the pellet was resuspended in 1 ml RIPA buffer and processed as described 
above. The BCA protein assay kit (ThermoFisher Scientific) was used to measure 
the protein concentration of cell extracts. A total of 5-15 μg protein per lane was 
analyzed SDS-PAGE and Western Blotting as described (18). Recombinant human 
GAD65 used for standard was from FIRS Laboratories RSR. Primary antibodies 
used were: GAD1701 (rabbit anti-GAD65/GAD67) (14) 1:5000, rabbit anti-flotillin1 
(donated by G. Van der Goot) 1:2000, mouse anti-CD9 antibody (Santa Cruz, sc-
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13118) 1:100, 76F-B4 (mouse anti-IA-2, donated by E. Bonifacio) (28) 1:20, mouse 
anti-beta actin (Sigma, A1978) 1:2000, chicken anti-Calreticulin (Abcam, ab14234) 
1:1000, rabbit anti-Gp96 (Abcam, ab13509) 1:1000, mouse anti-PDI (BD 
Transduction Laboratories, 610947) 1:500 and mouse anti-Alix (Cell Signaling, 2171) 
1:1000.  
 
4.3.7  Quantitation of insulin in exosomes by ELISA 
EVs from human or rat islets were lysed in PBS+1% Triton and subjected to 
serial dilutions prior to quantitative analyses using ELISA kits for human or rat insulin 
and proinsulin (Mercodia). 
 
4.3.8  Immunofluorescence 
Single islet cells were fixed with 4% PFA and blocked/permeabilized in 
PBS+0.3% Triton, 10% goat or donkey serum. The primary antibodies mouse anti-
GAD65 (15) 1:1000, sheep anti-TGN38 (Biorad, AHP499) 1:100, rabbit anti-flotillin1 
1:200, rabbit anti-CHOP (Santa Cruz, sc-575) 1:100, guinea pig anti-insulin (Linco, 
4011-01) 1:1000 and rabbit anti-CD81 (Sigma, SAB3500454) 1:300 were incubated 
overnight at 4°C in PBS+0.3% Triton, 5% goat/donkey serum. Alexa Fluor-
conjugated secondary antibodies (Life Technologies) were incubated at 1:200 in 
PBS+0.3% Triton for 30 min at RT. Coverslips were mounted with Prolong Gold 
antifade reagent with or without DAPI (Life Technologies). Samples were imaged on 
a Zeiss LSM700 confocal microscope and images processed in ImageJ.   
 
4.3.9  Treatment and transfections of islet monolayer cultures 
Rat islet cells were incubated with rat cytokines (IFNγ and IL1β, 10 U/ml each) 
for 4, 8 or 24 hours.  
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Transfection with the MAGT1-GFP plasmid (29) and GFP-Rab11 WT plasmid 
(30) were performed using LipofectamineTM2000 (Life Technologies). Cell labeling 
using BODIPY®TR-Ceramide (Life Technologies) was done according to the 
manufacturers protocol. 
 
4.3.10  Uptake of islet-exosomes by antigen presenting cells  
Rat islet-exosomes (10 ng protein/ml) were labeled with 5 μM of BODIPY®TR-
Ceramide (Life Technologies) in PBS for 30 min at RT (31), followed by two PBS 
washes and ultracentrifugations at 110,000xg for 70 min at 4°C.  
Bodipy-labeled exosomes (20-25 μg protein/ml) were incubated with 100,000 
DR4+/+ BMDCs or Priess cells labeled with 0.5 μM carboxyfluorescein succinimidyl 
ester (CFSE) (Life Technologies). Uptake was analyzed on a Zeiss LSM700 confocal 
microscope with a stage-mounted incubation chamber at 37°C, 5%CO2. Cells 
collected at the end of the experiment were blocked with anti-mouse CD16/32 
(BioLegend, 101302) 1:200, stained with LIVE/DEAD® Violet (Life Technologies) and 
CD11c-APC antibody (eBioscience, 17-0114-82) 1:800, and analyzed by BDTMLSRII 
Flow Cytometer (BD Biosciences) and FlowJo software.  
 
4.3.11  Immunostimulation of BMDCs by islet-derived exosomes  
Rat and human islet-EVs (40 and 50 μg protein/ml) were incubated for 24 
hours with 50,000 DR4+/+BMDCs. PBS and CpG-A (5 μg/ml, ODN1585, InvivoGen) 
were used as negative and positive controls respectively. Concentrations of TNFα, 
IL6 and IL1β in the cell supernatant were measured by ELISA (eBioscience).  
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4.3.12  Preparation of GAD65-liposomes mimicking exosomes 
Liposomes were prepared according to the protocol by Masserini et al. (32). 
Ganglioside GM3, cholesterol and sphingomyelin (Avanti Polar Lipids Inc.) were 
dissolved in chloroform-methanol (2:1 v/v) in a molar ratio of 8:1:1. After rehydration 
of the lipid film in PBS, liposomes were size-selected by extrusion through 100 nm 
nucleopore track-etched membranes (Whatman) using a LipexTM extruder (Northern 
Lipids Inc.).  Endotoxin-free recombinant human GAD65 (1 mg/ml) produced in yeast 
(rhGAD65) (FIRS Laboratories RSR) was incubated with liposomes (1x1011 
particles/ml), in a total volume of 100 μl, at RT for 2h, and purified by 
ultracentrifugation (100,000xg for 70 minutes) to remove unbound protein. Anchoring 
of GAD65 to liposome membranes can be easily achieved due to the presence of 
hydrophobic post-translational modifications including a double palmitoylation (33). 
The BCA protein assay kit (ThermoFisher Scientific) was used to analyze the 
concentration of GAD65 conjugated to liposomes. 
 
4.3.13  Immunogenicity of GAD65-liposomes 
To test antigenicity of free GAD65 compared to liposome-conjugated GAD65, 
free rhGAD65 protein and GAD65-liposomes were incubated for 24 hours with 
50,000 DR4+/+ NOD BMDCs. DR4 (DRA1*0101, DRB1*0401) restricted T33.1 T cells 
were added and incubation continued overnight. PBS or empty liposomes (in 
equivalent amount to the highest concentration of GAD65-liposomes used in the 
assay) were used as negative controls and 0.5 μg/ml GAD274-286 peptide (GenScript) 
was used as a positive control. IL2 secretion by T cells was analyzed by ELISA.  
 
4.3.14  Statistical analyses 
Means among three or more groups were compared by analysis of variance 
(ANOVA) in GraphPad Prism 6. If deemed significant, Tukey’s post-hoc pairwise 
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comparisons were performed. Means between two groups were compared using 
Student's t-test. A confidence level of 95% was considered significant. 
 
4.3.15  Ethical approval 
Animals were used under EPFL animal regulation guidelines and an IACUC 
approved protocol. Human islets were received from University Hospital of Geneva 
and San Raffaele Scientific Institute, Milan, through ECIT, and approved by the 
Institutional Review Board of Geneva University Hospital (CER Nr. 05–028) and the 
Ethics Committee of San Raffaele Institute (IPF002-2014). 
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4.4   RESULTS  
?
4.4.1  Rat and human pancreatic islets release the GAD65, IA-2 and 
insulin/proinsulin autoantigens in EVs with characteristics of exosomes 
EVs were isolated from primary rat and human pancreatic islet cells and the rat 
insulinoma cell line INS-1E by differential centrifugations of culture supernatants (26). 
Transmission electron microscopic (TEM) analysis of EVs from rat and human islets 
demonstrated the presence of vesicles with size and shape compatible with those of 
exosomes (34) (Figure 1A). Nanoparticle-tracking analysis (NTA) indicated a 
uniform size distribution, with a major peak at 143±5 nm and 139±5 nm for rat and 
human EVs respectively (Figure 1B), similar to the size of exosomes from neural 
stem cells (34). 
The proteome of EVs from rat or human islets and INS-1E cells were analyzed 
by LC-MS/MS and found to contain proteins previously identified in exosomes from 
other cell types (Supplementary Table 1). Those included flotillin1, which appears to 
control sorting of specific proteins toward MVB destined for exosomal secretion (35), 
the tetraspanins CD9 and CD81, which may play a critical role in mediating protein 
loading and inclusion into endosomal membranes and exosomes (36,37) while Alix 
and CD63 were not detected. Furthermore, Rab11, Rab27a, Rab27b and Rab35, 
which are implicated in the biogenesis of exosomes (38,39), and Rab1, which is 
involved in vesicle trafficking from ER to Golgi intermediate membranes (40), were 
detected in islet EVs together with the autoantigen proinsulin/insulin 
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(Supplementary Table 1). As shown in Figure 1C, insulin was an integral part of 
islet exosomes, rather than a contamination from secreted insulin and accounted for 
7-8% of human- and 2-3% of rat-islet exosome proteins as measured by ELISA 
(Figure 1D). Proinsulin constituted ~12% and ~0.5% of total insulin in human and rat 
islet exosomes respectively (Figure 1D). The rare beta cell autoantigens GAD65 and 
IA-2 were not detected in islet-EVs by LC-MS/MS of total islet cells. GAD65 and IA-2 
are difficult to detect by LC-MS/MS likely due to their hydrophobicity and poor 
peptide ionization. However, both proteins were detected in human islet exosomes 
following pre-purification by SDS-PAGE and elution of gel slices in their mobility 
range (Supporting Figure 3).   
We next analyzed expression of GAD65 and IA-2 and the exosomal markers 
flotillin1 and CD9 by Western blotting (WB) of islet EVs and compared with 
expression in total islet lysates. These analyses unequivocally identified the 
autoantigens GAD65 and IA-2 in both human and rat EVs (Figure 1E, F, 
Supplementary Figure 1A and 1B). Human islets only express the GAD65 isoform, 
while rat islets primarily express the GAD65 isoform but also the non-autoantigenic 
isoform GAD67, which can form heterodimers with GAD65 and become membrane 
bound in rat islet beta cells (15). Both isoforms were detected in rat islet exosomes 
(Figure 1E, Supplementary Figure 1A). In contrast to a previous report (9), GAD65 
was not detected in lysates of the mouse insulinoma cell line MIN6. Furthermore, as 
reported previously (14-16), only GAD67 but not GAD65 was detected in mouse islet 
and rat INS-1E cells (Supplementary Figure 1A). The ratio of GAD65 in exosomes 
and total lysates was approximately 1:2 in human islets and 1:5 in rat islets (Figure 
1E). Since approximately half of total beta cell GAD65 is firmly membrane-anchored 
(41), the concentration ratio of GAD65 in EVs vs total beta cell membranes was ~1:1 
for human and ~2:5 for rat. The transmembrane IA-2 autoantigen of 68-70 kD (28) 
was detected in human and rat islet-exosomes (Figure 1F, Supplementary Figure 
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1B); the concentration ratio between exosomes and total islet lysate was ~1:2 for IA-
2 in human and ~1:6 in rat islets (Figure 1F).  
The WB analyses revealed a 25-fold enrichment of the exosomal marker 
flotillin1 in EVs from both human and rat pancreatic islets compared to islet lysates 
(Figure 1G). CD9 was detected in human islet-EVs on WB but was not enriched over 
lysates (Figure 1G). The exosome marker Alix was detected in islet lysates and EVs 
from INS-1E cells, but was below detection limit in islet-EVs (Supplementary Figure 
1C), consistent with the notion that in islet cells, flotillin1-, CD9- and CD81-positive 
exosomes represent a population of exosomes distinct from and more abundant than 
Alix-, syndecan/syntenin- and CD63-positive exosomes (42).  
Together, the results suggest that human and rat pancreatic islets release EVs 
presenting characteristics of flotillin1-, CD9- and CD81-positive exosomes. 
Importantly, islet-exosomes contain the GAD65, IA-2 and insulin/proinsulin 
autoantigens associated with development of T1D in humans.  
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Figure 1. Human and rat islets release extracellular vesicles, mainly exosomes, containing the 
exosomal markers flotillin1 and CD9 and the beta cell autoantigens GAD65, IA-2 and 
proinsulin/insulin. 
(A) EM analysis of rat and human islet extracellular vesicles (EVs) with “cup-shaped” morphology and 
30–200 nm in diameter, with an average size of 120 nm, in both rat and human preparations. Vesicle 
sizes were estimated by measuring the diameters of 20 exosomes in five different fields. While some 
vesicles are larger (150-200 nm), the main constituents of the EV preparations are exosomes (30-150 
nm). Scale bars: 200 nm. (B) Particle-size distribution of EVs from rat and human islets using 
nanoparticle tracking analyses. Data are representative of n = 3 independent experiments. (C) Aliquots 
of purified rat islet-exosomes were resuspended in PBS, PBS supplemented with NaCl to a final 
concentration of 0.5 M, or PBS containing 1% Triton X-100 and incubated for 1h followed by 
sedimentation at 110,000xg for 1h. Pellets were extracted in PBS/1% Triton X-100 and supernatants 
were subjected to serial dilutions and analyzed for insulin/proinsulin by ELISA. Insulin is only released 
from exosomes by detergent suggesting that is an integral part of exosomes rather than a contaminant 
from islet cell culture media. Analyses were performed in technical triplicates. Results are reported as 
mean ± SD. (D) Insulin/proinsulin content of human and rat islet-exosomes measured by ELISA after 
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extraction in PBS containing 1% Triton X-100. Data for human insulin/proinsulin are shown as mean ± 
SD of 3 independent experiments. Data for rat insulin/proinsulin are reported as mean ± SD for the 
triplicate rat islet EV lysates shown in (C). Data are representative of 3 independent experiments. (E-G) 
Western blot analyses of (E) GAD65, (F) IA-2 and (G) CD9 and flotillin1 expression in total lysates or EV 
preparations of rat and human islets. Human islets only express the GAD65 isoform of GAD, while rat 
islets express both GAD65 and the non-autoantigenic isoform GAD67. The results shown are 
representative of 2-5 independent experiments.  
 
4.4.2  Trafficking of the autoantigen GAD65 to EVs may involve a pathway from 
the Golgi compartment to MVB via the perinuclear recycling endosome 
compartment 
We investigated whether there is a convergence between pathways for 
exosome formation and the known intracellular trafficking of GAD65, which would 
facilitate loading of the autoantigen into EVs/exosomes. 
Two pathways have been proposed for sorting membrane proteins to MVBs 
and exosomes. The first involves endocytosis of plasma membrane proteins and 
transport through early endosomes to late endosomes (LEs) and MVBs (10). The 
second involves transport from the trans Golgi network (TGN) to recycling 
endosomes and LE/MVB (31,38). Firmly membrane-anchored GAD65 is primarily 
localized to the TGN and peripheral vesicles in beta cells but is not detected at the 
plasma membrane (33,43). Furthermore, the transmembrane protein IA-2 and 
proinsulin/insulin are processed in the ER and Golgi prior to targeting to the 
membrane and lumen of insulin secretory granules respectively which is where 
proinsulin undergoes the final processing to insulin prior to regulated secretion (7). 
We explored the possibility that islet beta cells form MVBs and exosomes using 
the TGN pathway, and asked whether GAD65 can be detected along this route. The 
small GTP-binding protein Rab11 is localized in the perinuclear endosomal recycling 
compartment (ERC) and is implicated in the control of trafficking to and from this 
compartment (44). Moreover, Rab11 is implicated in the exosomal biogenesis 
pathway originating at the TGN (38) and appears to promote the fusion of MVBs with 
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the plasma membrane to release exosomes (45). We, therefore, assessed the 
possible colocalization of Rab11 with GAD65 and the TGN marker TGN38 in rat islet 
cells expressing GFP-Rab11a. As reported previously (43), GAD65 colocalized with 
the TGN38 marker protein in the TGN (Figure 2A, arrowheads). Furthermore, 
GAD65 and GFP-Rab11a colocalized in the perinuclear ERC, as well as in a few 
smaller vesicular structures close to the surface of beta cells (Figure 2A, arrows). 
Colocalization between GAD65 and the exosomal marker flotillin1 was detected in 
beta cells both in vesicle-like compartments in proximity to the Golgi compartment as 
well as in the periphery of the cell (Figure 2B, arrows). Similarly, the exosomal 
marker CD81 and insulin/proinsulin colocalized extensively in vesicles budding off 
from the TGN (Figure 2C, arrows) or localized in the periphery (Figure 2C, 
arrowheads). 
Laulagnier et al. (31) found that a population of exosomes released by RBL-
2H3 cells is characterized by lipid composition similar to that of Golgi membranes 
and preferably absorbs a fluorescent Bodipy-Ceramide stain used for labeling of 
Golgi membranes. We confirmed that Bodipy-Ceramide specifically labels the Golgi 
compartment in rat islet cells (Figure 2D). We assessed the efficiency and specificity 
of Bodipy-Ceramide labeling of rat islet-exosomes using NTA. No significant 
differences were detected in the vesicle size distribution between the light scattering 
and the fluorescence acquisition settings (Figure 2E), suggesting that the labeling 
procedure indeed targets exosomes. Thus the lipid composition of islet-exosomes 
may resemble that of the Golgi, suggesting that in primary islet cells, a sizable 
fraction of MVBs may originate from Golgi membranes. 
 Taken together, the results support the notion of an exosome biogenesis 
pathway for beta cell autoantigens that originates in the TGN. For GAD65, the 
pathway appears to pass through the ERC and involve Rab11.  
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Figure 2. Analyses of a putative pathway for biogenesis of beta cell EVs from the trans-Golgi 
network. 
(A) Confocal analyses of primary rat islet cells transfected with GFP-Rab11 and immunostained for 
GAD65 (green) and the trans-Golgi marker TGN38 (blue) revealing colocalization of GAD65 and TGN38 
(arrowheads), minimal colocalization of TGN38 and GFP-Rab11, and colocalization of GAD65 and 
GFP-Rab11 (arrows) in the perinuclear endosomal recycling compartment close to the Golgi region and 
in vesicular structures in the cell periphery. (B) Confocal analyses of immunostaining of primary human 
islet cells for GAD65 (green), the exosomal marker flotillin1 (red) reveals colocalization in vesicular 
structures in proximity to (i) the Golgi compartment, (ii) between Golgi and peripheral structures and (iii) 
in the periphery close to the plasma membrane. (C) Confocal analyses of immunostaining of primary rat 
islet cells for insulin/proinsulin (green), the exosomal marker CD81 (red) and TGN38 (magenta) reveals 
co-localization of CD81 and insulin/proinsulin in vesicles budding off the Golgi compartment (arrows) 
and localized in the periphery (arrowheads). Nuclei are stained in blue with DAPI.   
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(D) Primary rat islet cells transfected with a plasmid encoding the Golgi protein MAGT1-GFP and 
incubated with Bodipy-Ceramide for 30 minutes reveal specific staining of lipids in Golgi membranes by 
the Bodipy-Ceramide dye. (E) Nanoparticle tracking analyses of Bodipy-Ceramide labeled rat islet-
exosomes reveal a uniform size distribution with a major peak at 137±5 nm similar to that determined 
with no fluorescence filter, suggesting that the labeling procedure is effective and exosome-specific. 
All scale bars are 10 μm.  
 
4.4.3  Uptake of islet-EVs results in stimulation of HLA-DR4+/+dendritic cells  
We next assessed the ability of professional APCs to take up islet-EVs. 
Incubation of Bodipy-labeled islet-exosomes with bone marrow-derived dendritic cells 
(BMDCs) from HLA-DR4+/+ transgenic mice (Figure 3A, 3B, Supplementary Figure 
2A and 2C) and the DR4+/+ human Priess B cell line (Supplementary Figure 2B and 
2D) revealed an efficient and rapid uptake within 2-3 hours, as shown by fluorescent 
microscopy and flow cytometry analyses. To test the potential ability of EVs to 
activate APCs, rat islet-EVs were incubated with DR4+/+ BMDCs. During 24 hours 
incubation, secretion of the pro-inflammatory molecules TNFα, IL6 and IL1β was 
significantly increased in the presence of islet-EVs compared to PBS (Figure 3C). 
Taken together, the results suggest that EVs from primary islets are efficiently taken 
up by APCs resulting in their stimulation.  
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Figure 3. Activation of BMDCs upon uptake of islet-exosomes. 
(A) Uptake of Bodipy-Ceramide labeled rat islet-exosomes by bone marrow-derived DR4+/+ dendritic 
cells analyzed by confocal live cell image acquisitions. At one hour, Bodipy-exosomes were detected at 
the surface of cells. Exosome internalization was observed around two hours after incubation, while a 
more diffuse red staining was detected at five hours, indicating diffusion of the dye within the cells. 
Scale bars: 10 μm. (B) Uptake of Bodipy-exosomes by BMDCs. Free Bodipy dye processed the same 
way as the Bodipy-labeled islet-exosomes was used as a control. The results are shown as mean 
fluorescence intensity (MFI) ± SD for a total of 20 cells sampled from three different fields. (C) Secretion 
of the pro-inflammatory cytokines TNFα, IL6, and IL1β by DR4+/+ BMDCs after stimulation by rat islet-
exosomes or PBS and CpG as negative and positive controls respectively. Analyses were performed in 
technical triplicates. The results are reported as mean ± SD and are representative of two independent 
experiments. Statistical analyses were performed using a one-way ANOVA analysis (p***<0.001).  
 
4.4.4  GAD65 exosome mimetics activate GAD65-specific T cells 
In order to investigate the potential autoantigenicity of GAD65 in islet 
exosomes, we used the GAD65-specific T cell hybridoma, T33.1, which recognizes 
the GAD65274-286 peptide in the context of HLA-DR4 (25,46). T33.1 cells require ~1-5 
μg/ml GAD65 for stimulation as measured by IL-2 secretion. Since the quantity of 
EVs that can be isolated from primary islets is limited (~2-3 μg/day from 10,000 
islets) and the concentration of GAD65 in islet-EVs is low (~0.05% of total exosomal 
protein), we sought to engineer an analog for antigen presentation of GAD65 that 
mimicked features of natural islet exosomes. Purified endotoxin free human 
recombinant GAD65 antigen was inserted in liposomes that approximated the size 
and membrane lipid composition of exosomes (10): unilamellar vesicles, 100 nm in 
diameter, containing cholesterol, sphingomyelin and ganglioside GM3 (Figure 4A). 
Different concentrations of either free GAD65 antigen or GAD65 bound to 
liposomes were incubated for 24 hours with DR4+/+ BMDCs as APCs, and then T33.1 
hybridoma cells (GAD65-specific T cells) were added and incubated for 24 hours. 
This concentration range of GAD65 induces activation of T33.1 hybridoma cells and 
release of interleukin-2 (IL2) in a dose dependent manner (25,46). The GAD65274-286 
peptide was used as a positive control at a concentration that consistently induces 
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IL2 release at around 150-200 μg/ml from T33.1 cells. Analyses of the IL2 
concentration in the supernatant revealed a 50-fold increase in T33.1 activation by 
GAD65-liposomes compared to the free autoantigen (Figure 4B), suggesting that 
presentation of GAD65 in the context of liposomes possessing lipids characteristic of 
exosomes significantly enhances T cell stimulation of the protein compared to free 
antigen. In a recent study (18), we have shown that compared to free GAD65, 
palmitoylated GAD65 more efficiently taken up by APCs and enhances stimulation of 
T cells consistent with the notion that in general, GAD65 inserted in a membrane is 
more immunogenic than free GAD65.    
 
Figure 4. GAD65-exosome mimetics induce strong GAD65-specific T cell activation.  
(A) Nanoparticle tracking analyses and transmission electron microscopy analyses of exosome-mimetic 
liposomes reveal an average size of ~100 nm. Scale bar: 200 nm. (B) Activation of GAD65-specific 
DR4-restricted T33.1 hybridoma cells by DR4+/+ BMDCs that had been incubated with either free 
GAD65 protein or GAD65 anchored to liposomes and using PBS, empty liposomes, or GAD274-286 
peptide (0.5 μg/ml) as negative and positive controls. Analyses were performed in technical triplicates. 
Statistical analyses were performed using a one-way ANOVA (p***<0.001). The results are 
representative of two independent experiments.  
 
4.4.5  Cytokine-induced ER stress increases EV release by pancreatic islets 
and induces the expression of immune stimulatory chaperones  
ER stress and the resulting beta cell dysfunction are implicated in the 
pathogenesis of T1D (3,47). We addressed the question whether induction of ER 
stress in primary beta cells by Th1 cytokines affects the quantity and/or composition 
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of released EVs. Rat islets were incubated with or without low concentrations (10 
U/ml) of IL1β and IFNγ. We confirmed induction of ER stress in cytokine-treated 
primary beta cells by detecting upregulation and nuclear translocation of the 
transcription factor CHOP (2) (Figure 5A). 
 
Figure 5. Cytokine-induced ER stress does not affect the size and physical properties of 
exosomes released by rat pancreatic islets.  
(A) Primary pancreatic islet cells immunostained for the stress marker CHOP (left panels) and insulin 
and GAD65 (right panels), upon cytokine exposure for the indicated number of hours. Nuclei are stained 
in blue with DAPI. The progressive upregulation and nuclear translocation of the transcription factor 
CHOP indicates the induction of ER stress in treated cells. Scale bar: 30 μm. (B-C) Transmission 
electron microscopy and nanoparticle-tracking analyses on EVs isolated from untreated islets (B) and 
cytokine-treated islets (C). NTA indicates the presence of a uniform size distribution of EVs, with a 
similar major peak for untreated (141±4 nm) and cytokine-treated islets (144 ±10 nm). Scale bars: 200 
nm. 
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No differences in the morphology and size of vesicles from cytokine-treated 
and untreated islets were observed by TEM or NTA (Figure 5B and 5C). However, 
analyses of total protein content measured by BCA and the total number of EVs 
measured by NTA revealed a 2-3-fold increase in EVs released from cytokine-treated 
islets vs non-treated islets (Figure 6A and 6B).  
LC-MS/MS analyses of the protein profile of EVs isolated from cytokine-treated 
islets revealed upregulation of immunomodulatory proteins involved in the ER stress 
response. These included the chaperones Gp96, calreticulin and the hypoxia-
upregulated protein, ORP150, which were increased 2, 3 and 3.5-fold, respectively, 
in EVs from cytokine-treated compared to untreated islets (Figure 6C). These 
proteins have been shown to be highly immunogenic when they leave the ER and 
appear on the surface of cells or outside cells (48). In contrast, other proteins were 
found at similar concentrations in cytokine-treated vs. untreated preparations, 
including exosomal markers (CD9, CD81 and flotillin1), GAPDH, and proteins 
involved in the cytosolic stress response, such as Hsp90 (Figure 6C). WB analyses 
confirmed the induction of the ER-chaperones calreticulin and Gp96 in exosomes 
from cytokine-treated islets, while exosomes from untreated cells were negative. In 
contrast, the ER-chaperone protein disulfide isomerase (PDI), which can also be 
detected on the surface of cells and secreted from cells (49), was detected at similar 
levels in exosomes from treated and untreated islets, suggesting that induction of 
calreticulin, Gp96 and ORP150 in islet-exosomes by cytokines is a selective process. 
The concentrations of GAD65, IA-2, insulin and flotillin1, however, were similar in 
EVs from cytokine-treated and untreated islets although their total amount was 
increased commensurate with the increase in released EVs (Figure 6D and results 
not shown). The data presented here suggest that induction of ER stress in beta cells 
can result in targeting of selected immunostimulatory ER chaperones to exosomes. 
Furthermore, exosomes isolated from human islets treated with IL1β and IFNγ (20 
U/ml and 10 U/ml respectively) induced a stronger activation of the DR4+/+ BMDCs 
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compared to those isolated from untreated islets, as shown by secretion of the 
immunostimulatory cytokines IL6 and TNFα (Figure 6E-F). 
 
 
Figure 6. Th1 cytokine treatment results in increased exosome release and co-release of 
immunogenic chaperones by islets cells.  
(A-B) Release, over a total period of 6 days, of exosomes from cytokine-treated (10 U/ml IFNγ and 10 
U/ml IL1β) vs untreated rat islets shown as (A) particle concentration by nanoparticle tracking analyses 
and (B) total protein content by BCA. Bars represent quantitation of exosome secretion without (black 
bars) and with (grey bars) correction for the number of islets. Data are expressed as mean ± SD of 4 
independent experiments. Statistical analyses were performed using a paired t test  (p*<0.05, p**<0.01). 
(C) Ratio of LC-MS/MS analyses of EV proteins from cytokine treated and untreated rat islet cells 
showing cytokine-induced upregulation of proteins involved in the ER stress response. Data are 
expressed as mean ± SD of 3 independent experiments. Statistical analyses were performed using a 
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one-way ANOVA (p*<0.05, p***<0.001). (D) Western blot analyses of EVs isolated from cytokine treated 
and untreated rat islet cells showing specific induction of the ER chaperones Gp96, Calreticulin and 
ORP150 by cytokine treatment. Data are representative of 3 independent experiments. (E-F) Exosomes 
isolated from untreated and cytokine-treated human islets were incubated (50 μg/ml) with DR4+/+ 
BMDCs for 24h. CpG (5 μg/ml) was used as positive control. Activation of the BMDCs was assessed by 
secretion of the pro-inflammatory cytokines IL6 (E) and TNFα (F). Data are expressed as mean ± SEM 
(n=3) and are representative of 2 independent experiments. Statistical analyses were performed using a 
one-way ANOVA (p*<0.05, p***<0.001).  
 
4.5   DISCUSSION  
It is not known why the GAD65, IA-2 and insulin/proinsulin autoantigens in 
human T1D are so susceptible to becoming targets of autoimmunity, nor is it known 
how they initially attract the attention of the immune system. Notably, GAD65 and IA-
2 are scarce intracellular beta cell membrane proteins, which are processed in the 
ER and Golgi compartments before targeting to secretory pathways. IA-2 is a 
transmembrane proteins localized in the limiting membrane of large dense core 
insulin secretory vesicles, whereas GAD65 is a peripheral membrane protein found 
in the membrane of distinct smaller microvesicles (15). While mature insulin is 
present in sufficient amounts in the circulation to induce and maintain immunological 
tolerance, proinsulin is an intracellular beta cell protein targeted by autoimmunity in 
NOD mice and man (7,9). It has been proposed that the initiation of T1D 
autoimmunity follows a period of prolonged ER stress, induced by inflammatory 
cytokines, and resulting in apoptosis (47) and presentation of beta cell proteins to 
self-reactive T cells. The data presented here reveal that primary islets release 
immunogenic exosomes containing the beta cell intracellular autoantigens, GAD65 
and IA-2, and proinsulin. Hybrid peptides between proinsulin and other secretory 
granule proteins are targets of CD4 T cells in T1D and are implicated in loss of self-
tolerance to insulin in human T1D (8). 
As shown previously for exosomes from insulinoma cell lines (9), EVs from 
primary islets are rapidly and efficiently taken up by APCs resulting in their activation.  
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The exosomal markers flotillin1, CD9 and CD81 were detected in islet-EVs. 
The biogenesis pathway for exosomes expressing those markers may originate in 
the TGN and involve Rab11-controlled transport through recycling endosomes (10). 
The data presented here suggest that trafficking of GAD65 from TGN to exosomes 
may follow this pathway.  
Beta cells have an extensive and highly active ER, reflecting their role in 
synthesizing and secreting large amounts of insulin. The enormous protein synthesis 
capacity of beta cells, however, makes them markedly susceptible to ER stress. Th1 
cytokines secreted by inflammatory cells induce ER stress in beta cells (47). 
Disturbances in the normal function of the ER to modify and fold newly synthesized 
proteins results in induction of the unfolded protein response, which is aimed at 
restoring cell ER homeostasis but can eventually trigger apoptosis if an imbalance in 
the folding capacity persists. In this study we show that induction of ER stress by pro-
inflammatory cytokines results in a 2-3 fold increase in exosome secretion by islet 
cells and consequently the proteins in them. We have recently shown (18) that ER 
stress induced by three different regimens results in perturbation of the palmitoylation 
cycle controlling GAD65 endomembrane distribution and accumulation of an 
immunogenic palmitoylated form of the protein in TGN membranes. We propose that 
aberrant trafficking during ER stress diverts more GAD65 to the exosomal pathway 
to maintain a similar concentration of the protein in exosomes during increased 
secretion.  
Different possibilities can be suggested to explain the increased release in EVs 
from beta cells in ER stress conditions. First, exosomes have been suggested to play 
a role in intercellular communication (10), and increased secretion may serve to 
signal ER stress conditions to neighboring cells. Second, exosomes may be a 
vehicle for disposing of cell material that is not needed or desirable for optimal 
responses to ER stress in a cell seeking to regain homeostasis.  
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Cytokine treatment also resulted in a change in the composition of EVs. 
Whereas the composition and relative quantity of autoantigens and exosome 
markers were similar with and without cytokine treatment, the latter resulted in a co-
release of ER-chaperone proteins known to act as strong pro-inflammatory 
molecules (50,51). These proteins, calreticulin, Gp96 and ORP150, can be found 
outside the ER, on the cell surface and released extracellularly (48). They are known 
for their role in triggering immune responses by promoting phagocytosis and/or by 
directly exerting adjuvant capacity (48,51). Some of these ER proteins or antibodies 
to them have been implicated in autoimmunity (52). It is possible that islet-exosomes 
carrying a combination of autoantigens and pro-inflammatory signals may be 
particularly immunogenic. 
We considered the possibility that the ER chaperones detected in exosome 
preparations from stressed beta cells originated from ER microsomes generated 
during cytokine-induced islet cell death that coincidentally co-purified with exosomes. 
While this possibility cannot be formally excluded, several factors argue against a 
significant contribution of ER-derived microsomes to our EV preparations. First, the 
relative amount of exosomal markers and autoantigens in EVs was similar with and 
without cytokine treatment. Thus a dilution effect of contaminating microsomes was 
not observed. Second, in contrast to the immunogenic ER chaperones mentioned 
above, the relative amount of PDI, an ER chaperone, which is not associated with 
induction of immunogenicity (53) (Schild and Rammensee personal communication), 
was not increased in EVs by cytokine treatment, suggesting that only specific ER 
proteins were enhanced. Third, the morphology and size of exosomes remained 
similar with cytokine treatment, consistent with a lack of the heterogeneity, which 
would be expected with addition of ER microsomes. 
The pathway involved in transport of ER proteins into exosomes under stress 
conditions has not been elucidated. Islet-EVs were particularly enriched in Rab1, 
which is involved in vesicle transport from ER-to-Golgi membranes. During 
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immunogenic cell death, calreticulin undergoes an ER-to-Golgi anterograde transport 
(54). An ER-to-Golgi anterograde transport of the ER proteins in conditions of ER 
stress would be consistent with a Golgi origin of some islet-exosomes and a 
trafficking pathway where autoantigens, exosome markers and heat shock proteins 
assemble in exosomes. Alternatively, as several studies have identified contact sites 
and interaction between ER membranes and endosomal compartments (55) 
including MVBs (56), it is possible that the ER chaperones are transported directly 
from the ER to endosomal compartments. Cytokine treatment of mouse islets to 
induce ER stress has also been shown to result in a detection of another ER 
chaperone, glucose-regulated protein 78 (GRP78), in the plasma membrane of 
primary islet cells and GRP78 was detected in the medium of cytokine treated INS-
1E cells. These findings support the notion that inflammatory conditions induced by 
IL1b and IFNg may results in aberrant surface location and secretion of some ER 
chaperones. Interestingly, cytokine treatment was also shown to result in citrullination 
of GRP78 and targeting of a citrullinated peptide by both B cells and T cells in NOD 
mice (57). Thus, additional studies are important for identification of potential post-
translational modifications of ER chaperones and autoantigens associated with islet-
exosomes in order to better understand their contribution to the induction of 
autoimmunity.  
Islet derived EVs are rapidly and efficiently taken up by APCs expressing the 
T1D susceptibility haplotype DRB1*0401, resulting in their activation. To investigate 
the potential auto-antigenicity of islet-exosomes, we adopted an established GAD65-
specific T cell assay using DR4+/+APCs and a DR4-restricted GAD65 specific T cell 
hybridoma (25). The amount of GAD65 required for antigen specific stimulation of 
T33.1 cells could not be achieved from the limited amount of exosomes that can be 
obtained from primary islets. Instead, we developed a platform where purified GAD65 
was bound to liposomes approximating the size and lipid composition of islet-
exosomes. APCs loaded with GAD65 liposomes were 1-2 orders of magnitude more 
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efficient in inducing activation of autoreactive T cells compared to the free antigen. 
Furthermore, preliminary experiments revealed that compared to ovalbumin, 
calreticulin enhances the stimulatory effect of GAD65-liposomes on BMDCs and 
activation of GAD65 specific T33.1 cells (Supporting Figure 4).   
The engineered platform based on exosome mimetics presents an initial 
attempt to assess the immunogenic potential of GAD65 in lipid membranes with 
some characteristics of exosomes and it is not perfect. For instance, the liposomes 
carry GAD65 on the surface rather than on the luminal face, which is more likely the 
position of GAD65 in exosomes. Furthermore, the immunogenicity of natural 
exosomes is likely the results of a particular compositions of proteins and lipids, 
some enhancing the uptake and presentation by APCs, others functioning as 
accessory molecules in the immune response. However, the reductionist approach of 
the liposomal platform can be explored to investigate the role of individual 
components in APC activation and antigen presentation. With further development, 
exosome-mimetics may become useful as therapeutic strategy to generate tolerance 
versus immunity to GAD65 and other autoantigens, when combined with molecules 
with known anti-inflammatory properties. 
In conclusion, we propose (Figure 7) that the release of the autoantigens 
GAD65, IA-2 and insulin/proinsulin in exosomes from pancreatic beta cells may play 
a role in triggering autoimmunity, especially in pro-inflammatory conditions eliciting 
ER stress and dysfunction, with consequent co-release of immunostimulatory ER 
chaperones.  With time it may become feasible to test the role of immunogenic 
chaperones using natural exosomes isolated from primary islets exposed to 
inflammatory stress. This approach may benefit from first testing the in vitro 
stimulatory effect on T cells specific for the more abundant exosomal autoantigens 
proinsulin and/or insulin and then taking advantage of the NOD mouse for in vivo 
studies targeting these proteins.  
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Figure 7. Proposed schematic model of combined release of autoantigens and pro-inflammatory 
ER proteins in beta cell exosomes under cytokine-induced ER stress conditions.  
ER stress can be induced in pancreatic beta cells by Th1 cytokines and other inflammatory factors, 
leading to upregulation of ER proteins involved in the unfolded protein response, and possibly their 
translocation to the Golgi. Once in the Golgi, these ER proteins can be transferred, loaded into the ILVs 
of MVBs, and released in exosomes. A localization in common between the islet autoantigens during 
their biosynthesis pathway is the Golgi compartment, thus their loading into exosomes, together with ER 
proteins is a possibility. In addition, ER stress can induce an increase in the amount of exosomes 
released by pancreatic beta cells. ER proteins outside the cell may be recognized as danger signals by 
APC, leading to cell activation and phagocytosis of autoantigen-containing exosomes. This may result in 
autoantigens being processed and presented to self-reactive T cells, triggering autoimmunity against 
pancreatic beta cells. (ER, Endoplasmic Reticulum; EE, Early Endosome; RE, Recycling Endosome; 
MVB, Multivesicular Body; ILVs, Intraluminal Vesicles; APC, Antigen Presenting Cell; TCR, T Cell 
Receptor). 
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4.7   SUPPLEMENTARY INFORMATION 
?
 
Pathway Protein Uniprot Matched Uniprot Matched Reference 
Accession 
Number 
Unique  Peptides Accession 
Number 
Unique Peptides 
Rat islets INS-1E  Human islets 
 
Cytoskeleton 
associated Beta tubulin P69897 26 22 P68371 20 (1) 
Alpha Tubulin Q6P9V9 27 16 P68363 18 (2) 
Actin P63259 44 24 P63261 30 (3) 
Moesin F1LP60 19 1 P26038 17 (3) 
Ezrin P31977 3 0 P15311 35 (4) 
Profilin1 P62963 5 3 P07737 6 (5) 
Cofilin1 P45592 5 8 P23528 9 (1) 
 
 
Signaling 14-3-3 protein zeta/delta P63102 26 12 P63104 12 (1) 
14-3-3 protein epsilon P62260 12 8 P62258 8 (3) 
Elongation factor 1-alpha 1 P62630 16 14 P68104 18 (6) 
 
Membrane trafficking Annexin 2 Q07936 11 0 P07355 25 (6) 
Annexin 6 D4ABR6 15 0 P08133 35 (7) 
Rab1 E9PU16 5 3 P62820 3 (8) 
Rab11a P62494 10 2 P62491 4 (9) 
Rab27a P23640 2 0 H3BN55 3 (10) 
Rab27b Q99P74 5 0 O00194 0 (10) 
Rab35 Q5U316 2 1 F5H157 2 (11) 
Flotillin1 Q9Z1E1 2 0 O75955 0 (12) 
Clathrin heavy chain F1M779 67 89 Q00610 52 (2) 
 
 
Tetraspanins CD9 P40241 1 0 A6NNI4 2 (13) 
CD81 Q6P9V1 3 5 A6NMH8 3 (6) 
 
Late endosome/  
Lysosome LAMP1 P14562 1 1 P11279 4 (13) 
 
 
Enzymes GAPDH P04797 13 16 P04406 22 (2) 
Pyruvate kinase M2 isoform P11980-2 18 17 P14618 29 (2) 
 
Heat shock response Hsc70 P63018 24 37 E9PKE3 19 (1) 
Hsp70 Q07439 12 2 P08107 15 (4) 
Hsp90alpha P82995 3 4 P07900 18 (3) 
Hsp90beta P63018 7 14 P08238 13 (3) 
 
Beta cell islet antigen Insulin1 P01322 7 12 P01308 20 
Insulin2 P01323 4 11 
 
Supplementary Table 1. Proteins identified by LC-MS/MS analysis in EV preparations from rat 
pancreatic islets, INS-1E cells and human pancreatic islets.  
The right column shows references for identification of each protein in exosomal preparations from other 
cell types. 
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Supplementary Figure 1. Analyses of protein expression in exosomes isolated from primary 
islets or insulinoma cells. 
(A) Uncropped scan related to the cropped scan of a Western blot showing GAD65/GAD67 in rat and 
human islets and exosomes in Figure 1. The uncropped Western blot shows rat, mouse and human islet 
proteins, rat and human exosome proteins and rat and mouse insulinoma protein immunostained using 
the GAD1701 antiserum that recognizes both GAD65 and GAD67. Rat islets express both GAD65 and 
the non-autoantigenic isoform GAD67 (left panel), while human islets only express the GAD65 isoform 
of GAD (right panel). Mouse islets and rat INS-1E cells only express GAD67, while mouse MIN6 cells 
express neither GAD isoform (left panel). Human recombinant GAD65, rat brain lysate and rat islet 
lysate were used as positive controls. (B) Uncropped scan related to the cropped scan of a Western blot 
showing human IA-2 in human islets and exosomes in Figure 1E. The Western blot of human islet and 
exosome proteins was immunostained with the 76F-B4 mouse monoclonal antibody to IA-2. (C) 
Western blot of rat islet exosome proteins, rat islet proteins, and rat insulinoma cell line INS-1E 
exosome proteins immunostained with a monoclonal antibody to the exosomal marker Alix. (A-C) Data 
are representative of 2-5 independent experiments. 
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Supplementary Figure 2. Uptake of islet exosomes by BMDCs and Priess B cells. 
Pancreatic islet derived-EVs were labeled with Bodipy-Ceramide and added at the concentration of 25 
μg/ml to 100,000 CFSE-labeled DR4+/+ BMDCs (A, C) or DR4+/+ human Priess B cells (B, D). After five 
hours of incubation, cells were analyzed by live cell imaging (A, B) and flow cytometry (C, D). Confocal 
acquisitions of CFSE (green), Bodipy-Ceramide (red) and bright field channels show that both DCs (A) 
and B cells (B) are positive for Bodipy-Ceramide. In addition, a very high percentage (around 99%) of 
BMDCs cells (C) and B cells (D) are Bodipy-Ceramide-positive by flow cytometry. Analyses of BMDCs 
were performed on the cell population positive for the CD11c antigen expressed by mature dendritic 
cells. Scale bars: 30 μm. 
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4.8   SUPPORTING INFORMATION 
Supporting Figure 1. Cell viability of untreated and cytokine-treated rat islets. 
(A) Rat islets were seeded in 10 cm Petri dishes (~500 islets/plate) and half of them were treated with 
10 U/ml of rIL1β and 10 U/ml of rIFNγ for a total of 6 days. Supernatants were collected every two days 
for exosome isolation. Cell viability was assessed every 3 days by collecting a sample of islets from 
each dish. A pool of ~30 islets was dissociated with Trypsin/EDTA followed by a dilution in fresh 
medium containing serum.  Cells were then stained immediately by Trypan Blue and live vs dead cells 
counted in a counting chamber. Results are reported as mean ± SD (n=5 different cell countings per 
group). (B) Rat islet single cells prepared as described above were treated or not with either 10 U/ml of 
rIL1β and 10 U/ml of rIFNγ for 24h or 100 μM of the apoptosis inducing compound camptothecin for 4h. 
Cell viability was assessed by confocal microscope analyses using the Annexin V Apoptosis detection 
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kit (Invitrogen). Results are reported as mean ± SD (n=6 different fields per group). Statistical analyses 
were performed using a one-way ANOVA analysis (p***<0.001). 
 
Supporting Figure 2. Cell viability of untreated and cytokine-treated human islets. 
(A) Human islets were seeded in Petri dishes (~500 islets/plate) and half of them was treated with 20 
U/ml of hIL1β and 10 U/ml of hIFNγ for a total of 6 days. Supernatants were collected every two days for 
exosome isolation. Cell viability was assessed every 3 days by collecting a sample of islets from each 
dish. A pool of ~30 islets was dissociated with Trypsin/EDTA followed by dilution in fresh medium 
containing serum. Cells were stained immediately by Trypan Blue and live vs dead cells counted using a 
counting chamber. Results are reported as mean ± SD (n=5 different cell countings per group). (B) 
Human islet single cells, prepared as described above, were treated or not with 20 U/ml of hIL1β and 10 
U/ml of hIFNγ for 24h or 100 μM of the apoptosis inducing compound camptothecin for 4h. Cell viability 
was assessed by confocal microscope analyses using the Annexin V Apoptosis detection kit 
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(Invitrogen). Results are reported as mean ± SD (n=6 different fields per group). Statistical analyses 
were performed using a one-way ANOVA analysis (p***<0.001).  
Supporting Figure 3. Detection of GAD65 and IA-2 in human islet-exosomes by LC-MS/MS. 
Five μg of human islet-exosomes or human islet-lysate were separated on a denaturing 4-12% 
polyacrylamide gradient gel. (A) Gel slices were excised in the indicated areas and proteins were eluted 
and analyzed by LC-MS/MS. (B) Number of exclusive unique peptides identified for GAD65 and IA-2, 
showing the presence of both proteins in human islet-exosomes. (C) In order to define the threshold of 
detection of GAD65 by mass spectrometry, increasing amounts of recombinant human GAD65 (0.5 ng-1 
μg) were analyzed in solution by LC-MS/MS. The amount of GAD65 in islet-exosomes was estimated by 
quantitative Western Blotting using serial dilutions of recombinant hGAD65 as a positive standard. Data 
show the limitations in detecting GAD65 by MS, which is likely due to its hydrophobicity and poor 
peptide ionization. While protein amounts of ≥5 ng are clearly identifiable by LC-MS/MS, the amount of 
GAD65 in 5 μg of islet-exosomes (2.5 ng) is close to the boundary of detection. The pre-purification step 
of exosome lysate by SDS-PAGE, however, improves the detection of GAD65 and also enables the 
detection of IA-2. 
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Supporting Figure 4. Enhanced immunogenicity of GAD65-exosome mimetics in presence of the 
ER chaperone Calreticulin. 
Activation of BMDCs (A-E) and GAD65 specific T33.1 T cells (F) by 1, 2.5 and 5 μg/ml of liposome 
bound GAD65 combined with 10 μg/ml purified endotoxin-free recombinant calreticulin or ovalbumin 
(OVA). PBS, empty liposomes, CpG (5 μg/ml) and the GAD274-286 peptide (0.5 μg/ml) were used as 
negative and positive controls respectively. (A-B) Flow cytometry analyses of BMDC expression of the 
costimulatory molecules CD80 and CD86 (A) and HLA-class II DR antigen expression (B). (C-E) ELISA 
analysis of TNFα (C), IL6 (D) and IL1β (E) secretion by BMDCs. (A-E) Data show the BMDC stimulation 
by calreticulin compared to the negative control protein OVA. The stimulation of BMDCs is not antigen 
dependent. (F) ELISA analysis of IL2 secretion by T33.1 T cells, showing significantly increased 
activation by liposomal GAD65 in combination with calreticulin versus OVA. Analyses were performed in 
technical triplicates. A one-way ANOVA was used for statistical analyses (p*<0.05; p***<0.001). 
Immunogenic properties of calreticulin were observed in four different independent experiments. 
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CHAPTER 5 
Conclusion 
5.1   SUMMARY AND DISCUSSION  
T1D is an autoimmune disease characterized by T cell infiltration in the islets of 
Langerhans and destruction of insulin-producing beta cells. The multifactorial aspect 
of the disease makes the research on the biological mechanisms implicated in the 
development of autoimmunity highly complex and challenging. Although much 
progress has been achieved and several biological predictive biomarkers of the 
disease are now known, a comprehensive and complete view including all the 
causes involved in the onset of the disease is not available yet.  
In addition to identified anomalies in the immune system of T1D patients (1), a 
recent and recognized key factor in the initiation of autoimmunity directly involves the 
tissue that is target of the disease, particularly the pancreatic beta cells (2-4). The 
enormous protein synthesis capacities of these cells makes them highly susceptible 
to stress, leading to the initiation of self-defense processes that can either restore the 
normal cell function and homeostasis or lead to a cell “suicide”, which could attract 
the attention of the immune system. 
The purpose of my thesis was to give a close look at beta cells in order to find 
out which potential intracellular abnormalities and pathways might be responsible for 
making beta cell antigens so vulnerable for the attack of the immune system.  
Thus, having the opportunity of looking inside a beta cell, with such a level of 
resolution that permits to visualize trafficking of autoantigens, is of high importance 
for investigating the pathogenesis of T1D. In the first manuscript (Chapter 2) we 
described a method that allows for the successful culture of monolayers of pancreatic 
islet cells. Although culturing techniques in 2D systems have been extensively 
reported for many different cell types, several difficulties have been encountered with 
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primary pancreatic islets. These mini-organs are indeed constituted by cells that work 
in close operation to maintain their homeostasis, and they usually loose their 
properties or do not survive when they are dissociated and separated from each 
other. We identified key factors (such as medium constituents and specific ECM 
molecules) that allow beta cells to survive after their dissociation, maintain their 
phenotype, adhere and spread well on surfaces. This allows the visualization of 
subcellular phenomena and details that could have not been observed in conditions 
where instead the cells look rounded and unhealthy. Also, this method represents the 
first successful attempt in culturing pancreatic islet cells not only on plastic 
coverslips, but also on glass surfaces, condition that is required for the application of 
super resolution imaging techniques such as STED. 
Therefore, the protocol for culturing monolayer of pancreatic islet cells 
described here might represent a breakthrough in the field of beta cell biology. This 
method could be useful not only for all the scientists studying T1D, but also for those 
focused on Type 2 Diabetes (T2D), another worldwide multifactorial disease affecting 
pancreatic beta cells and characterized by insulin resistance (5). 
Moreover, this method allowed us to identify a cilia-centric mechanism of beta 
cell proliferation. We discovered that culture conditions capable of boosting beta cell 
spreading, such as switching from low to high glucose concentration combined with 
serum starvation and its reintroduction, are capable of inducing reabsorption of 
primary cilia in beta cells, which are then stimulated to proliferate. Similarly to the 
protocol for monolayer islet cell culture, the method of cilia disassembly proposed in 
Chapter 2 might be of inspiration for many people working on T1D and T2D. 
Restoring beta cell mass and function through induction of beta cell proliferation is 
currently one of most investigated alternatives to overcome the issue of insulin 
deficiency that affects both types of Diabetes (6).  
Our method for culturing islet monolayer also allowed us to perform high-
resolution microscopy studies on beta cells and obtain most of the results reported in 
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the other two manuscripts (Chapters 3 and 4), which illustrate two interconnected 
mechanisms that could be responsible for the initiation of autoimmunity in T1D. 
The first one (Chapter 3) shows how ER stress induced by pro-inflammatory 
factors or a saturated fatty acid can block the palmitoylation cycle of the antigen 
GAD65, leading to an accumulation of the palmitoylated form of the protein in the 
Golgi compartment. Furthermore, we show that the palmitoylated form of GAD65 is 
more immunogenic and can stimulate a stronger activation of GAD65-specific T cells 
compared to the form not carrying this post-translation modification. Since 
palmitoylation facilitates the interaction of proteins with cell membranes, the 
increased immunogenicity of the palmitoylated form of GAD65 is probably due to the 
fact that, once released in the extracellular space, the antigen has a stronger affinity 
for the plasma membrane of APCs and is taken up by more efficiently.  
In addition, aberrant trafficking of GAD65 seems to be an active phenomenon 
during development of autoimmunity in T1D: immunostaining on human pancreatic 
sections from pre-diabetic GAD65-autoantibody positive individuals and patients with 
ongoing T cell infiltration in the islets reveals a significantly higher accumulation of 
GAD65 in the Golgi compartment compared to healthy controls.  
Accumulation of GAD65 in trans-Golgi membranes might also be involved in 
another biological mechanism implicated in the initiation of autoimmunity, which is 
illustrated in the third and last manuscript (Chapter 4). Specifically beta cells seem to 
secrete autoantigens in a subtype of exosomes involving a biogenesis pathway 
originating in the trans-Golgi network and intersecting with recycling endosomes and 
Rab11.  
Our work represents the first extensive characterization of exosomes and their 
protein content isolated from primary human and rat pancreatic islet cells. Given the 
limited availability of primary islets of Langerhans in general and human islets in 
particular, this study is probably unique at this time. We show that both human and 
rat islet-exosomes contain major autoantigens in T1D, insulin, proinsulin, GAD65 and 
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IA-2. Some of these autoantigens are intracellular proteins normally not visible by the 
immune system; therefore, their release into the extracellular space in exosomes 
may represent a route of exposure to the immune system and a possible mechanism 
underlying the initiation of autoimmunity in T1D. 
Interestingly, the release of exosomes, and consequently the amount of 
autoantigens contained in them, is enhanced when primary pancreatic islets are 
exposed to pro-inflammatory cytokines. Since a strong connection between Th1 
cytokines and induction of ER stress in beta cells has been observed by our group 
and others (7,8), it is likely that ER stress by itself may be responsible for the 
increased exosome release, but this aspect was not directly investigated in our work. 
In addition, pro-inflammatory cytokines strongly induce or upregulate the presence in 
exosomes of chaperones resident in the ER and involved in ER stress response, 
such as calreticulin, gp96 and ORP150. In addition to their role in restoring the 
correct protein folding and homeostasis in cell stress conditions, these chaperones, 
once released in the extracellular space, can act as “danger signals” and initiate 
inflammatory immune responses (9,10). 
We also show that islet-exosomes can be efficiently taken up by APCs, such as 
BMDCs and B lymphocytes. Furthermore, activation of dendritic cells is enhanced 
when these APCs are incubated with exosomes from cytokine-treated islets 
compared to those isolated from untreated islets, suggesting that the presence of 
pro-inflammatory ER chaperones may be responsible for the increased exosome 
immunogenicity. 
In addition to an effect of exosomes on the innate branch of the immune 
system, the presence of autoantigens in islet-exosomes may also enhance activation 
of an adaptive immune response. To test this hypothesis, we took advantage of an 
established in vitro assay constituted by GAD65-specific T cells and BMDCs carrying 
the HLA class II DR4.? While this system works very well when the antigen is 
administered in a pure context (see for instance Chapter 3.3.4), two major issues do 
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not make this assay ideal for investigating more complex biological scenarios and 
conditions (including islet-lysates and islet-exosomes): first, the limited sensitivity due 
to which relatively high protein concentrations are required to induce a T cell 
response, and second, the presence of other proteins and possibly other beta cell 
antigens that might compete for uptake and presentation. 
Thus, in order to analyze the immunogenicity of the autoantigen GAD65 
associated to biological EVs, we engineered a liposome-based system mimicking the 
features of the natural exosomes, and to which we anchored the GAD65 
recombinant protein. We used this system to test the T cell activation induced by 
GAD65-exosome mimetics compared to a scenario in which the protein is present as 
free antigen. In order to make a direct and reliable comparison between these two 
conditions, we administered the same exact concentrations of protein (both unbound 
and liposome-bound). In this manner, we were able to show that the T cell activation 
is about 50 times more efficient when GAD65 is bound to the exosome-mimetics 
compared to when is present as free protein. This system also allowed us to 
investigate the contribution of the ER chaperone calreticulin in increasing the 
immunogenicity of the GAD65-exosome mimetics. In this way, we observed that 
adding calreticulin (but not a control protein like OVA) to the GAD65-liposomes not 
only boosts the activation of the BMDCs used as APCs but also of the GAD65 
autoreactive T cells.  
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5.2   FUTURE DIRECTIONS  
The engineered platform based on exosome mimetics constitutes an initial 
attempt to assess the immunogenic potential of autoantigens associated to lipid 
membranes with some features of exosomes and has its limitations. For instance, 
the liposomes carry GAD65 on the surface rather than on the luminal face, which is 
more likely the position of GAD65 in exosomes. Furthermore, the immunogenicity of 
exosomes is likely the results of a particular compositions of proteins and lipids, 
some enhancing the uptake and presentation by APCs, others functioning as “danger 
signal” molecules in the immune response. However, the reductionist approach of 
the liposomal platform represents a reproducible and useful tool to explore the role of 
individual components in APC activation and antigen presentation. When combined 
with molecules with known anti-inflammatory properties, exosome-mimetics may 
become useful as therapeutic strategy to generate tolerance versus immunity to 
GAD65 and other autoantigens.  
Finally, the discovery that pro-inflammatory ER chaperones can be released in 
association to exosomes, especially under cytokine-induced stress conditions, opens 
the possibility for investigating novel pharmaceutical approaches to prevent or cure 
T1D. For instance, administration of antibodies or blocking peptides against CD91, a 
known receptor for calreticulin and gp96 (11) that is highly expressed on 
macrophages (12) and a subtype of dendritic cells (13,14), could be exploited as a 
therapeutic strategy to prevent the uptake and activation of APCs by islet-exosomes.  
 
?
?
?
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